<div id="page0" style="width:595.3pt;height:793.7pt">
<p style="top:749.7pt;left:46.5pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">162</span></b><span style="font-family:Lato,serif;font-size:7.0pt"> &#x2003;</span><sup><span style="font-family:Lato,serif;font-size:8.2pt">|</span></sup><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003; </span><span style="font-family:Lato,serif;font-size:7.0pt"> </span></p>
<p style="top:750.7pt;left:244.9pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">wileyonlinelibrary.com/journal/jcpe </span></p>
<p style="top:750.7pt;left:405.7pt;line-height:7.0pt"><i><span style="font-family:Lato,serif;font-size:7.0pt">J Clin Periodontol. </span></i><span style="font-family:Lato,serif;font-size:7.0pt">2019;46(Suppl. 21):162&#x2013;182.</span></p>
<img style="position:absolute;transform:matrix(.31940789,0,-0,.3187552,506.8864,53.995538)" src="data:image/jpeg;base64,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">
<p style="top:749.7pt;left:75.2pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">&#xa9; 2019 John Wiley &amp; Sons A/S. </span></p>
<p style="top:759.7pt;left:75.2pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Published by John Wiley &amp; Sons Ltd</span></p>
<p style="top:620.4pt;left:46.5pt;line-height:10.0pt"><b><span style="font-family:Lato,serif;font-size:10.0pt">1&#x2003;</span></b><span style="font-family:Lato,serif;font-size:10.0pt">|</span><b><span style="font-family:Lato,serif;font-size:10.0pt">&#x2003;INTRODUCTION</span></b></p>
<p style="top:647.6pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Reconstruction of oral and maxillofacial bone deficiencies is often a </span></p>
<p style="top:660.6pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">clinical challenge. Ridge remodelling following tooth loss is the most </span></p>
<p style="top:673.6pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">common cause for alveolar bone deficiencies in the horizontal and/</span></p>
<p style="top:686.6pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">or vertical dimensions (Chiapasco &amp; Casentini, 2018; Rocchietta, </span></p>
<p style="top:699.6pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Ferrantino, &amp; Simion, 2018), and in the posterior edentulous max-</span></p>
<p style="top:712.6pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">illa, this is further complicated by pneumatization of the maxillary </span></p>
<p style="top:725.6pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">sinus(es) (Corbella, Weinstein, Francetti, Taschieri, &amp; Del Fabbro, </span></p>
<p style="top:622.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">2017; Danesh- Sani, Engebretson, &amp; Janal, 2017). More challenging </span></p>
<p style="top:635.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">segmental defects, which include the inferior mandibular border, </span></p>
<p style="top:648.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">often result from trauma, tumour resection, or radiation- related os-</span></p>
<p style="top:661.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">teonecrosis (Chanchareonsook, Junker, Jongpaiboonkit, &amp; Jansen, </span></p>
<p style="top:674.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">2014). Further, congenital anomalies are frequently associated </span></p>
<p style="top:687.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">with alveolar defects such as orofacial clefts involving the maxilla </span></p>
<p style="top:700.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(Janssen, Weijs, Koole, Rosenberg, &amp; Meijer, 2014).</span></p>
<p style="top:713.0pt;left:320.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Several regenerative surgical approaches have been proposed </span></p>
<p style="top:726.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">to prevent and/or reconstruct alveolar defects, most commonly, </span></p>
<p style="top:1.1pt;left:44.8pt;line-height:12.0pt"><span style="font-family:STIX,serif;font-size:12.0pt"> </span></p>
<p style="top:31.2pt;left:46.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Received: 6 August 2018&#x2003;</span><span style="font-family:Lato,serif;font-size:9.6pt"> |</span><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003; Revised: 17 October 2018&#x2003;</span><span style="font-family:Lato,serif;font-size:9.6pt"> |</span><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003; Accepted: 26 October 2018</span></p>
<p style="top:45.7pt;left:46.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">DOI: 10.1111/jcpe.13049</span></p>
<p style="top:71.2pt;left:46.5pt;line-height:9.0pt"><span style="font-family:Lato,serif;font-size:9.0pt">S U P P L E M E N T  A R T I C L E</span></p>
<p style="top:100.0pt;left:46.5pt;line-height:18.0pt"><b><span style="font-family:Lato,serif;font-size:18.0pt">Cell therapy for orofacial bone regeneration: A systematic </span></b></p>
<p style="top:123.0pt;left:46.5pt;line-height:18.0pt"><b><span style="font-family:Lato,serif;font-size:18.0pt">review and meta- analysis</span></b></p>
<p style="top:168.3pt;left:46.5pt;line-height:12.0pt"><b><span style="font-family:Lato,serif;font-size:12.0pt">Siddharth Shanbhag</span></b><sup><b><span style="font-family:Lato,serif;font-size:8.4pt">1</span></b></sup></p>
<p style="top:168.3pt;left:171.6pt;line-height:12.0pt"><b><span style="font-family:Lato,serif;font-size:12.0pt">&#x2003;</span></b><span style="font-family:Lato,serif;font-size:12.0pt">|</span><b><span style="font-family:Lato,serif;font-size:12.0pt">&#x2003;Salwa Suliman</span></b><sup><b><span style="font-family:Lato,serif;font-size:8.4pt">1</span></b></sup><b><span style="font-family:Lato,serif;font-size:12.0pt">&#x2003;</span></b><span style="font-family:Lato,serif;font-size:12.0pt">|</span><b><span style="font-family:Lato,serif;font-size:12.0pt">&#x2003;Nikolaos Pandis</span></b><sup><b><span style="font-family:Lato,serif;font-size:8.4pt">2</span></b></sup><b><span style="font-family:Lato,serif;font-size:12.0pt">&#x2003;</span></b><span style="font-family:Lato,serif;font-size:12.0pt">|</span><b><span style="font-family:Lato,serif;font-size:12.0pt">&#x2003;Andreas Stavropoulos</span></b><sup><b><span style="font-family:Lato,serif;font-size:8.4pt">3</span></b></sup></p>
<p style="top:168.3pt;left:535.7pt;line-height:12.0pt"><b><span style="font-family:Lato,serif;font-size:12.0pt">&#x2003;</span></b><span style="font-family:Lato,serif;font-size:12.0pt">|</span><b><span style="font-family:Lato,serif;font-size:12.0pt">&#x2003; </span></b></p>
<p style="top:188.3pt;left:46.5pt;line-height:12.0pt"><b><span style="font-family:Lato,serif;font-size:12.0pt">Mariano Sanz</span></b><sup><b><span style="font-family:Lato,serif;font-size:8.4pt">4</span></b></sup></p>
<p style="top:188.3pt;left:137.4pt;line-height:12.0pt"><b><span style="font-family:Lato,serif;font-size:12.0pt">&#x2003;</span></b><span style="font-family:Lato,serif;font-size:12.0pt">|</span><b><span style="font-family:Lato,serif;font-size:12.0pt">&#x2003;Kamal Mustafa</span></b><sup><b><span style="font-family:Lato,serif;font-size:8.4pt">1</span></b></sup></p>
<p style="top:225.5pt;left:46.5pt;line-height:4.9pt"><span style="font-family:Lato,serif;font-size:4.9pt">1</span><span style="font-family:Lato,serif;font-size:7.0pt">Department of Clinical Dentistry, Center </span></p>
<p style="top:236.9pt;left:46.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">for Clinical Dental Research, University of </span></p>
<p style="top:246.9pt;left:46.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Bergen, Bergen, Norway</span></p>
<p style="top:259.0pt;left:46.5pt;line-height:4.9pt"><span style="font-family:Lato,serif;font-size:4.9pt">2</span><span style="font-family:Lato,serif;font-size:7.0pt">Department of Orthodontics and </span></p>
<p style="top:270.4pt;left:46.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Dentofacial Orthopedics, University of Bern, </span></p>
<p style="top:280.4pt;left:46.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Bern, Switzerland</span></p>
<p style="top:292.5pt;left:46.5pt;line-height:4.9pt"><span style="font-family:Lato,serif;font-size:4.9pt">3</span><span style="font-family:Lato,serif;font-size:7.0pt">Department of Periodontology, Faculty </span></p>
<p style="top:303.9pt;left:46.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">of Odontology, Malm&#xf6; University, Malm&#xf6;, </span></p>
<p style="top:313.9pt;left:46.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Sweden</span></p>
<p style="top:326.0pt;left:46.5pt;line-height:4.9pt"><span style="font-family:Lato,serif;font-size:4.9pt">4</span><span style="font-family:Lato,serif;font-size:7.0pt">Section of Periodontology, Faculty of </span></p>
<p style="top:337.4pt;left:46.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Odontology, University Complutense of </span></p>
<p style="top:347.4pt;left:46.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Madrid, Madrid, Spain</span></p>
<p style="top:367.4pt;left:46.5pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">Correspondence</span></b></p>
<p style="top:377.4pt;left:46.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Kamal Mustafa, Department of Clinical </span></p>
<p style="top:387.5pt;left:46.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Dentistry &#x2013; Tissue Engineering group, </span></p>
<p style="top:397.5pt;left:46.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Faculty of Medicine, University of Bergen, </span></p>
<p style="top:407.5pt;left:46.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Bergen, Norway.</span></p>
<p style="top:417.5pt;left:46.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Email: kamal.mustafa@uib.no</span></p>
<p style="top:434.0pt;left:46.5pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">Funding information</span></b><span style="font-family:Lato,serif;font-size:7.0pt"> </span></p>
<p style="top:444.0pt;left:46.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">This review was supported by funding </span></p>
<p style="top:454.0pt;left:46.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">from Helse Vest, Norway (project number: </span></p>
<p style="top:464.0pt;left:46.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">912048 K.M.), and the Bergen Stem Cell </span></p>
<p style="top:474.0pt;left:46.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Consortium (project number: 502027, K.M.)</span></p>
<p style="top:232.0pt;left:209.2pt;line-height:10.0pt"><b><span style="font-family:Lato,serif;font-size:10.0pt">Abstract</span></b></p>
<p style="top:247.8pt;left:209.2pt;line-height:9.0pt"><b><span style="font-family:Lato,serif;font-size:9.0pt">Aim: </span></b><span style="font-family:Lato,serif;font-size:9.0pt">The objective of the present review was to answer the focused question: what </span></p>
<p style="top:262.8pt;left:209.2pt;line-height:9.0pt"><span style="font-family:Lato,serif;font-size:9.0pt">is the effect of cell therapy in terms of orofacial bone regeneration compared to </span></p>
<p style="top:277.8pt;left:209.2pt;line-height:9.0pt"><span style="font-family:Lato,serif;font-size:9.0pt">grafting with only biomaterial scaffolds and/or autogenous bone?</span></p>
<p style="top:292.8pt;left:209.2pt;line-height:9.0pt"><b><span style="font-family:Lato,serif;font-size:9.0pt">Methods: </span></b><span style="font-family:Lato,serif;font-size:9.0pt">Electronic databases were searched for relevant controlled clinical and </span></p>
<p style="top:307.8pt;left:209.2pt;line-height:9.0pt"><span style="font-family:Lato,serif;font-size:9.0pt">pre- clinical (large- animal) studies. Separate meta- analyses of quantitative data re-</span></p>
<p style="top:322.8pt;left:209.2pt;line-height:9.0pt"><span style="font-family:Lato,serif;font-size:9.0pt">garding histological or radiographic new bone formation were performed.</span></p>
<p style="top:337.8pt;left:209.2pt;line-height:9.0pt"><b><span style="font-family:Lato,serif;font-size:9.0pt">Results: </span></b><span style="font-family:Lato,serif;font-size:9.0pt">Forty- seven eligible clinical and 57 pre- clinical studies were included. Clinical </span></p>
<p style="top:352.8pt;left:209.2pt;line-height:9.0pt"><span style="font-family:Lato,serif;font-size:9.0pt">studies were categorized based on the use of &#x201c;minimally manipulated&#x201d; whole tissues </span></p>
<p style="top:367.8pt;left:209.2pt;line-height:9.0pt"><span style="font-family:Lato,serif;font-size:9.0pt">(e.g., bone marrow) or ex vivo expanded cells from &#x201c;uncommitted&#x201d; (bone marrow, adi-</span></p>
<p style="top:382.8pt;left:209.2pt;line-height:9.0pt"><span style="font-family:Lato,serif;font-size:9.0pt">pose tissue) or &#x201c;committed&#x201d; sources (periosteum, bone). Based on limited and hetero-</span></p>
<p style="top:397.8pt;left:209.2pt;line-height:9.0pt"><span style="font-family:Lato,serif;font-size:9.0pt">geneous clinical evidence, implantation of cells (mostly whole bone marrow), in </span></p>
<p style="top:412.8pt;left:209.2pt;line-height:9.0pt"><span style="font-family:Lato,serif;font-size:9.0pt">combination with biomaterial scaffolds results in bone regeneration which is (a) supe-</span></p>
<p style="top:427.8pt;left:209.2pt;line-height:9.0pt"><span style="font-family:Lato,serif;font-size:9.0pt">rior compared to implantation of scaffolds alone in sinus and horizontal ridge aug-</span></p>
<p style="top:442.8pt;left:209.2pt;line-height:9.0pt"><span style="font-family:Lato,serif;font-size:9.0pt">mentation, and (b) comparable to autogenous bone in alveolar cleft repair.</span></p>
<p style="top:457.8pt;left:209.2pt;line-height:9.0pt"><b><span style="font-family:Lato,serif;font-size:9.0pt">Conclusions: </span></b><span style="font-family:Lato,serif;font-size:9.0pt">Although current evidence points to the benefits of cell therapy in cer-</span></p>
<p style="top:472.8pt;left:209.2pt;line-height:9.0pt"><span style="font-family:Lato,serif;font-size:9.0pt">tain clinical indications, it is unclear whether the use of ex vivo expanded cells, either </span></p>
<p style="top:487.8pt;left:209.2pt;line-height:9.0pt"><span style="font-family:Lato,serif;font-size:9.0pt">uncommitted or committed, is superior to whole tissue fractions in terms of bone </span></p>
<p style="top:502.8pt;left:209.2pt;line-height:9.0pt"><span style="font-family:Lato,serif;font-size:9.0pt">regeneration. The relatively larger effect sizes in favour of cell therapy observed in </span></p>
<p style="top:517.8pt;left:209.2pt;line-height:9.0pt"><span style="font-family:Lato,serif;font-size:9.0pt">pre- clinical studies are diminished in clinical trials. Future controlled studies should </span></p>
<p style="top:532.8pt;left:209.2pt;line-height:9.0pt"><span style="font-family:Lato,serif;font-size:9.0pt">include cost- effectiveness analyses to guide clinical decision- making.</span></p>
<p style="top:558.3pt;left:209.2pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">K E Y W O R D S</span></b></p>
<p style="top:570.5pt;left:209.2pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">bone grafting, bone tissue engineering, cell therapy, mesenchymal stem cells, meta-analysis, </span></p>
<p style="top:583.5pt;left:209.2pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">systematic review</span></p>
<img style="position:absolute;transform:matrix(.44444449,0,-0,.44444449,629.04006,-11.997314)" src="data:image/png;base64,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">
<p style="top:11.6pt;left:578.8pt;line-height:5.1pt"><span style="font-family:Times New Roman,serif;font-size:5.1pt"> 1600051x, 2019, S21, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jcpe.13049 by Universit&#xe4;tsbibliothek Zuerich, Wiley Online Library on [27/12/2022]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</span></p>


<p style="top:23.8pt;left:511.9pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003;&#x2002; &#x2003;</span></b><b><span style="font-family:Lato,serif;font-size:9.1pt">|</span></b><b><span style="font-family:Lato,serif;font-size:7.0pt"> &#x2003;163</span></b></p>
<img style="position:absolute;transform:matrix(.31940789,0,-0,.3187552,395.0849,3.744316)" src="data:image/jpeg;base64,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">
<p style="top:23.9pt;left:44.8pt;line-height:7.0pt"><span style="font-family:Lato-Regular,serif;font-size:7.0pt">SHANBHAG </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">et</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt"> </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">Al</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt">.</span></p>
<p style="top:49.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">alveolar ridge/socket preservation (SP) following dental extraction </span></p>
<p style="top:62.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(Avila- Ortiz et al., 2016), vertical and horizontal ridge augmentation </span></p>
<p style="top:75.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(RA) (Daugela, Cicciu, &amp; Saulacic, 2016; Elnayef et al., 2017, 2018), </span></p>
<p style="top:88.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">maxillary sinus- floor augmentation (SA) (Danesh- Sani et al., 2017), </span></p>
<p style="top:101.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">and alveolar cleft (AC) repair in the palatal aspect of the maxilla (Wu </span></p>
<p style="top:114.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">et al., 2017). All of these techniques mainly involve the use of autoge-</span></p>
<p style="top:127.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">nous bone (AB) grafts and/or bone substitute materials, and often </span></p>
<p style="top:140.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">in combination with barrier membranes, that is the guided bone re-</span></p>
<p style="top:153.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">generation (GBR) principle (Elgali, Omar, Dahlin, &amp; Thomsen, 2017); </span></p>
<p style="top:166.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">in the case of more advanced (e.g., segmental) defects, vascularized </span></p>
<p style="top:179.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">tissue flaps are used (Hayden, Mullin, &amp; Patel, 2012). Although AB </span></p>
<p style="top:192.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">transplantation is still considered the gold standard, larger defects </span></p>
<p style="top:205.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">may require volumes of bone locally unavailable, leading to the need </span></p>
<p style="top:218.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">for harvesting from a second surgical site, usually involving general </span></p>
<p style="top:231.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">anaesthesia, hospitalization and significantly increased costs (Dahlin </span></p>
<p style="top:244.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">&amp; Johansson, 2011). Thus, the morbidity associated with invasive </span></p>
<p style="top:257.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">AB harvesting and flap transfer, especially from a remote donor site, </span></p>
<p style="top:270.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">along with its unpredictable resorption rate, are major limiting fac-</span></p>
<p style="top:283.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">tors (Nkenke &amp; Neukam, 2014; Shanbhag, Shanbhag, &amp; Stavropoulos, </span></p>
<p style="top:296.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">2014). Alternatives have included a range of allogeneic, xenogeneic </span></p>
<p style="top:309.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">and alloplastic AB substitutes, but no consensus currently exists </span></p>
<p style="top:322.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">on the effectiveness of one material over the other, in comparison </span></p>
<p style="top:335.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">with AB, or for specific clinical indications (Al- Nawas &amp; Schiegnitz, </span></p>
<p style="top:348.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">2014; Milinkovic &amp; Cordaro, 2014; Sanz- S&#xe1;nchez, Ortiz- Vig&#xf3;n, Sanz- </span></p>
<p style="top:361.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Mart&#xed;n, Figuero, &amp; Sanz, 2015).</span></p>
<p style="top:374.0pt;left:57.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Adult or postnatal stem cells represent promising candidates for </span></p>
<p style="top:387.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">regenerative therapy, since they have the potential to replicate in </span></p>
<p style="top:400.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">an undifferentiated state as well as to differentiate along commit-</span></p>
<p style="top:413.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ted lineages. Although adult stem cells are utilised in the clinic since </span></p>
<p style="top:426.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">many decades as haematopoietic stem cell (HSC) therapy through </span></p>
<p style="top:439.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">bone marrow transplantation (Mohty, Richardson, McCarthy, &amp; </span></p>
<p style="top:452.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Attal, 2015), more recently, a multipotent population of mesen-</span></p>
<p style="top:465.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">chymal stromal or &#x201c;stem&#x201d; cells (MSCs) was identified in the non- </span></p>
<p style="top:478.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">haematopoietic fraction of bone marrow (Friedenstein, Chailakhjan, </span></p>
<p style="top:491.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">&amp; Lalykina, 1970). These MSCs have been defined by various char-</span></p>
<p style="top:504.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">acteristics, such as plastic adherence, self- renewal or colony forming </span></p>
<p style="top:517.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">unit (CFU)- potential, stromal phenotype and surface marker expres-</span></p>
<p style="top:530.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">sion (CD73</span><sup><span style="font-family:Lato,serif;font-size:5.6pt">+</span></sup><span style="font-family:Lato,serif;font-size:8.0pt">CD90</span><sup><span style="font-family:Lato,serif;font-size:5.6pt">+</span></sup><span style="font-family:Lato,serif;font-size:8.0pt">CD105</span><sup><span style="font-family:Lato,serif;font-size:5.6pt">+</span></sup><span style="font-family:Lato,serif;font-size:8.0pt">CD34</span><sup><span style="font-family:Lato,serif;font-size:5.6pt">&#x2212;</span></sup><span style="font-family:Lato,serif;font-size:8.0pt">CD45</span><sup><span style="font-family:Lato,serif;font-size:5.6pt">&#x2212;</span></sup><span style="font-family:Lato,serif;font-size:8.0pt">HLA- DR</span><sup><span style="font-family:Lato,serif;font-size:5.6pt">&#x2212;</span></sup><span style="font-family:Lato,serif;font-size:8.0pt">), and the ability to </span></p>
<p style="top:543.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">differentiate into at least three stromal lineages, that is bone, fat and </span></p>
<p style="top:556.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">cartilage (Dominici et al., 2006). In addition to their differentiation </span></p>
<p style="top:569.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">capacity, MSCs also exert paracrine or trophic effects, via secretion </span></p>
<p style="top:582.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">of soluble bioactive molecules, which &#x201c;empower&#x201d; host progenitor </span></p>
<p style="top:595.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">cells and modulate immune cells (and thereby the immune response), </span></p>
<p style="top:608.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">to promote regeneration (Wang, Chen, Cao, &amp; Shi, 2014). In fact, re</span><span style="font-family:Lato,serif;font-size:8.0pt">-</span></p>
<p style="top:621.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">cent observations point to trophic activity as the primary mechanism </span></p>
<p style="top:634.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">of MSC- mediated regeneration, rather than direct differentiation </span></p>
<p style="top:647.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(Caplan, 2017; Haumer et al., 2018).</span></p>
<p style="top:660.0pt;left:57.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">In this context, tissue engineering aims to combine and de</span><span style="font-family:Lato,serif;font-size:8.0pt">-</span></p>
<p style="top:673.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">liver the cellular (progenitor cells), extracellular (scaffolds) and/</span></p>
<p style="top:686.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">or molecular elements (growth factors) involved in physiological </span></p>
<p style="top:699.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">regenerative processes, for therapeutic applications. Specifically, </span></p>
<p style="top:712.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">regarding bone tissue engineering (BTE), this usually involves har-</span></p>
<p style="top:725.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">vesting osteogenic cells from an autologous source (e.g., bone </span></p>
<p style="top:244.1pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">marrow, adipose tissue), their &#x201c;chair- side&#x201d; manipulation or ex vivo </span></p>
<p style="top:257.1pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">amplification, and combination with an appropriate biomaterial </span></p>
<p style="top:270.1pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">scaffold for in vivo implantation (Evans et al., 2007; Oryan, Kamali, </span></p>
<p style="top:283.1pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Moshiri, &amp; Baghaban Eslaminejad, 2017). Thus, the &#x201c;triad&#x201d; of </span><i><span style="font-family:Lato,serif;font-size:8.0pt">osteo-</span></i></p>
<p style="top:296.1pt;left:305.8pt;line-height:8.0pt"><i><span style="font-family:Lato,serif;font-size:8.0pt">genic</span></i><span style="font-family:Lato,serif;font-size:8.0pt"> cells, </span><i><span style="font-family:Lato,serif;font-size:8.0pt">osteoinductive</span></i><span style="font-family:Lato,serif;font-size:8.0pt"> signals (growth factors released by cells), </span></p>
<p style="top:309.1pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">and </span><i><span style="font-family:Lato,serif;font-size:8.0pt">osteoconductive</span></i><span style="font-family:Lato,serif;font-size:8.0pt"> scaffolds, aims to replicate the properties of </span></p>
<p style="top:322.1pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">AB, and alleviate the need for invasive harvesting (Oppenheimer, </span></p>
<p style="top:335.1pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Mesa, &amp; Buchman, 2012). The cells can be harvested by minimally, </span></p>
<p style="top:348.1pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">and relatively less, invasive techniques (compared to AB har-</span></p>
<p style="top:361.1pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">vesting) from various tissues, most commonly bone marrow and </span></p>
<p style="top:374.1pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">adipose tissues, under local anaesthesia, and without the need </span></p>
<p style="top:387.1pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">for hospitalization. Thus, BTE strategies are indeed emerging as </span></p>
<p style="top:400.1pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">promising alternatives to AB and/or biomaterial- based grafting, </span></p>
<p style="top:413.1pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">as demonstrated by several pre- clinical and some clinical studies </span></p>
<p style="top:426.1pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(for reviews, see Janssen et al., 2014; Padial- Molina et al., 2015; </span></p>
<p style="top:439.1pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Shanbhag et al., 2015; Shanbhag, Pandis, Mustafa, Nyengaard, &amp; </span></p>
<p style="top:452.1pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Stavropoulos, 2016, 2018; Miguita, Mantesso, Pannuti, &amp; Deboni, </span></p>
<p style="top:465.1pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">2017). Among these BTE strategies, three main interventions </span></p>
<p style="top:478.1pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">using cell therapies have been tested: (a) use of &#x201c;minimally manip-</span></p>
<p style="top:491.1pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ulated&#x201d; whole tissue fractions; (b) use of more- than- minimally ma-</span></p>
<p style="top:504.1pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">nipulated or ex vivo expanded </span><i><span style="font-family:Lato,serif;font-size:8.0pt">uncommitted</span></i><span style="font-family:Lato,serif;font-size:8.0pt"> stem/progenitor cells; </span></p>
<p style="top:517.1pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">and (c) use of ex vivo expanded </span><i><span style="font-family:Lato,serif;font-size:8.0pt">committed</span></i><span style="font-family:Lato,serif;font-size:8.0pt"> bone- derived cells.</span></p>
<p style="top:530.1pt;left:318.8pt;line-height:8.0pt"><i><span style="font-family:Lato,serif;font-size:8.0pt">Minimally manipulated whole tissue fractions</span></i><span style="font-family:Lato,serif;font-size:8.0pt"> have mainly in-</span></p>
<p style="top:543.1pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">cluded bone marrow aspirates&#x2014;either whole (BMA) or concen-</span></p>
<p style="top:556.1pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">trated (BMAC), adipose stromal vascular fraction (A- SVF), and </span></p>
<p style="top:569.1pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">tissue &#x201c;micrografts.&#x201d; The rationale for using whole tissue fractions </span></p>
<p style="top:582.1pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">are (a) feasibility of a chair- side protocol, (b) minimum cell manip-</span></p>
<p style="top:595.1pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ulation, (c) cost- effectiveness, and (d) delivery of a heterogeneous </span></p>
<p style="top:608.1pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">cell population. In addition to minimizing the time and costs associ</span><span style="font-family:Lato,serif;font-size:8.0pt">-</span></p>
<p style="top:621.1pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ated with clinical- grade cell culture&#x2014;which requires expensive Good </span></p>
<p style="top:634.1pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Manufacturing Practice (GMP)&#x2013;grade facilities, this approach gen-</span></p>
<p style="top:647.1pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">erates a population of cells that is not comprised solely of MSCs, </span></p>
<p style="top:660.1pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">but also includes a number of other cell types with therapeutic </span></p>
<p style="top:673.1pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">potential, including HSCs, endothelial cells (ECs), and immune cells </span></p>
<p style="top:686.1pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(monocytes, macrophages, etc.) (Fraser et al., 2014). This preserves </span></p>
<p style="top:699.1pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">the physiological microenvironment or &#x201c;niche,&#x201d; with all cells in their </span></p>
<p style="top:712.1pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">natural ratios, including those which produce paracrine signals to in-</span></p>
<p style="top:725.1pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">duce host osteoprogenitors and MSCs (Jager et al., 2011).</span></p>
<p style="top:65.9pt;left:322.8pt;line-height:9.0pt"><span style="font-family:Lato,serif;font-size:9.0pt;color:#57585a">Clinical relevance</span></p>
<p style="top:85.7pt;left:322.8pt;line-height:8.0pt"><i><span style="font-family:Lato,serif;font-size:8.0pt">Scientific rationale for study:</span></i><span style="font-family:Lato,serif;font-size:8.0pt"> Although cell therapy has </span></p>
<p style="top:98.7pt;left:322.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">shown the potential to enhance bone regeneration, there </span></p>
<p style="top:111.7pt;left:322.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">are several aspects regarding the source(s) of cells, their </span></p>
<p style="top:124.7pt;left:322.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">manipulation, mode of application, as well as the cost- </span></p>
<p style="top:137.7pt;left:322.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">benefit that need further elaboration.</span><i><span style="font-family:Lato,serif;font-size:8.0pt">Principal findings:</span></i><span style="font-family:Lato,serif;font-size:8.0pt"> </span></p>
<p style="top:150.7pt;left:322.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Cell therapy may enhance alveolar bone regeneration in </span></p>
<p style="top:163.7pt;left:322.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">specific clinical indications.</span><i><span style="font-family:Lato,serif;font-size:8.0pt">Practical implications:</span></i><span style="font-family:Lato,serif;font-size:8.0pt"> Further </span></p>
<p style="top:176.7pt;left:322.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">clinical trials are needed before cell therapy can become a </span></p>
<p style="top:189.7pt;left:322.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">routine clinical procedure.</span></p>
<p style="top:11.6pt;left:578.8pt;line-height:5.1pt"><span style="font-family:Times New Roman,serif;font-size:5.1pt"> 1600051x, 2019, S21, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jcpe.13049 by Universit&#xe4;tsbibliothek Zuerich, Wiley Online Library on [27/12/2022]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</span></p>


<p style="top:23.8pt;left:46.5pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">164&#x2003; </span></b><b><span style="font-family:Lato,serif;font-size:9.1pt">|</span></b><b><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003; &#x2003;&#x2002;</span></b></p>
<img style="position:absolute;transform:matrix(.31940789,0,-0,.3187552,54.97612,3.7443963)" src="data:image/jpeg;base64,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">
<p style="top:23.8pt;left:493.4pt;line-height:7.0pt"><span style="font-family:Lato-Regular,serif;font-size:7.0pt">SHANBHAG </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">et</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt"> </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">Al</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt">.</span></p>
<p style="top:49.0pt;left:59.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Bone marrow is known to contain a heterogeneous population of </span></p>
<p style="top:62.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">progenitor cells (including MSCs, HSCs, and endothelial progenitor </span></p>
<p style="top:75.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">cells), and supporting growth factors and cytokines (Chahla et al., </span></p>
<p style="top:88.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">2016; Patterson et al., 2017). Concentration of the mononuclear cell </span></p>
<p style="top:101.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">fraction (MNC) of bone marrow (which includes MSCs) via density </span></p>
<p style="top:114.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">gradient centrifugation steps to remove red blood cells, granulo-</span></p>
<p style="top:127.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">cytes, immature myeloid precursors, and platelets, represents an </span></p>
<p style="top:140.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">attractive clinical strategy, since it is currently FDA- approved and </span></p>
<p style="top:153.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">shown to be efficacious as a point- of- care method of autologous </span></p>
<p style="top:166.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">cell delivery (Chahla et al., 2017; Jager et al., 2011). Moreover, since </span></p>
<p style="top:179.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">self- renewing, plastic- adherent MSCs represent only a small fraction </span></p>
<p style="top:192.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(0.001%&#x2013;0.01%) of MNC within the bone marrow, it may be hypoth-</span></p>
<p style="top:205.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">esized that a concentrate (BMAC) could increase the likelihood of </span></p>
<p style="top:218.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">attachment of these cells when loaded onto biomaterial scaffolds, </span></p>
<p style="top:231.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">and thereby ensure successful delivery to the defect site (El- Jawhari, </span></p>
<p style="top:244.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Sanjurjo- Rodriguez, Jones, &amp; Giannoudis, 2016).</span></p>
<p style="top:257.0pt;left:59.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">An emerging and relatively less invasive alternative tissue source </span></p>
<p style="top:270.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">for minimally manipulated cell fractions is A- SVF, which, like bone </span></p>
<p style="top:283.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">marrow, contains a sub- population of adipose stem/stromal cells </span></p>
<p style="top:296.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(ASCs) in addition to hematopoietic and ECs. Since the frequency </span></p>
<p style="top:309.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">of ASCs in A- SVF is reportedly much higher than that of BMSCs in </span></p>
<p style="top:322.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">BMA(C), the direct use of A- SVF, without culture- expansion, has </span></p>
<p style="top:335.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">been advocated (Fraser et al., 2014). However, although the use </span></p>
<p style="top:348.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">of minimally manipulated whole tissue fractions may be time-  and </span></p>
<p style="top:361.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">cost- effective, the yield of progenitor cells obtained is relatively low. </span></p>
<p style="top:374.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">MSCs represent &lt;1% of the MNC in BMA, and approximately 1.4% </span></p>
<p style="top:387.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">in A- SVF, based on CFU potential (Prins, Schulten, Ten Bruggenkate, </span></p>
<p style="top:400.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Klein- Nulend, &amp; Helder, 2016). This has encouraged ex vivo expan-</span></p>
<p style="top:413.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">sion strategies, which aim to exponentially increase the number of </span></p>
<p style="top:426.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">cells of a specific phenotype, that is </span><i><span style="font-family:Lato,serif;font-size:8.0pt">committed</span></i><span style="font-family:Lato,serif;font-size:8.0pt"> or </span><i><span style="font-family:Lato,serif;font-size:8.0pt">uncommitted</span></i><span style="font-family:Lato,serif;font-size:8.0pt">, avail-</span></p>
<p style="top:439.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">able for implantation, and thereby improve clinical outcomes (Petite </span></p>
<p style="top:452.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">et al., 2000).</span></p>
<p style="top:465.0pt;left:59.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">The use of expanded </span><i><span style="font-family:Lato,serif;font-size:8.0pt">uncommitted</span></i><span style="font-family:Lato,serif;font-size:8.0pt"> cells is based on the fact that </span></p>
<p style="top:478.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">MSCs, originally identified in bone marrow (BMSCs), are the most </span></p>
<p style="top:491.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">commonly reported cells in autologous regenerative therapies. </span></p>
<p style="top:504.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">MSCs have also been isolated from less invasive sources such as ad-</span></p>
<p style="top:517.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ipose tissue (ASCs), dental tissues and a range of adnexal gestational </span></p>
<p style="top:530.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">tissues, among others (Nancarrow- Lei, Mafi, Mafi, &amp; Khan, 2017). </span></p>
<p style="top:543.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Although MSCs from different tissue sources share biological char-</span></p>
<p style="top:556.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">acteristics, they have been reported to show functional differences </span></p>
<p style="top:569.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">in their properties, such as surface phenotype and differentiation </span></p>
<p style="top:582.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">potential (Al- Nbaheen et al., 2013). However, whether or not the tis</span><span style="font-family:Lato,serif;font-size:8.0pt">-</span></p>
<p style="top:595.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">sue of origin regulates the epigenetics of MSCs and affects their sub-</span></p>
<p style="top:608.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">sequent in vivo differentiation potential remains to be determined in </span></p>
<p style="top:621.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">a comparative clinical study.</span></p>
<p style="top:634.0pt;left:59.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">The use of expanded </span><i><span style="font-family:Lato,serif;font-size:8.0pt">committed</span></i><span style="font-family:Lato,serif;font-size:8.0pt"> cells is based on obtaining as </span></p>
<p style="top:647.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">tissue source the alveolar bone itself&#x2014;specifically, the periosteum </span></p>
<p style="top:660.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">and cancellous bone/marrow. The periosteum has been described </span></p>
<p style="top:673.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">as an osteoprogenitor cell- containing bone envelope with high re-</span></p>
<p style="top:686.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">generative potential (Hutmacher &amp; Sittinger, 2003), while marrow- </span></p>
<p style="top:699.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">resident osteoblasts (OBs) are the fundamental cells of bone </span></p>
<p style="top:712.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">tissue involved in its formation, function, repair, and maintenance </span></p>
<p style="top:725.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(Jayakumar &amp; Di Silvio, 2010). Although multipotent MSC- like cells </span></p>
<p style="top:49.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">have been identified in both periosteum (Olbrich, Rieger, Reinert, &amp; </span></p>
<p style="top:62.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Alexander, 2012) and alveolar bone (Mason, Tarle, Osibin, Kinfu, &amp; </span></p>
<p style="top:75.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Kaigler, 2014), for the purpose of this review, cells obtained from </span></p>
<p style="top:88.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">these tissues were considered to be more osteogenically &#x201c;commit-</span></p>
<p style="top:101.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ted&#x201d; than those from other tissues (Akintoye et al., 2006; Pettersson, </span></p>
<p style="top:114.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Kingham, Wiberg, &amp; Kelk, 2017).</span></p>
<p style="top:127.0pt;left:320.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">It was therefore the primary objective of the present review to </span></p>
<p style="top:140.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">systematically assess the literature to answer the focused question: </span></p>
<p style="top:153.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">in clinical studies, what is the effect of cell therapy in terms of oro-</span></p>
<p style="top:166.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">facial bone regeneration compared to grafting with only biomaterial </span></p>
<p style="top:179.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">scaffolds and/or AB? Secondary objectives were (a) to assess the </span></p>
<p style="top:192.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">preclinical to clinical translation of cell therapy by comparing preclin-</span></p>
<p style="top:205.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ical and clinical data, and (b) to determine which is the most suitable </span></p>
<p style="top:218.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">cell therapy approach for regenerating bone deficiencies.</span></p>
<p style="top:255.4pt;left:307.5pt;line-height:10.0pt"><b><span style="font-family:Lato,serif;font-size:10.0pt">2&#x2003;</span></b><span style="font-family:Lato,serif;font-size:10.0pt">|</span><b><span style="font-family:Lato,serif;font-size:10.0pt">&#x2003;MATERIALS AND METHODS</span></b></p>
<p style="top:283.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Following Cochrane (Higgins &amp; Green, 2011) and Preferred Reporting </span></p>
<p style="top:296.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Items for Systematic Reviews guidelines (Moher, Liberati, Tetzlaff, &amp; </span></p>
<p style="top:309.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Altman, 2009), an electronic literature search based on pre- defined </span></p>
<p style="top:322.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">inclusion criteria was performed in 3 repositories (PubMed, Embase </span></p>
<p style="top:335.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">and Cochrane library) up to May 2018 (Figure 1). Sampling of the </span></p>
<p style="top:348.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">clinical evidence was focused on controlled trials&#x2014;either rand-</span></p>
<p style="top:361.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">omized (RCT) or non- randomized (CT). Uncontrolled studies (UT) </span></p>
<p style="top:374.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">and cases reports (with &#x2265;3 patients) of cell- based BTE were also </span></p>
<p style="top:387.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">identified to capture possible relevant information regarding cell </span></p>
<p style="top:400.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">sources, delivery strategies, and adverse events, although data re-</span></p>
<p style="top:413.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">garding bone regeneration from these studies were not considered </span></p>
<p style="top:426.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">for the meta- analyses. Sampling of pre- clinical data was limited to </span></p>
<p style="top:439.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">large- animal models and regards mainly an update of our previously </span></p>
<p style="top:452.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">published reviews (Shanbhag et al., 2016, 2018). These data were </span></p>
<p style="top:465.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">only included to compare with the clinical data, which is the focus of </span></p>
<p style="top:478.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">the present review. Quantitative data regarding histomorphometric </span></p>
<p style="top:491.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">or radiographic bone regeneration was included in meta- analyses. </span></p>
<p style="top:504.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Separate analyses were performed for clinical (grouped by indica-</span></p>
<p style="top:517.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">tion/defect- type and method of outcome evaluation) and pre- clinical </span></p>
<p style="top:530.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">studies (grouped by species and defect- type). Details of the review </span></p>
<p style="top:543.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">methodology are reported in the Appendix.</span></p>
<p style="top:573.9pt;left:307.5pt;line-height:10.0pt"><b><span style="font-family:Lato,serif;font-size:10.0pt">3&#x2003;</span></b><span style="font-family:Lato,serif;font-size:10.0pt">|</span><b><span style="font-family:Lato,serif;font-size:10.0pt">&#x2003;RESULTS</span></b></p>
<p style="top:599.9pt;left:307.5pt;line-height:10.0pt"><b><span style="font-family:Lato,serif;font-size:10.0pt">3.1&#x2003;</span></b><span style="font-family:Lato,serif;font-size:10.0pt">|</span><b><span style="font-family:Lato,serif;font-size:10.0pt">&#x2003;Summary of included studies</span></b></p>
<p style="top:621.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">After screening, 47 controlled clinical studies were included, of </span></p>
<p style="top:634.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">which 22 were RCTs, mostly with a low to unclear risk of bias </span></p>
<p style="top:647.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(Supporting Information Figure S8). Additionally, 30 UT and case </span></p>
<p style="top:660.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">series were identified (Supporting Information Tables S1&#x2013;S3). </span></p>
<p style="top:673.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">A majority of the evidence was derived from studies of SA and </span></p>
<p style="top:686.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">horizontal RA (30 controlled studies). Additionally, studies of SP, </span></p>
<p style="top:699.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">AC and cranial defect (CD) repair, and reconstruction follow-</span></p>
<p style="top:712.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ing fracture, cystectomy or tumour resection, were identified </span></p>
<p style="top:725.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(Table 1). Most studies included a &#x201c;split- mouth&#x201d; design, utilized a </span></p>
<p style="top:11.6pt;left:578.8pt;line-height:5.1pt"><span style="font-family:Times New Roman,serif;font-size:5.1pt"> 1600051x, 2019, S21, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jcpe.13049 by Universit&#xe4;tsbibliothek Zuerich, Wiley Online Library on [27/12/2022]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</span></p>


<p style="top:23.8pt;left:511.9pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003;&#x2002; &#x2003;</span></b><b><span style="font-family:Lato,serif;font-size:9.1pt">|</span></b><b><span style="font-family:Lato,serif;font-size:7.0pt"> &#x2003;165</span></b></p>
<img style="position:absolute;transform:matrix(.31940789,0,-0,.3187552,395.0849,3.744316)" src="data:image/jpeg;base64,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">
<p style="top:23.9pt;left:44.8pt;line-height:7.0pt"><span style="font-family:Lato-Regular,serif;font-size:7.0pt">SHANBHAG </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">et</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt"> </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">Al</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt">.</span></p>
<p style="top:529.9pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">GBR approach for augmentation, that is a membrane to cover the </span></p>
<p style="top:542.9pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">cell- scaffold construct, and reported the placement of implants </span></p>
<p style="top:555.9pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">in regenerated sites. Outcomes were assessed via in situ clinical </span></p>
<p style="top:568.9pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">examination and/or radiography [computed tomography (CT) or </span></p>
<p style="top:581.9pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">cone- beam CT (CBCT)], or via histological and/or micro- CT (</span><span style="font-family:STIX,serif;font-size:8.0pt">&#x3bc;</span><span style="font-family:Lato,serif;font-size:8.0pt">- CT) </span></p>
<p style="top:594.9pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">assessments of biopsy specimens. The primary outcome measure </span></p>
<p style="top:607.9pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">was quantitative assessments of new bone formation (NBF) via </span></p>
<p style="top:620.9pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">histomorphometry or </span><span style="font-family:STIX,serif;font-size:8.0pt">&#x3bc;</span><span style="font-family:Lato,serif;font-size:8.0pt">- CT of biopsies, or in situ CT- based assess-</span></p>
<p style="top:633.9pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ments of &#x201c;bone fill&#x201d; (BF) within the treated defects.</span></p>
<p style="top:646.9pt;left:57.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Scaffolds used (xenogeneic and alloplastic) to deliver cells to the </span></p>
<p style="top:659.9pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">regeneration sites were: (a) </span><i><span style="font-family:Lato,serif;font-size:8.0pt">ceramic</span></i><span style="font-family:Lato,serif;font-size:8.0pt"> scaffolds, such as deproteinized </span></p>
<p style="top:672.9pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">bovine bone mineral (DBBM), hydroxyl- apatite (HA), beta- tricalcium </span></p>
<p style="top:685.9pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">phosphate (</span><span style="font-family:STIX,serif;font-size:8.0pt">&#x3b2;</span><span style="font-family:Lato,serif;font-size:8.0pt">- TCP), biphasic HA/</span><span style="font-family:STIX,serif;font-size:8.0pt">&#x3b2;</span><span style="font-family:Lato,serif;font-size:8.0pt">- TCP (BCP) and freeze- dried bone </span></p>
<p style="top:698.9pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">allograft (FDBA); (b) </span><i><span style="font-family:Lato,serif;font-size:8.0pt">polymeric</span></i><span style="font-family:Lato,serif;font-size:8.0pt"> scaffolds, such as collagen (COL) or </span></p>
<p style="top:711.9pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">gelatin sponges, platelet- rich/poor plasma (PRP/PPP) or fibrin (PRF), </span></p>
<p style="top:724.9pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">and polylactic&#x2013;polyglycolic acid copolymer (PLGA); or (c) </span><i><span style="font-family:Lato,serif;font-size:8.0pt">composite</span></i><span style="font-family:Lato,serif;font-size:8.0pt"> </span></p>
<p style="top:529.9pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">scaffolds, including various combinations of the above (Lee, Cuddihy, </span></p>
<p style="top:542.9pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">&amp; Kotov, 2008).</span></p>
<p style="top:555.9pt;left:318.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Cell therapy approaches were categorized according to US </span></p>
<p style="top:568.9pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Food and Drug Administration (FDA) guidelines on the use of </span></p>
<p style="top:581.9pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Human Cells, Tissues, and cellular and tissue- based Products </span></p>
<p style="top:594.9pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(HCT/P; Code of Federal Regulation Title 21- CFR- 1271) and </span></p>
<p style="top:607.9pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">the European Medicines Agency (EMA) guidelines on the use </span></p>
<p style="top:620.9pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Advanced Therapy Medicinal Products (ATMP; European </span></p>
<p style="top:633.9pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Regulation 1394/2007), as: (1) &#x201c;minimally manipulated&#x201d; whole </span></p>
<p style="top:646.9pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">tissue fractions, usually involving a point- of- care or chair- side </span></p>
<p style="top:659.9pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">procedure, or (2) &#x201c;more- than- minimally manipulated&#x201d;, that is ex </span></p>
<p style="top:672.9pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">vivo culture- expanded cells, further categorized (for the pur-</span></p>
<p style="top:685.9pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">pose of this review) as (a) uncommitted stem/progenitor cells, </span></p>
<p style="top:698.9pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">and (b) committed bone- derived cells (Supporting Information </span></p>
<p style="top:711.9pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Figure S1). Summaries of the included clinical studies in each cat-</span></p>
<p style="top:724.9pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">egory are presented in Tables 2&#x2013;4.</span></p>
<p style="top:342.0pt;left:220.3pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Indication</span></b></p>
<p style="top:342.0pt;left:407.2pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Uncontrolled</span></b></p>
<p style="top:342.0pt;left:504.3pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Controlled</span></b></p>
<p style="top:358.0pt;left:220.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">SA</span></p>
<p style="top:358.0pt;left:407.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">7</span></p>
<p style="top:358.0pt;left:504.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">25</span></p>
<p style="top:372.0pt;left:220.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">RA</span></p>
<p style="top:372.0pt;left:407.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">4</span></p>
<p style="top:372.0pt;left:504.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">6</span></p>
<p style="top:386.0pt;left:220.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">SA and/or RA (in the same patients or in different </span></p>
<p style="top:396.5pt;left:224.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">patients in the same study)</span></p>
<p style="top:386.0pt;left:407.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">10</span></p>
<p style="top:386.0pt;left:504.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2013;</span></p>
<p style="top:410.6pt;left:220.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Ridge/SP</span></p>
<p style="top:410.6pt;left:407.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2013;</span></p>
<p style="top:410.6pt;left:504.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">5</span></p>
<p style="top:424.6pt;left:220.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">AC</span></p>
<p style="top:424.6pt;left:407.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">3</span></p>
<p style="top:424.6pt;left:504.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">7</span></p>
<p style="top:438.7pt;left:220.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">CD</span></p>
<p style="top:438.7pt;left:407.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">3</span></p>
<p style="top:438.7pt;left:504.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2013;</span></p>
<p style="top:452.7pt;left:220.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Other (fracture, cyst, tumour resection)</span></p>
<p style="top:452.7pt;left:407.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">3</span></p>
<p style="top:452.7pt;left:504.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">4</span></p>
<p style="top:466.7pt;left:220.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Total</span></p>
<p style="top:466.7pt;left:407.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">30</span></p>
<p style="top:466.7pt;left:504.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">47</span></p>
<p style="top:483.2pt;left:214.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">SA: sinus augmentation; RA: ridge augmentation; SP: socket preservation; AC: alveolar cleft; CD: </span></p>
<p style="top:493.7pt;left:214.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">cranial defect.</span></p>
<p style="top:335.9pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">TA B LE&#xa0;1&#x2003;</span><span style="font-family:Lato,serif;font-size:8.0pt">Distribution of included </span></p>
<p style="top:346.9pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">clinical studies according to indications</span></p>
<p style="top:288.3pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">FI G U R E&#xa0;1&#x2003;</span><span style="font-family:Lato,serif;font-size:8.0pt">Flow chart for study </span></p>
<p style="top:299.3pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">inclusion (n = number of articles)</span></p>
<img style="position:absolute;transform:matrix(.31980629,0,-0,.31998209,-126.15747,-298.5312)" src="data:image/jpeg;base64,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">
<p style="top:11.6pt;left:578.8pt;line-height:5.1pt"><span style="font-family:Times New Roman,serif;font-size:5.1pt"> 1600051x, 2019, S21, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jcpe.13049 by Universit&#xe4;tsbibliothek Zuerich, Wiley Online Library on [27/12/2022]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</span></p>


<p style="top:23.8pt;left:46.5pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">166&#x2003; </span></b><b><span style="font-family:Lato,serif;font-size:9.1pt">|</span></b><b><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003; &#x2003;&#x2002;</span></b></p>
<img style="position:absolute;transform:matrix(.31940789,0,-0,.3187552,54.97612,3.7443963)" src="data:image/jpeg;base64,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">
<p style="top:23.8pt;left:493.4pt;line-height:7.0pt"><span style="font-family:Lato-Regular,serif;font-size:7.0pt">SHANBHAG </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">et</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt"> </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">Al</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt">.</span></p>
<p style="top:725.3pt;left:53.3pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">TA B LE&#xa0;2&#x2003;</span><span style="font-family:Lato,serif;font-size:8.0pt">Summary of controlled studies using whole tissue fractions</span></p>
<p style="top:721.1pt;left:90.5pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">Study (design)</span></b></p>
<p style="top:627.3pt;left:90.5pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">Site</span></b></p>
<p style="top:554.6pt;left:90.5pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">Patients (sex, age)</span></b></p>
<p style="top:480.3pt;left:72.5pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">Cell therapy group</span></b></p>
<p style="top:286.1pt;left:90.5pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">Control group</span></b></p>
<p style="top:201.3pt;left:90.5pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">Follow- up</span></b></p>
<p style="top:154.8pt;left:90.5pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">Method</span></b></p>
<p style="top:101.6pt;left:90.5pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">Outcome</span></b></p>
<p style="top:480.3pt;left:90.5pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">Cell source (culture)</span></b></p>
<p style="top:359.6pt;left:90.5pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">Scaffold</span></b></p>
<p style="top:721.1pt;left:106.3pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">BMA or BMAC (n = 19)</span></b></p>
<p style="top:721.1pt;left:119.9pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt"> Wojtowicz et al., 2003; </span></p>
<p style="top:717.1pt;left:130.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Wojtowicz, Chaberek, </span></p>
<p style="top:717.1pt;left:140.9pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Urbanowska, &amp; </span></p>
<p style="top:717.1pt;left:151.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Ostrowski, 2007 (CC)</span></p>
<p style="top:627.3pt;left:119.9pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Cyst&#x2014;max or man </span></p>
<p style="top:623.3pt;left:130.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">(15&#x2013;21 mm)</span></p>
<p style="top:554.6pt;left:119.9pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">17 (17M, 27&#x2013;44 y)</span></p>
<p style="top:480.3pt;left:118.8pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Iliac BMA (</span><i><span style="font-family:Lato,serif;font-size:7.0pt">whole</span></i><span style="font-family:Lato,serif;font-size:7.0pt">, 1.4 &#xb1; 0.1 x10</span><span style="font-family:Lato,serif;font-size:4.9pt">8</span><span style="font-family:Lato,serif;font-size:7.0pt"> </span></p>
<p style="top:476.3pt;left:129.3pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">MNC + 0.9 &#xb1; 0.1 &#xd7; 10</span><span style="font-family:Lato,serif;font-size:4.9pt">6</span><span style="font-family:Lato,serif;font-size:7.0pt"> CD34 +  </span></p>
<p style="top:476.3pt;left:140.9pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">cells/transplant) </span><i><span style="font-family:Lato,serif;font-size:7.0pt">or</span></i><span style="font-family:Lato,serif;font-size:7.0pt"> BMA (</span><i><span style="font-family:Lato,serif;font-size:7.0pt">Ficoll</span></i><span style="font-family:Lato,serif;font-size:7.0pt">, </span></p>
<p style="top:476.3pt;left:150.3pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">0.6 &#xb1; 0.1 &#xd7; 10</span><span style="font-family:Lato,serif;font-size:4.9pt">8</span><span style="font-family:Lato,serif;font-size:7.0pt"> MNC + 1.9 &#xb1; 0.2 &#xd7; </span></p>
<p style="top:476.3pt;left:160.8pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">10</span><span style="font-family:Lato,serif;font-size:4.9pt">6</span><span style="font-family:Lato,serif;font-size:7.0pt"> CD34 + cells/transplant)</span></p>
<p style="top:359.6pt;left:118.8pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">DBBM (Bio- Oss</span><span style="font-family:Lato,serif;font-size:4.9pt">&#xae;</span><span style="font-family:Lato,serif;font-size:7.0pt">) + </span></p>
<p style="top:355.6pt;left:130.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">PRF/Col mem</span></p>
<p style="top:286.1pt;left:119.9pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">PRP + DBBM + PRF/</span></p>
<p style="top:282.1pt;left:130.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Col mem</span></p>
<p style="top:201.3pt;left:119.9pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">3 m</span></p>
<p style="top:154.8pt;left:119.9pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Radio</span></p>
<p style="top:101.6pt;left:119.9pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">PRP &gt; BMA</span></p>
<p style="top:721.1pt;left:175.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt"> Gimbel et al., 2007 (CC)</span></p>
<p style="top:627.3pt;left:175.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">AC&#x2014;uni</span></p>
<p style="top:554.6pt;left:175.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">69 (6&#x2013;12 y)</span></p>
<p style="top:480.3pt;left:175.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Iliac BMA (40 ml, passed through </span></p>
<p style="top:476.3pt;left:186.0pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">heparinized column)</span></p>
<p style="top:359.6pt;left:175.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Col sponge </span></p>
<p style="top:355.6pt;left:185.0pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">(Healos</span><span style="font-family:Lato,serif;font-size:4.9pt">&#xae;</span><span style="font-family:Lato,serif;font-size:7.0pt">)</span></p>
<p style="top:286.1pt;left:175.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Iliac AB (conventional </span></p>
<p style="top:282.1pt;left:186.0pt;line-height:7.0pt"><i><span style="font-family:Lato,serif;font-size:7.0pt">or</span></i><span style="font-family:Lato,serif;font-size:7.0pt"> minimal invasive)</span></p>
<p style="top:201.3pt;left:175.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">6w, 6 m, 2y</span></p>
<p style="top:154.8pt;left:175.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Clinical </span></p>
<p style="top:154.8pt;left:186.0pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Patient- </span></p>
<p style="top:154.8pt;left:196.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">reported</span></p>
<p style="top:101.6pt;left:175.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">+ (pain, cost </span></p>
<p style="top:101.6pt;left:186.0pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">T&lt;C)</span></p>
<p style="top:721.1pt;left:210.2pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt"> Sauerbier et al., 2010 </span></p>
<p style="top:717.1pt;left:220.7pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">(CT); </span><i><span style="font-family:Lato,serif;font-size:7.0pt">Duttenhoefer</span></i><span style="font-family:Lato,serif;font-size:7.0pt"> et al.</span><i><span style="font-family:Lato,serif;font-size:7.0pt">,</span></i><span style="font-family:Lato,serif;font-size:7.0pt"> </span></p>
<p style="top:717.1pt;left:231.2pt;line-height:7.0pt"><i><span style="font-family:Lato,serif;font-size:7.0pt">2014</span></i></p>
<p style="top:627.3pt;left:210.2pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">SA (&lt;3 mm) &#x2014;uni/bi</span></p>
<p style="top:554.6pt;left:210.2pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">11 (47&#x2013;69 y)</span></p>
<p style="top:480.3pt;left:209.1pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Iliac BMAC (Harvest</span><span style="font-family:Lato,serif;font-size:4.9pt">&#xae;</span><span style="font-family:Lato,serif;font-size:7.0pt">, 3 ml)</span></p>
<p style="top:359.6pt;left:209.1pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">DBBM (Bio- Oss</span><span style="font-family:Lato,serif;font-size:4.9pt">&#xae;</span><span style="font-family:Lato,serif;font-size:7.0pt">)</span></p>
<p style="top:286.1pt;left:210.2pt;line-height:7.0pt"><i><span style="font-family:Lato,serif;font-size:7.0pt">BMA (Ficoll)</span></i><span style="font-family:Lato,serif;font-size:7.0pt">  + DBBM</span></p>
<p style="top:201.3pt;left:210.2pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">3 m</span><span style="font-family:Lato,serif;font-size:7.0pt"> </span></p>
<p style="top:197.3pt;left:220.7pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">2.5 y</span></p>
<p style="top:154.8pt;left:210.2pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Histo </span></p>
<p style="top:154.8pt;left:220.7pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">IS</span></p>
<p style="top:101.6pt;left:210.2pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">NS</span></p>
<p style="top:101.6pt;left:220.7pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">NS</span></p>
<p style="top:721.1pt;left:244.8pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt"> Sauerbier et al., 2011 </span></p>
<p style="top:717.1pt;left:255.3pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">(RCT)</span></p>
<p style="top:627.3pt;left:244.8pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">SA (&lt;3 mm) &#x2014;uni/bi</span></p>
<p style="top:554.6pt;left:244.8pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">26 (38&#x2013;68 y)</span></p>
<p style="top:480.3pt;left:243.7pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Iliac BMAC (Harvest</span><span style="font-family:Lato,serif;font-size:4.9pt">&#xae;</span><span style="font-family:Lato,serif;font-size:7.0pt">, 3 ml)</span></p>
<p style="top:359.6pt;left:243.7pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">DBBM (Bio-Oss</span><span style="font-family:Lato,serif;font-size:4.9pt">&#xae;</span><span style="font-family:Lato,serif;font-size:7.0pt">)</span></p>
<p style="top:286.1pt;left:244.8pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">DBBM + Man AB </span></p>
<p style="top:282.1pt;left:255.3pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">(70:30)</span></p>
<p style="top:201.3pt;left:244.8pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">3&#x2013;4 m</span></p>
<p style="top:154.8pt;left:244.8pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Histo</span></p>
<p style="top:101.6pt;left:244.8pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">NS</span></p>
<p style="top:721.1pt;left:268.9pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt"> Rickert et al., 2011 (RCT); </span></p>
<p style="top:717.1pt;left:279.4pt;line-height:7.0pt"><i><span style="font-family:Lato,serif;font-size:7.0pt">Rickert</span></i><span style="font-family:Lato,serif;font-size:7.0pt"> et al.</span><i><span style="font-family:Lato,serif;font-size:7.0pt">,</span></i><span style="font-family:Lato,serif;font-size:7.0pt"> </span><i><span style="font-family:Lato,serif;font-size:7.0pt">2014</span></i></p>
<p style="top:627.3pt;left:268.9pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">SA (&lt;4 mm) &#x2014;bi</span></p>
<p style="top:554.6pt;left:268.9pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">12 (48&#x2013;69 y)</span></p>
<p style="top:480.3pt;left:267.9pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Iliac BMAC (Harvest</span><span style="font-family:Lato,serif;font-size:4.9pt">&#xae;</span><span style="font-family:Lato,serif;font-size:7.0pt">, 3 ml)</span></p>
<p style="top:359.6pt;left:267.9pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">DBBM (Bio-Oss</span><span style="font-family:Lato,serif;font-size:4.9pt">&#xae;</span><span style="font-family:Lato,serif;font-size:7.0pt">)</span></p>
<p style="top:286.1pt;left:268.9pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">DBBM + Man AB </span></p>
<p style="top:282.1pt;left:279.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">(70:30)</span></p>
<p style="top:201.3pt;left:268.9pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">13&#x2013;16 w</span><span style="font-family:Lato,serif;font-size:7.0pt"> </span></p>
<p style="top:197.3pt;left:279.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">12 m</span></p>
<p style="top:154.8pt;left:268.9pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Histo </span></p>
<p style="top:154.8pt;left:279.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">IS</span></p>
<p style="top:101.6pt;left:268.9pt;line-height:7.0pt"><i><span style="font-family:Lato,serif;font-size:7.0pt">S</span></i></p>
<p style="top:101.6pt;left:279.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">C&gt;T</span></p>
<p style="top:721.1pt;left:293.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt"> Wildburger et al., 2014 </span></p>
<p style="top:717.1pt;left:304.0pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">(RCT), </span><i><span style="font-family:Lato,serif;font-size:7.0pt">Kuhl</span></i><span style="font-family:Lato,serif;font-size:7.0pt"> et al.</span><i><span style="font-family:Lato,serif;font-size:7.0pt">,</span></i><span style="font-family:Lato,serif;font-size:7.0pt"> </span><i><span style="font-family:Lato,serif;font-size:7.0pt">2014</span></i></p>
<p style="top:627.3pt;left:293.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">SA (&lt;3 mm) &#x2014;bi</span></p>
<p style="top:554.6pt;left:293.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">7 (47&#x2013;72 y)</span></p>
<p style="top:480.3pt;left:292.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Iliac BMAC (Harvest</span><span style="font-family:Lato,serif;font-size:4.9pt">&#xae;</span><span style="font-family:Lato,serif;font-size:7.0pt">, 3 ml)</span></p>
<p style="top:359.6pt;left:292.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">DBBM (Bio-Oss</span><span style="font-family:Lato,serif;font-size:4.9pt">&#xae;</span><span style="font-family:Lato,serif;font-size:7.0pt">)</span></p>
<p style="top:286.1pt;left:293.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">DBBM only</span></p>
<p style="top:201.3pt;left:293.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">3, 6 m</span><span style="font-family:Lato,serif;font-size:7.0pt"> </span></p>
<p style="top:197.3pt;left:304.0pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">0.5, 6 m</span></p>
<p style="top:154.8pt;left:293.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Histo </span></p>
<p style="top:154.8pt;left:304.0pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">CT (V)</span></p>
<p style="top:101.6pt;left:293.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">NS</span></p>
<p style="top:101.6pt;left:304.0pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">NS</span></p>
<p style="top:721.1pt;left:318.0pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt"> Payer et al., 2014 (RCT), </span></p>
<p style="top:717.1pt;left:328.5pt;line-height:7.0pt"><i><span style="font-family:Lato,serif;font-size:7.0pt">Kuhl</span></i><span style="font-family:Lato,serif;font-size:7.0pt"> et al.</span><i><span style="font-family:Lato,serif;font-size:7.0pt">,</span></i><span style="font-family:Lato,serif;font-size:7.0pt"> </span><i><span style="font-family:Lato,serif;font-size:7.0pt">2014</span></i></p>
<p style="top:627.3pt;left:318.0pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">SA (&lt;3 mm) &#x2014;bi</span></p>
<p style="top:554.6pt;left:318.0pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">6 (3M, 43&#x2013;70 y)</span></p>
<p style="top:480.3pt;left:318.0pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Tibial BMA (8 ml)</span></p>
<p style="top:359.6pt;left:316.9pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">DBBM (Bio- Oss</span><span style="font-family:Lato,serif;font-size:4.9pt">&#xae;</span><span style="font-family:Lato,serif;font-size:7.0pt">)</span></p>
<p style="top:286.1pt;left:318.0pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">DBBM only</span></p>
<p style="top:201.3pt;left:318.0pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">3, 6 m</span><span style="font-family:Lato,serif;font-size:7.0pt"> </span></p>
<p style="top:197.3pt;left:328.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">0.5, 6 m</span></p>
<p style="top:154.8pt;left:318.0pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Histo </span></p>
<p style="top:154.8pt;left:328.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">CT (V)</span></p>
<p style="top:101.6pt;left:318.0pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">NS</span></p>
<p style="top:101.6pt;left:328.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">NS</span></p>
<p style="top:721.1pt;left:342.2pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt"> Sununliganon (2013) </span></p>
<p style="top:717.1pt;left:352.7pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">(RCT)</span></p>
<p style="top:627.3pt;left:342.2pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">SA (&lt;5 mm) &#x2014;uni/bi </span></p>
<p style="top:623.3pt;left:352.7pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">&#xb1; impl</span></p>
<p style="top:554.6pt;left:342.2pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">4 (bi, 2F, 30&#x2013;71 y); 9 </span></p>
<p style="top:550.6pt;left:352.7pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">(uni, 6M, 23&#x2013;72 y)</span></p>
<p style="top:480.3pt;left:341.1pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Iliac BMAC (MarrowStim</span><span style="font-family:Lato,serif;font-size:4.9pt">&#xae;</span><span style="font-family:Lato,serif;font-size:7.0pt">, 3 ml)</span></p>
<p style="top:359.6pt;left:341.1pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">BBM (Endobon</span><span style="font-family:Lato,serif;font-size:4.9pt">&#xae;</span><span style="font-family:Lato,serif;font-size:7.0pt">)</span></p>
<p style="top:286.1pt;left:342.2pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">BBM only </span><i><span style="font-family:Lato,serif;font-size:7.0pt">or</span></i></p>
<p style="top:282.1pt;left:352.7pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Iliac AB</span></p>
<p style="top:201.3pt;left:342.2pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">7 m </span></p>
<p style="top:197.3pt;left:352.7pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">3, 6 m, 1, </span></p>
<p style="top:197.3pt;left:363.2pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">2y</span></p>
<p style="top:154.8pt;left:342.2pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Histo (qual) </span></p>
<p style="top:154.8pt;left:352.4pt;line-height:7.0pt"><span style="font-family:STIX,serif;font-size:7.0pt">&#x3bc;</span><span style="font-family:Lato,serif;font-size:7.0pt">CT (BV/</span></p>
<p style="top:154.8pt;left:363.2pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">TV%)</span></p>
<p style="top:101.6pt;left:342.2pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">NS</span></p>
<p style="top:101.6pt;left:352.7pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">NS</span></p>
<p style="top:721.1pt;left:376.8pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt"> Bertolai et al., 2015 (RCT)</span></p>
<p style="top:627.3pt;left:376.8pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">SA (&lt;5 mm) &#x2014;bi</span></p>
<p style="top:554.6pt;left:376.8pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">20 (10M, 55.2 y)</span></p>
<p style="top:480.3pt;left:375.7pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Iliac BMAC (Regen</span><span style="font-family:Lato,serif;font-size:4.9pt">&#xae;</span><span style="font-family:Lato,serif;font-size:7.0pt">, 14&#x2013;15 ml)</span></p>
<p style="top:359.6pt;left:376.8pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">FDBA + PRP</span></p>
<p style="top:286.1pt;left:376.8pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">FDBA only</span></p>
<p style="top:201.3pt;left:376.8pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">3 m</span></p>
<p style="top:154.8pt;left:376.8pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Histo (qual)</span></p>
<p style="top:101.6pt;left:376.8pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">T&gt;C</span></p>
<p style="top:721.1pt;left:390.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt"> Pasquali et al., 2015 </span></p>
<p style="top:717.1pt;left:400.9pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">(RCT)</span></p>
<p style="top:627.3pt;left:390.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">SA (&lt;4 mm) &#x2014;bi</span></p>
<p style="top:554.6pt;left:390.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">8 (~55y)</span></p>
<p style="top:480.3pt;left:389.3pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Iliac BMAC (Harvest</span><span style="font-family:Lato,serif;font-size:4.9pt">&#xae;</span><span style="font-family:Lato,serif;font-size:7.0pt">, 4 ml)</span></p>
<p style="top:359.6pt;left:389.3pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">DBBM (Bio- Oss</span><span style="font-family:Lato,serif;font-size:4.9pt">&#xae;</span><span style="font-family:Lato,serif;font-size:7.0pt">)</span></p>
<p style="top:286.1pt;left:390.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">DBBM only</span></p>
<p style="top:201.3pt;left:390.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">6 m</span></p>
<p style="top:154.8pt;left:390.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Histo</span></p>
<p style="top:101.6pt;left:390.4pt;line-height:7.0pt"><i><span style="font-family:Lato,serif;font-size:7.0pt">S</span></i></p>
<p style="top:721.1pt;left:414.6pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt"> De Oliveira et al., 2016 </span></p>
<p style="top:717.1pt;left:425.1pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">(RCT)</span></p>
<p style="top:627.3pt;left:414.6pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">SA (&lt;4 mm) &#x2014;uni/bi</span></p>
<p style="top:554.6pt;left:414.6pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">15 (12F, ~55y)</span></p>
<p style="top:480.3pt;left:414.6pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Iliac BMA&#x2014;single </span><i><span style="font-family:Lato,serif;font-size:7.0pt">or</span></i><span style="font-family:Lato,serif;font-size:7.0pt"> double </span></p>
<p style="top:476.3pt;left:425.1pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">centrifugation</span></p>
<p style="top:359.6pt;left:413.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">DBBM (Bio- Oss</span><span style="font-family:Lato,serif;font-size:4.9pt">&#xae;</span><span style="font-family:Lato,serif;font-size:7.0pt">)</span></p>
<p style="top:286.1pt;left:414.6pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">DBBM only</span></p>
<p style="top:201.3pt;left:414.6pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">6 m</span></p>
<p style="top:154.8pt;left:414.6pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Histo</span></p>
<p style="top:101.6pt;left:414.6pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">NS</span></p>
<p style="top:721.1pt;left:438.7pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt"> Pelegrine, da Costa, </span></p>
<p style="top:717.1pt;left:449.2pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Correa, &amp; Marques, 2010 </span></p>
<p style="top:717.1pt;left:459.7pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">(RCT)</span></p>
<p style="top:627.3pt;left:438.7pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">SP</span></p>
<p style="top:554.6pt;left:438.7pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">13 (7M, 28&#x2013;70 y)</span></p>
<p style="top:480.3pt;left:438.7pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Iliac BMA (4&#x2013;5 ml)</span></p>
<p style="top:359.6pt;left:438.7pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">None</span></p>
<p style="top:286.1pt;left:438.7pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Empty (clot)</span></p>
<p style="top:201.3pt;left:438.7pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">6 m</span></p>
<p style="top:154.8pt;left:438.7pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Histo</span></p>
<p style="top:101.6pt;left:438.7pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">NS</span></p>
<p style="top:721.1pt;left:473.3pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt"> Da Costa, Pelegrine, </span></p>
<p style="top:717.1pt;left:483.8pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Fagundes, Simoes Mde, </span></p>
<p style="top:717.1pt;left:494.3pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">&amp; Taha, 2011 (RCT)</span></p>
<p style="top:627.3pt;left:473.3pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">RA&#x2014;ant max (hor; </span></p>
<p style="top:623.3pt;left:483.8pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">&lt;5 mm)</span></p>
<p style="top:554.6pt;left:473.3pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">10 (8F, 40&#x2013;55 y)</span></p>
<p style="top:480.3pt;left:472.3pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Iliac BMAC (Harvest</span><span style="font-family:Lato,serif;font-size:4.9pt">&#xae;</span><span style="font-family:Lato,serif;font-size:7.0pt"> 4 ml)</span></p>
<p style="top:359.6pt;left:473.3pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Allograft block</span></p>
<p style="top:286.1pt;left:473.3pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Allograft only</span></p>
<p style="top:201.3pt;left:473.3pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">6 m</span></p>
<p style="top:154.8pt;left:473.3pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Histo</span></p>
<p style="top:101.6pt;left:473.3pt;line-height:7.0pt"><i><span style="font-family:Lato,serif;font-size:7.0pt">S</span></i></p>
<p style="top:721.1pt;left:508.0pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt"> Pelegrine et al., 2016 </span></p>
<p style="top:717.1pt;left:518.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">(RCT)</span></p>
<p style="top:627.3pt;left:508.0pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">RA&#x2014;ant max (hor; </span></p>
<p style="top:623.3pt;left:518.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">&lt;3 mm)</span></p>
<p style="top:554.6pt;left:508.0pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">8 (~52y)</span></p>
<p style="top:480.3pt;left:506.9pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Iliac BMAC (Harvest</span><span style="font-family:Lato,serif;font-size:4.9pt">&#xae;</span><span style="font-family:Lato,serif;font-size:7.0pt"> 4 ml)</span></p>
<p style="top:359.6pt;left:506.9pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">EBM (Bio- Gen</span><span style="font-family:Lato,serif;font-size:4.9pt">&#xae;</span><span style="font-family:Lato,serif;font-size:7.0pt">)</span></p>
<p style="top:286.1pt;left:508.0pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">EBM only</span></p>
<p style="top:201.3pt;left:508.0pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">4 m </span></p>
<p style="top:197.3pt;left:518.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">4, 8 m</span></p>
<p style="top:154.8pt;left:508.0pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Histo </span></p>
<p style="top:154.8pt;left:518.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">CBCT (BG)</span></p>
<p style="top:101.6pt;left:508.0pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">NS</span></p>
<p style="top:81.4pt;left:534.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(Continues)</span></p>
<p style="top:11.6pt;left:578.8pt;line-height:5.1pt"><span style="font-family:Times New Roman,serif;font-size:5.1pt"> 1600051x, 2019, S21, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jcpe.13049 by Universit&#xe4;tsbibliothek Zuerich, Wiley Online Library on [27/12/2022]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</span></p>


<p style="top:23.8pt;left:511.9pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003;&#x2002; &#x2003;</span></b><b><span style="font-family:Lato,serif;font-size:9.1pt">|</span></b><b><span style="font-family:Lato,serif;font-size:7.0pt"> &#x2003;167</span></b></p>
<img style="position:absolute;transform:matrix(.31940789,0,-0,.3187552,395.0849,3.744316)" src="data:image/jpeg;base64,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">
<p style="top:23.9pt;left:44.8pt;line-height:7.0pt"><span style="font-family:Lato-Regular,serif;font-size:7.0pt">SHANBHAG </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">et</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt"> </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">Al</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt">.</span></p>
<p style="top:721.1pt;left:79.6pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">Study (design)</span></b></p>
<p style="top:627.3pt;left:79.6pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">Site</span></b></p>
<p style="top:554.6pt;left:79.6pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">Patients (sex, age)</span></b></p>
<p style="top:480.3pt;left:61.7pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">Cell therapy group</span></b></p>
<p style="top:286.1pt;left:79.6pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">Control group</span></b></p>
<p style="top:201.3pt;left:79.6pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">Follow- up</span></b></p>
<p style="top:154.8pt;left:79.6pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">Method</span></b></p>
<p style="top:101.6pt;left:79.6pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">Outcome</span></b></p>
<p style="top:480.3pt;left:79.6pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">Cell source (culture)</span></b></p>
<p style="top:359.6pt;left:79.6pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">Scaffold</span></b></p>
<p style="top:721.1pt;left:95.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt"> Lavareda Correa et al., </span></p>
<p style="top:717.1pt;left:105.9pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">2017 (RCT)</span></p>
<p style="top:627.3pt;left:95.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">RA&#x2014;ant max (hor; </span></p>
<p style="top:623.3pt;left:105.9pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">2&#x2013;4 mm)</span></p>
<p style="top:554.6pt;left:95.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">10 (8F, 36&#x2013;52 y)</span></p>
<p style="top:480.3pt;left:94.3pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Iliac BMAC (Harvest</span><span style="font-family:Lato,serif;font-size:4.9pt">&#xae;</span><span style="font-family:Lato,serif;font-size:7.0pt"> 4 ml)</span></p>
<p style="top:359.6pt;left:95.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Allograft block + </span></p>
<p style="top:355.6pt;left:105.9pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">granules</span></p>
<p style="top:286.1pt;left:95.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Allograft only</span></p>
<p style="top:201.3pt;left:95.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">6 m</span></p>
<p style="top:154.8pt;left:95.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Histo </span></p>
<p style="top:154.8pt;left:105.9pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">CBCT (BV, </span></p>
<p style="top:154.8pt;left:116.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">BD)</span></p>
<p style="top:101.6pt;left:95.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">NS </span></p>
<p style="top:101.6pt;left:105.9pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">NS</span></p>
<p style="top:721.1pt;left:130.0pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt"> Marx &amp; Harrell, 2014 </span></p>
<p style="top:717.1pt;left:140.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">(RCT)</span></p>
<p style="top:627.3pt;left:130.0pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">RA&#x2014;man SD (6&#x2013;8 </span></p>
<p style="top:623.3pt;left:140.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">cm)</span></p>
<p style="top:554.6pt;left:130.0pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">40 (22M, 19&#x2013;78 y)</span></p>
<p style="top:480.3pt;left:128.9pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Iliac BMA (10 ml; 15.5 &#xd7; 10</span><span style="font-family:Lato,serif;font-size:4.9pt">6</span><span style="font-family:Lato,serif;font-size:7.0pt">/ml </span></p>
<p style="top:476.3pt;left:140.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">TNC + 54 &#xb1; 38/ml CD34 + ) </span><i><span style="font-family:Lato,serif;font-size:7.0pt">or</span></i><span style="font-family:Lato,serif;font-size:7.0pt"> </span></p>
<p style="top:476.3pt;left:149.9pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">BMAC (Harvest</span><span style="font-family:Lato,serif;font-size:4.9pt">&#xae;</span><span style="font-family:Lato,serif;font-size:7.0pt"> 10 ml; 98 &#xd7; 10</span><span style="font-family:Lato,serif;font-size:4.9pt">6</span><span style="font-family:Lato,serif;font-size:7.0pt">/</span></p>
<p style="top:476.3pt;left:161.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">ml TNC + 1000 &#xb1; 750/mL CD34 + </span></p>
<p style="top:476.3pt;left:172.0pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">cells)</span></p>
<p style="top:359.6pt;left:130.0pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Allograft + </span></p>
<p style="top:355.6pt;left:140.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">rhBMP- 2/Col </span></p>
<p style="top:355.6pt;left:151.0pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">sponge</span></p>
<p style="top:286.1pt;left:130.0pt;line-height:7.0pt"><i><span style="font-family:Lato,serif;font-size:7.0pt">BMA</span></i><span style="font-family:Lato,serif;font-size:7.0pt"> + scaffold</span></p>
<p style="top:201.3pt;left:130.0pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">6 m</span></p>
<p style="top:154.8pt;left:130.0pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Histo </span></p>
<p style="top:154.8pt;left:140.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">CT</span></p>
<p style="top:101.6pt;left:130.0pt;line-height:7.0pt"><i><span style="font-family:Lato,serif;font-size:7.0pt">S </span></i></p>
<p style="top:101.6pt;left:140.5pt;line-height:7.0pt"><i><span style="font-family:Lato,serif;font-size:7.0pt">S</span></i></p>
<p style="top:721.1pt;left:185.7pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt"> Talaat, Ghoneim, Salah, &amp; </span></p>
<p style="top:717.1pt;left:196.2pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Adly, 2018 (RCT)</span></p>
<p style="top:627.3pt;left:185.7pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Cyst&#x2014;mand</span></p>
<p style="top:554.6pt;left:185.7pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">20 (13M, 18&#x2013;50 y)</span></p>
<p style="top:480.3pt;left:184.6pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Iliac BMAC (Harvest</span><span style="font-family:Lato,serif;font-size:4.9pt">&#xae;</span><span style="font-family:Lato,serif;font-size:7.0pt"> 6&#x2013;9 ml)</span></p>
<p style="top:359.6pt;left:185.7pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">PRP + Col sponge</span></p>
<p style="top:286.1pt;left:185.7pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Empty defects</span></p>
<p style="top:201.3pt;left:185.7pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">3, 6, 12 m</span></p>
<p style="top:154.8pt;left:185.7pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Panoramic</span></p>
<p style="top:101.6pt;left:185.7pt;line-height:7.0pt"><i><span style="font-family:Lato,serif;font-size:7.0pt">S</span></i></p>
<p style="top:721.1pt;left:209.8pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt"> Du et al., 2017 (CT)</span></p>
<p style="top:627.3pt;left:209.8pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">AC&#x2014;uni</span></p>
<p style="top:554.6pt;left:209.8pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">20 (12F, 8&#x2013;28 y)</span></p>
<p style="top:480.3pt;left:208.7pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Iliac BMAC (TBD</span><span style="font-family:Lato,serif;font-size:4.9pt">&#xae;</span><span style="font-family:Lato,serif;font-size:7.0pt"> 1 ml)</span></p>
<p style="top:359.6pt;left:208.7pt;line-height:7.0pt"><span style="font-family:STIX,serif;font-size:7.0pt">&#x3b2;</span><span style="font-family:Lato,serif;font-size:7.0pt">- TCP (Bio- lu</span><span style="font-family:Lato,serif;font-size:4.9pt">&#xae;</span><span style="font-family:Lato,serif;font-size:7.0pt">)</span></p>
<p style="top:286.1pt;left:209.8pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Iliac AB</span></p>
<p style="top:201.3pt;left:209.8pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">6, 12 m</span></p>
<p style="top:154.8pt;left:209.8pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">CT (BV/TV%)</span></p>
<p style="top:101.6pt;left:209.8pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">NS</span></p>
<p style="top:721.1pt;left:223.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt"> Al- Ahmady et al., 2018 </span></p>
<p style="top:717.1pt;left:233.9pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">(RCT)</span></p>
<p style="top:627.3pt;left:223.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">AC&#x2014;uni</span></p>
<p style="top:554.6pt;left:223.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">20 (12F, 8&#x2013;18 y)</span></p>
<p style="top:480.3pt;left:223.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Iliac BMA (</span><i><span style="font-family:Lato,serif;font-size:7.0pt">Ficoll</span></i><span style="font-family:Lato,serif;font-size:7.0pt"> 2 ml)</span></p>
<p style="top:359.6pt;left:223.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Col sponge- nHA + </span></p>
<p style="top:355.6pt;left:233.9pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">PRF</span></p>
<p style="top:286.1pt;left:223.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Iliac AB</span></p>
<p style="top:201.3pt;left:223.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">6, 12 m</span></p>
<p style="top:154.8pt;left:223.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">CBCT (grade)</span></p>
<p style="top:101.6pt;left:223.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">T&gt;C</span></p>
<p style="top:721.1pt;left:247.6pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">Adipose SVF (n = 1)</span></b></p>
<p style="top:721.1pt;left:261.2pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt"> Prins et al., 2016 (CT); </span></p>
<p style="top:717.1pt;left:271.7pt;line-height:7.0pt"><i><span style="font-family:Lato,serif;font-size:7.0pt">Farre-Guasch</span></i><span style="font-family:Lato,serif;font-size:7.0pt"> et al.</span><i><span style="font-family:Lato,serif;font-size:7.0pt">,</span></i><span style="font-family:Lato,serif;font-size:7.0pt"> </span><i><span style="font-family:Lato,serif;font-size:7.0pt">2018</span></i><span style="font-family:Lato,serif;font-size:7.0pt"> </span></p>
<p style="top:627.3pt;left:261.2pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">SA (4&#x2013;8 mm) &#x2014;uni/</span></p>
<p style="top:623.3pt;left:271.7pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">bi</span></p>
<p style="top:554.6pt;left:261.2pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">10 (6F, 46&#x2013;69 y)</span></p>
<p style="top:480.3pt;left:260.1pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Abdominal SVF (Celution</span><span style="font-family:Lato,serif;font-size:4.9pt">&#xae;</span><span style="font-family:Lato,serif;font-size:7.0pt">, 5 ml </span></p>
<p style="top:476.3pt;left:271.7pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">cell susp., mixed pop., 83% CD90 </span></p>
<p style="top:476.3pt;left:281.1pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">+ , 67% CD34 + ), 2 &#xd7; 10</span><span style="font-family:Lato,serif;font-size:4.9pt">7</span><span style="font-family:Lato,serif;font-size:7.0pt"> cells/2 </span></p>
<p style="top:476.3pt;left:291.6pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">g scaffold/SA (1.4 &#xd7; 10</span><span style="font-family:Lato,serif;font-size:4.9pt">5</span><span style="font-family:Lato,serif;font-size:7.0pt"> CFU- F/g)</span></p>
<p style="top:359.6pt;left:260.1pt;line-height:7.0pt"><span style="font-family:STIX,serif;font-size:7.0pt">&#x3b2;</span><span style="font-family:Lato,serif;font-size:7.0pt">- TCP (Ceros</span><span style="font-family:Lato,serif;font-size:4.9pt">&#xae;</span><span style="font-family:Lato,serif;font-size:7.0pt">) or </span></p>
<p style="top:355.6pt;left:271.7pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">BCP (Bone </span></p>
<p style="top:355.6pt;left:281.1pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Ceramic</span><span style="font-family:Lato,serif;font-size:4.9pt">&#xae;</span><span style="font-family:Lato,serif;font-size:7.0pt">)</span></p>
<p style="top:286.1pt;left:260.9pt;line-height:7.0pt"><span style="font-family:STIX,serif;font-size:7.0pt">&#x3b2;</span><span style="font-family:Lato,serif;font-size:7.0pt">- TCP </span><i><span style="font-family:Lato,serif;font-size:7.0pt">or</span></i><span style="font-family:Lato,serif;font-size:7.0pt"> BCP only</span></p>
<p style="top:201.3pt;left:261.2pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">6 m </span></p>
<p style="top:197.3pt;left:271.7pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">6 m </span></p>
<p style="top:197.3pt;left:282.2pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">2.5y</span></p>
<p style="top:154.8pt;left:261.2pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Histo </span></p>
<p style="top:154.8pt;left:271.4pt;line-height:7.0pt"><span style="font-family:STIX,serif;font-size:7.0pt">&#x3bc;</span><span style="font-family:Lato,serif;font-size:7.0pt">CT </span></p>
<p style="top:154.8pt;left:282.2pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">IHC (CD34, </span></p>
<p style="top:154.8pt;left:292.7pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">SMA) </span></p>
<p style="top:154.8pt;left:303.2pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">IS</span></p>
<p style="top:101.6pt;left:261.2pt;line-height:7.0pt"><i><span style="font-family:Lato,serif;font-size:7.0pt">S</span></i><span style="font-family:Lato,serif;font-size:7.0pt">NS </span></p>
<p style="top:101.6pt;left:282.2pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt"> NS </span></p>
<p style="top:101.6pt;left:303.2pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">100%</span></p>
<p style="top:721.1pt;left:316.8pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">Micrografts (n = 4)</span></b></p>
<p style="top:721.1pt;left:330.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt"> d&#x2019;Aquino et al., 2009 </span></p>
<p style="top:717.1pt;left:341.0pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">(CT); </span><i><span style="font-family:Lato,serif;font-size:7.0pt">Giuliani</span></i><span style="font-family:Lato,serif;font-size:7.0pt"> et al., </span><i><span style="font-family:Lato,serif;font-size:7.0pt">2013</span></i></p>
<p style="top:627.3pt;left:330.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">SP&#x2014;bi</span></p>
<p style="top:554.6pt;left:330.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">7</span></p>
<p style="top:480.3pt;left:329.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Dental pulp- derived (Rigenera</span><span style="font-family:Lato,serif;font-size:4.9pt">&#xae;</span><span style="font-family:Lato,serif;font-size:7.0pt">)</span></p>
<p style="top:359.6pt;left:330.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Col sponge </span></p>
<p style="top:355.6pt;left:339.9pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">(Gingistat</span><span style="font-family:Lato,serif;font-size:4.9pt">&#xae;</span><span style="font-family:Lato,serif;font-size:7.0pt">)</span></p>
<p style="top:286.1pt;left:330.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Col sponge only</span></p>
<p style="top:201.3pt;left:330.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">3 m</span><span style="font-family:Lato,serif;font-size:7.0pt"> </span></p>
<p style="top:197.3pt;left:341.0pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">36 m</span></p>
<p style="top:154.8pt;left:330.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Histo (qual) </span></p>
<p style="top:154.8pt;left:341.0pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Histo</span></p>
<p style="top:101.6pt;left:330.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">T&gt;C </span></p>
<p style="top:101.6pt;left:341.0pt;line-height:7.0pt"><i><span style="font-family:Lato,serif;font-size:7.0pt">S</span></i></p>
<p style="top:721.1pt;left:354.6pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt"> Monti et al., (2016) (CT)</span></p>
<p style="top:627.3pt;left:354.6pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">SP&#x2014;bi</span></p>
<p style="top:554.6pt;left:354.6pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">6 (4F, 22&#x2013;60 y)</span></p>
<p style="top:480.3pt;left:353.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Dental pulp-derived (Rigenera</span><span style="font-family:Lato,serif;font-size:4.9pt">&#xae;</span><span style="font-family:Lato,serif;font-size:7.0pt">)</span></p>
<p style="top:286.1pt;left:354.6pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Col sponge only</span></p>
<p style="top:201.3pt;left:354.6pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">45&#x2013;70 days</span></p>
<p style="top:154.8pt;left:354.6pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Histo (qual)</span></p>
<p style="top:101.6pt;left:354.6pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">T&gt;C</span></p>
<p style="top:721.1pt;left:368.2pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt"> D&#x2019;Aquino et al. (2016) </span></p>
<p style="top:717.1pt;left:378.7pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">(CT)</span></p>
<p style="top:627.3pt;left:368.2pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">SP (multi- rooted) </span></p>
<p style="top:623.3pt;left:378.7pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">&#x2014;bi</span></p>
<p style="top:554.6pt;left:368.2pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">35 (21F, 25&#x2013;64 y)</span></p>
<p style="top:480.3pt;left:368.2pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Max periosteum- derived </span></p>
<p style="top:476.3pt;left:377.7pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">(Rigenera</span><span style="font-family:Lato,serif;font-size:4.9pt">&#xae;</span><span style="font-family:Lato,serif;font-size:7.0pt">)</span></p>
<p style="top:359.6pt;left:368.2pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Col sponge </span></p>
<p style="top:355.6pt;left:377.7pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">(Gingistat</span><span style="font-family:Lato,serif;font-size:4.9pt">&#xae;</span><span style="font-family:Lato,serif;font-size:7.0pt">)</span></p>
<p style="top:286.1pt;left:368.2pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Col sponge only</span></p>
<p style="top:201.3pt;left:368.2pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">45&#x2013;90 days</span></p>
<p style="top:154.8pt;left:368.2pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Clinical </span></p>
<p style="top:154.8pt;left:378.7pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Histo (qual)</span></p>
<p style="top:101.6pt;left:368.2pt;line-height:7.0pt"><i><span style="font-family:Lato,serif;font-size:7.0pt">S</span></i></p>
<p style="top:101.6pt;left:378.7pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">T&gt;C</span></p>
<p style="top:721.1pt;left:392.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt"> Rodriguez et al. (2017) </span></p>
<p style="top:717.1pt;left:402.9pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">(CT)</span></p>
<p style="top:627.3pt;left:392.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">SA&#x2014;uni</span></p>
<p style="top:554.6pt;left:392.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">24 (12F, 45&#x2013;64 y)</span></p>
<p style="top:480.3pt;left:392.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Max periosteum-derived </span></p>
<p style="top:476.3pt;left:401.8pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">(Rigenera</span><span style="font-family:Lato,serif;font-size:4.9pt">&#xae;</span><span style="font-family:Lato,serif;font-size:7.0pt">)</span></p>
<p style="top:359.6pt;left:392.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">PLGA/HA</span></p>
<p style="top:286.1pt;left:392.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">PLGA/HA </span><i><span style="font-family:Lato,serif;font-size:7.0pt">or</span></i><span style="font-family:Lato,serif;font-size:7.0pt"> DBBM </span></p>
<p style="top:282.1pt;left:401.8pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">(Bio- Oss</span><span style="font-family:Lato,serif;font-size:4.9pt">&#xae;</span><span style="font-family:Lato,serif;font-size:7.0pt">)</span></p>
<p style="top:201.3pt;left:392.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">4 m</span></p>
<p style="top:154.8pt;left:392.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Histo</span></p>
<p style="top:101.6pt;left:392.4pt;line-height:7.0pt"><i><span style="font-family:Lato,serif;font-size:7.0pt">S</span></i></p>
<p style="top:725.7pt;left:418.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">CT: controlled trial; RCT: randomized CT; CC: case&#x2013;control; SA: sinus augmentation; RA: ridge augmentation/GBR; SP: socket preservation; AC: alveolar cleft; SD: segmental or continuity defects; CD: </span></p>
<p style="top:725.7pt;left:429.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">cranial defect; ORN: osteoradionecrosis; uni: unilateral; bi: bilateral; imp: simultaneous implant placement; man: mandible; max: maxilla; hor: horizontal; M: male; F: female; y: years; m: months; w: weeks; </span></p>
<p style="top:725.7pt;left:439.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Histo: histomorphometry; Histo (qual): qualitative histology; IHC: immunohistochemistry; Radio: radiographic; CT: computed tomography; V: volume; </span><span style="font-family:STIX,serif;font-size:7.5pt">&#x3bc;</span><span style="font-family:Lato,serif;font-size:7.5pt">CT; micro- CT; BV/TV: bone volume/total volume; BG: </span></p>
<p style="top:725.7pt;left:450.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">bone gain; T: test group; C: control group; Comp: complications; IS: implant survival; +: favourable bone regeneration outcomes; BMA: bone marrow aspirate; BMAC: bone marrow aspirate concentrate; AB: </span></p>
<p style="top:725.7pt;left:460.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">autogenous bone; HA: hydroxyl- apatite; </span><span style="font-family:STIX,serif;font-size:7.5pt">&#x3b2;</span><span style="font-family:Lato,serif;font-size:7.5pt">- TCP: beta- tricalcium phosphate; BCP: biphasic calcium phosphate; BAG: bioactive glass; GAG: glycosaminoglycans; Col: collagen; DBBM: demineralized bovine </span></p>
<p style="top:725.7pt;left:471.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">bone mineral; ABB: anorganic bovine bone; Pep: PepGen; PRP: platelet- rich plasma; PRF: platelet- rich fibrin; rhBMP- 2: recombinant human bone morphogenetic protein- 2; FD: freeze- dried; PLA: poly- </span></p>
<p style="top:725.7pt;left:481.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">lactide; PLGA: polylactic- co- glycolic acid; </span><i><span style="font-family:Lato,serif;font-size:7.5pt">study/year in italics</span></i><span style="font-family:Lato,serif;font-size:7.5pt">: follow- up study reporting on the same patient sample; </span><i><span style="font-family:Lato,serif;font-size:7.5pt">S</span></i><span style="font-family:Lato,serif;font-size:7.5pt">: statistically significant differences between T and C groups; NS: no statistically signifi-</span></p>
<p style="top:725.7pt;left:492.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">cant differences between T and C groups.</span></p>
<p style="top:725.3pt;left:43.3pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">TA B LE&#xa0;2&#x2003;</span><span style="font-family:Lato,serif;font-size:8.0pt">(Continued)</span></p>
<p style="top:11.6pt;left:578.8pt;line-height:5.1pt"><span style="font-family:Times New Roman,serif;font-size:5.1pt"> 1600051x, 2019, S21, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jcpe.13049 by Universit&#xe4;tsbibliothek Zuerich, Wiley Online Library on [27/12/2022]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</span></p>


<p style="top:23.8pt;left:46.5pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">168&#x2003; </span></b><b><span style="font-family:Lato,serif;font-size:9.1pt">|</span></b><b><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003; &#x2003;&#x2002;</span></b></p>
<img style="position:absolute;transform:matrix(.31940789,0,-0,.3187552,54.97612,3.7443963)" src="data:image/jpeg;base64,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">
<p style="top:23.8pt;left:493.4pt;line-height:7.0pt"><span style="font-family:Lato-Regular,serif;font-size:7.0pt">SHANBHAG </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">et</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt"> </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">Al</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt">.</span></p>
<p style="top:49.0pt;left:59.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Fifty- seven eligible pre- clinical in vivo studies in large- animal </span></p>
<p style="top:62.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">models [dogs, minipigs and small- ruminants (sheep and goats)] were </span></p>
<p style="top:75.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">also identified (Supporting Information Tables S4&#x2013;S6). These studies </span></p>
<p style="top:88.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">represented SA, RA [in the form of critical size defects (CSD)], and </span></p>
<p style="top:101.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">AC models. The following section is focused on results of the meta- </span></p>
<p style="top:114.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">analyses. Details of the included clinical studies, along with relevant </span></p>
<p style="top:127.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">supporting literature, are presented in the discussion.</span></p>
<p style="top:157.9pt;left:46.5pt;line-height:10.0pt"><b><span style="font-family:Lato,serif;font-size:10.0pt">3.2&#x2003;</span></b><span style="font-family:Lato,serif;font-size:10.0pt">|</span><b><span style="font-family:Lato,serif;font-size:10.0pt">&#x2003;Meta- analyses: Effect sizes of cell therapy</span></b></p>
<p style="top:179.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">The clinical evidence is mostly based on randomized (SA, RA) and </span></p>
<p style="top:192.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">non- randomized controlled trials (AC repair). Twenty- six studies re-</span></p>
<p style="top:205.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">porting quantitative outcomes of bone regeneration based on histo-</span></p>
<p style="top:218.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">morphometry (NBF), </span><span style="font-family:STIX,serif;font-size:8.0pt">&#x3bc;</span><span style="font-family:Lato,serif;font-size:8.0pt">- CT [regenerated bone volume/total volume </span></p>
<p style="top:231.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(BV/TV)] or CT (BF) were included in separate meta- analyses. Pooled </span></p>
<p style="top:244.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">estimates of treatment effect [effect sizes (ES)] were calculated for </span></p>
<p style="top:257.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">the outcomes NBF, BV/TV and BF in SA/RA, SA and AC repair, re-</span></p>
<p style="top:270.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">spectively. For SA studies, sub- group analyses were performed ac-</span></p>
<p style="top:283.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">cording to the time of biopsy, that is at 3&#x2013;4 months or 6 months after </span></p>
<p style="top:296.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">augmentation. Additionally, regression analyses were performed to </span></p>
<p style="top:309.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">evaluate the effect of time (&lt;/&gt;6 months) and types of cells used </span></p>
<p style="top:322.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(whole tissue, uncommitted or committed) on bone regeneration. </span></p>
<p style="top:335.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Overall, the clinical meta- analyses revealed:</span></p>
<p style="top:361.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">a). in SA, significantly greater bone regeneration was observed </span></p>
<p style="top:374.0pt;left:55.9pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">after cell therapy in 1 meta-analysis of histomorphometric re-</span></p>
<p style="top:387.0pt;left:55.9pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">sults (ES: 4.12% NBF, 6 studies, vs. scaffolds, 6 months) and in </span></p>
<p style="top:400.0pt;left:55.9pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">1 meta-analysis of </span><span style="font-family:STIX,serif;font-size:8.0pt">&#x3bc;</span><span style="font-family:Lato,serif;font-size:8.0pt">-CT results (ES: 4.76% BV/TV, 3 studies, </span></p>
<p style="top:413.0pt;left:55.9pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">vs. scaffolds, 4&#x2013;7 months), while in 1 meta-analysis of histo-</span></p>
<p style="top:426.0pt;left:55.9pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">morphometric results no benefit was observed (12 studies, vs. </span></p>
<p style="top:439.0pt;left:55.9pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">scaffolds, 3&#x2013;4 months). Based on a meta-regression analysis of </span></p>
<p style="top:452.0pt;left:55.9pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">histomorphometric data from 15 studies, there were no differ-</span></p>
<p style="top:465.0pt;left:55.9pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ences between the various cell therapy strategies, that is whole </span></p>
<p style="top:478.0pt;left:55.9pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">tissues vs. expanded uncommitted cells vs. expanded committed </span></p>
<p style="top:491.0pt;left:55.9pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">cells, in terms of the amount of bone regeneration (Supporting </span></p>
<p style="top:504.0pt;left:55.9pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Information Table S7).</span></p>
<p style="top:517.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">b). in horizontal RA, significantly greater bone regeneration was ob-</span></p>
<p style="top:530.0pt;left:55.9pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">served after cell therapy in 1 meta-analysis of histomorphometric </span></p>
<p style="top:543.0pt;left:55.9pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">results (ES: 13.42% NBF, 3 studies, vs. scaffolds; 1 study, vs. scaf</span><span style="font-family:Lato,serif;font-size:8.0pt">-</span></p>
<p style="top:556.0pt;left:55.9pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">fold + AB, 4&#x2013;6 months).</span></p>
<p style="top:569.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">c). in AC defects, 1 meta-analysis failed to show a benefit of cell ther-</span></p>
<p style="top:582.0pt;left:55.9pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">apy over AB, as evaluated with CT (3 studies, 6 months).</span></p>
<p style="top:608.0pt;left:59.4pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Overall, the clinical meta- analyses revealed moderate to high het</span><span style="font-family:Lato,serif;font-size:8.0pt">-</span></p>
<p style="top:621.0pt;left:46.4pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">erogeneity (I</span><sup><span style="font-family:Lato,serif;font-size:5.6pt">2</span></sup><span style="font-family:Lato,serif;font-size:8.0pt"> 70%&#x2013;99%), and wide predictive intervals, often crossing </span></p>
<p style="top:634.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">the line of no effect (Table 5, Supporting Information Figures S2&#x2013;S4).</span></p>
<p style="top:647.0pt;left:59.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">A meta- analysis of 57 eligible preclinical studies was also per-</span></p>
<p style="top:660.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">formed to compare the preclinical and clinical evidence for cell ther-</span></p>
<p style="top:673.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">apy and thereby assess its translation. To allow comparison with </span></p>
<p style="top:686.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">clinical data, similar pooled estimates (ES) were calculated for histo-</span></p>
<p style="top:699.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">morphometric NBF. Sub- group analyses according to species and </span></p>
<p style="top:712.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">observation times were performed; analysis according to cell types </span></p>
<p style="top:725.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(whole tissue, uncommitted or committed) could not be performed </span></p>
<p style="top:49.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">due to insufficient numbers of studies/comparisons in each sub- </span></p>
<p style="top:62.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">group. Overall, the pre- clinical meta- analyses revealed:</span></p>
<p style="top:88.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">a). in SA models, significantly greater bone regeneration was ob-</span></p>
<p style="top:101.0pt;left:317.0pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">served after cell therapy in dogs (ES: 10.21% NBF, 5 studies, vs. </span></p>
<p style="top:114.0pt;left:317.0pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">scaffolds, &lt;6 months) and small-ruminants (ES: 11.11% NBF, 3 </span></p>
<p style="top:127.0pt;left:317.0pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">studies, vs. AB, 2&#x2013;4 months).</span></p>
<p style="top:140.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">b). in CSD models, significantly greater bone regeneration was ob-</span></p>
<p style="top:153.0pt;left:317.0pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">served after cell therapy in dogs (ES: 12.14/20.11% NBF, 12 stud-</span></p>
<p style="top:166.0pt;left:317.0pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ies, vs. scaffolds, 1&#x2013;2/2&#x2013;4 months and ES: 48.73%, 3 studies, vs. </span></p>
<p style="top:179.0pt;left:317.0pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">scaffolds, 12 months), pigs (ES: 14.84% NBF, 4 studies, vs. scaf-</span></p>
<p style="top:192.0pt;left:317.0pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">folds, 2&#x2013;3 months) and small-ruminants (25.78% NBF, 3 studies, </span></p>
<p style="top:205.0pt;left:317.0pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">vs. scaffolds, 3&#x2013;5 months).</span></p>
<p style="top:218.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">c). in AC defect models, no significant benefit of cell therapy over AB </span></p>
<p style="top:231.0pt;left:317.0pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">was observed in dogs (3 studies, 2&#x2013;5 months).</span></p>
<p style="top:257.0pt;left:320.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Similar to clinical studies, the pre- clinical meta- analyses also re-</span></p>
<p style="top:270.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">vealed moderate to high heterogeneity (I</span><sup><span style="font-family:Lato,serif;font-size:5.6pt">2</span></sup><span style="font-family:Lato,serif;font-size:8.0pt"> 60%&#x2013;99%) with wide pre-</span></p>
<p style="top:283.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">dictive intervals (Table 5, Supporting Information Figures S5&#x2013;S7). </span></p>
<p style="top:296.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">However, for all comparisons, larger ES were observed in the pre- </span></p>
<p style="top:309.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">clinical vs. clinical meta- analyses.</span></p>
<p style="top:346.4pt;left:307.5pt;line-height:10.0pt"><b><span style="font-family:Lato,serif;font-size:10.0pt">4&#x2003;</span></b><span style="font-family:Lato,serif;font-size:10.0pt">|</span><b><span style="font-family:Lato,serif;font-size:10.0pt">&#x2003;DISCUSSION</span></b></p>
<p style="top:374.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">The primary objective of the present review was to assess the cur-</span></p>
<p style="top:387.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">rent clinical evidence on the effectiveness of cell therapy for orofa-</span></p>
<p style="top:400.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">cial bone regeneration, compared to grafting with only biomaterial </span></p>
<p style="top:413.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">scaffolds and/or AB. Based on limited data from 26 (of 47 included) </span></p>
<p style="top:426.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">controlled studies, implantation of cells in combination with scaf-</span></p>
<p style="top:439.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">folds seems to be (a) superior to implantation of scaffolds alone in SA </span></p>
<p style="top:452.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(based on histological and </span><span style="font-family:STIX,serif;font-size:8.0pt">&#x3bc;</span><span style="font-family:Lato,serif;font-size:8.0pt">- CT outcomes) and horizontal RA (based </span></p>
<p style="top:465.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">on histological outcomes), and (b) comparable to AB grafts in AC re-</span></p>
<p style="top:478.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">pair (based on CT outcomes). Although the meta- analyses revealed </span></p>
<p style="top:491.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">statistically significant outcomes for these comparisons, heteroge-</span></p>
<p style="top:504.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">neity in the studies was high as evidenced by the wide prediction in-</span></p>
<p style="top:517.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">tervals (Table 5). While the current available evidence is insufficient </span></p>
<p style="top:530.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">to determine the best strategy in terms of cell&#x2013;types and &#x2013;sources </span></p>
<p style="top:543.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(whole tissue, uncommitted or committed), a discussion around this </span></p>
<p style="top:556.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">topic seems to be clinically important and is presented herein.</span></p>
<p style="top:586.9pt;left:307.5pt;line-height:10.0pt"><b><span style="font-family:Lato,serif;font-size:10.0pt">4.1&#x2003;</span></b><span style="font-family:Lato,serif;font-size:10.0pt">|</span><b><span style="font-family:Lato,serif;font-size:10.0pt">&#x2003;Use of minimally manipulated whole </span></b></p>
<p style="top:599.9pt;left:307.5pt;line-height:10.0pt"><b><span style="font-family:Lato,serif;font-size:10.0pt">tissue fractions</span></b></p>
<p style="top:621.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">A majority of included studies reported the use of minimally ma-</span></p>
<p style="top:634.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">nipulated whole tissue fractions, particularly bone marrow&#x2014;as </span></p>
<p style="top:647.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">either whole (BMA) or concentrated (BMAC) aspirates (Table 2, </span></p>
<p style="top:660.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Supploring Information Table S1). In several studies, significantly </span></p>
<p style="top:673.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">greater NBF was observed when using autologous BMAC- loaded </span></p>
<p style="top:686.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">vs. cell- free scaffolds (most commonly DBBM) in SA and RA. While </span></p>
<p style="top:699.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">a majority of studies reported harvesting from the iliac crest, one </span></p>
<p style="top:712.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">study each reported harvesting from the femur (Ibanez, Agustina, </span></p>
<p style="top:725.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Ibanez, &amp; Ibanez, 2012) and tibia (Payer et al., 2014). Regarding the </span></p>
<p style="top:11.6pt;left:578.8pt;line-height:5.1pt"><span style="font-family:Times New Roman,serif;font-size:5.1pt"> 1600051x, 2019, S21, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jcpe.13049 by Universit&#xe4;tsbibliothek Zuerich, Wiley Online Library on [27/12/2022]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</span></p>


<p style="top:23.8pt;left:511.9pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003;&#x2002; &#x2003;</span></b><b><span style="font-family:Lato,serif;font-size:9.1pt">|</span></b><b><span style="font-family:Lato,serif;font-size:7.0pt"> &#x2003;169</span></b></p>
<img style="position:absolute;transform:matrix(.31940789,0,-0,.3187552,395.0849,3.744316)" src="data:image/jpeg;base64,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">
<p style="top:23.9pt;left:44.8pt;line-height:7.0pt"><span style="font-family:Lato-Regular,serif;font-size:7.0pt">SHANBHAG </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">et</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt"> </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">Al</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt">.</span></p>
<p style="top:725.3pt;left:39.3pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">TA B LE&#xa0;3&#x2003;</span><span style="font-family:Lato,serif;font-size:8.0pt">Summary of controlled studies using &#x201c;uncommitted&#x201d; culture- expanded cells</span></p>
<p style="top:722.7pt;left:70.4pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Study (design)</span></b></p>
<p style="top:641.6pt;left:70.4pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Site</span></b></p>
<p style="top:580.1pt;left:59.9pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Patients (sex, </span></b></p>
<p style="top:580.1pt;left:70.4pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">age)</span></b></p>
<p style="top:519.0pt;left:56.4pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Cell therapy group</span></b></p>
<p style="top:259.6pt;left:70.4pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Control group</span></b></p>
<p style="top:187.6pt;left:70.4pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Follow- up</span></b></p>
<p style="top:141.9pt;left:70.4pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Method</span></b></p>
<p style="top:99.0pt;left:70.4pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Outcome</span></b></p>
<p style="top:519.0pt;left:70.4pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Cell source (culture)</span></b></p>
<p style="top:426.1pt;left:70.4pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Cell number</span></b></p>
<p style="top:339.5pt;left:70.4pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Scaffold</span></b></p>
<p style="top:722.7pt;left:84.4pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">BMSCs (n = 5)</span></b></p>
<p style="top:722.7pt;left:98.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Hernandez Alfero </span></p>
<p style="top:718.7pt;left:109.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">et al. (2005) (RCT)</span></p>
<p style="top:641.6pt;left:98.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">SA (3&#x2013;13 mm) </span></p>
<p style="top:637.6pt;left:109.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2014;bilat</span></p>
<p style="top:580.1pt;left:98.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">5 (5F, 37&#x2013;75 y)</span></p>
<p style="top:519.0pt;left:97.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Replicell</span><span style="font-family:Lato,serif;font-size:5.2pt">&#xae;</span><span style="font-family:Lato,serif;font-size:7.5pt"> or </span></p>
<p style="top:515.0pt;left:107.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Ixymyelocel- t</span><span style="font-family:Lato,serif;font-size:5.2pt">&#xae;</span><span style="font-family:Lato,serif;font-size:7.5pt"> Iliac </span></p>
<p style="top:515.0pt;left:119.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x201c;TRCs&#x201d; (IMDM + 10% </span></p>
<p style="top:515.0pt;left:130.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">FBS + 10% HS, </span></p>
<p style="top:515.0pt;left:140.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">12&#x2013;14 days)</span></p>
<p style="top:426.1pt;left:97.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">7&#x2013;20 &#xd7; 10</span><span style="font-family:Lato,serif;font-size:5.2pt">7</span><span style="font-family:Lato,serif;font-size:7.5pt"> cells/SA</span></p>
<p style="top:339.5pt;left:98.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">DBBM </span></p>
<p style="top:335.5pt;left:107.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(Bio- Oss</span><span style="font-family:Lato,serif;font-size:5.2pt">&#xae;</span><span style="font-family:Lato,serif;font-size:7.5pt">) + PPF</span></p>
<p style="top:259.6pt;left:98.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">DBBM+ PPF</span></p>
<p style="top:187.6pt;left:98.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">4 m</span></p>
<p style="top:141.9pt;left:98.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Histo </span></p>
<p style="top:141.9pt;left:109.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">CT</span></p>
<p style="top:99.0pt;left:98.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">NS</span></p>
<p style="top:722.7pt;left:154.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Kaigler et al. (2015) </span></p>
<p style="top:718.7pt;left:165.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(RCT)</span></p>
<p style="top:641.6pt;left:154.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">SA (2&#x2013;6.2 mm) </span></p>
<p style="top:637.6pt;left:165.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2014;unilat</span></p>
<p style="top:580.2pt;left:154.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">26 (10F, </span></p>
<p style="top:576.2pt;left:165.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">26&#x2013;66 y)</span></p>
<p style="top:519.0pt;left:153.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Replicell</span><span style="font-family:Lato,serif;font-size:5.2pt">&#xae;</span><span style="font-family:Lato,serif;font-size:7.5pt"> or </span></p>
<p style="top:515.0pt;left:163.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Ixymyelocel-t</span><span style="font-family:Lato,serif;font-size:5.2pt">&#xae;</span><span style="font-family:Lato,serif;font-size:7.5pt"> Iliac </span></p>
<p style="top:515.0pt;left:175.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x201c;TRCs&#x201d;</span></p>
<p style="top:426.1pt;left:153.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">1.6&#x2013;15 &#xd7; 10</span><span style="font-family:Lato,serif;font-size:5.2pt">7</span><span style="font-family:Lato,serif;font-size:7.5pt"> cells/SA</span></p>
<p style="top:339.5pt;left:153.4pt;line-height:7.5pt"><span style="font-family:STIX,serif;font-size:7.5pt">&#x3b2;</span><span style="font-family:Lato,serif;font-size:7.5pt">- TCP (Cerasorb</span><span style="font-family:Lato,serif;font-size:5.2pt">&#xae;</span><span style="font-family:Lato,serif;font-size:7.5pt">)</span></p>
<p style="top:259.6pt;left:154.2pt;line-height:7.5pt"><span style="font-family:STIX,serif;font-size:7.5pt">&#x3b2;</span><span style="font-family:Lato,serif;font-size:7.5pt">- TCP only</span></p>
<p style="top:187.6pt;left:154.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">4 m</span></p>
<p style="top:141.9pt;left:154.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Histo </span></p>
<p style="top:141.9pt;left:164.7pt;line-height:7.5pt"><span style="font-family:STIX,serif;font-size:7.5pt">&#x3bc;</span><span style="font-family:Lato,serif;font-size:7.5pt">CT</span></p>
<p style="top:99.0pt;left:154.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Unclear</span></i></p>
<p style="top:99.0pt;left:165.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">NS overall</span></p>
<p style="top:722.7pt;left:189.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Kaigler et al. (2013) </span></p>
<p style="top:718.7pt;left:200.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(RCT)</span></p>
<p style="top:641.6pt;left:189.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">SP&#x2014;unilat</span></p>
<p style="top:580.1pt;left:189.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">24 (13F, </span></p>
<p style="top:576.1pt;left:200.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">31&#x2013;63 y)</span></p>
<p style="top:519.0pt;left:188.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Replicell</span><span style="font-family:Lato,serif;font-size:5.2pt">&#xae;</span><span style="font-family:Lato,serif;font-size:7.5pt"> or </span></p>
<p style="top:515.0pt;left:198.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Ixymyelocel-t</span><span style="font-family:Lato,serif;font-size:5.2pt">&#xae;</span><span style="font-family:Lato,serif;font-size:7.5pt"> Iliac </span></p>
<p style="top:515.0pt;left:210.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x201c;TRCs&#x201d;</span></p>
<p style="top:426.1pt;left:188.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">1.5 &#xd7; 10</span><span style="font-family:Lato,serif;font-size:5.2pt">7</span><span style="font-family:Lato,serif;font-size:7.5pt"> cells/SP</span></p>
<p style="top:339.5pt;left:189.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Gelatin sponge </span></p>
<p style="top:335.5pt;left:198.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(Gelfoam</span><span style="font-family:Lato,serif;font-size:5.2pt">&#xae;</span><span style="font-family:Lato,serif;font-size:7.5pt">)</span></p>
<p style="top:259.6pt;left:189.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Gelatin sponge </span></p>
<p style="top:255.6pt;left:200.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">only</span></p>
<p style="top:187.6pt;left:189.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">6, 12 w</span></p>
<p style="top:141.9pt;left:189.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Histo </span></p>
<p style="top:141.9pt;left:199.8pt;line-height:7.5pt"><span style="font-family:STIX,serif;font-size:7.5pt">&#x3bc;</span><span style="font-family:Lato,serif;font-size:7.5pt">CT</span></p>
<p style="top:99.0pt;left:189.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">NS </span></p>
<p style="top:99.0pt;left:200.0pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">S 6w</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, NS 12w</span></p>
<p style="top:722.7pt;left:224.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Bajestan et al. (2017) </span></p>
<p style="top:718.7pt;left:235.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(RCT)</span></p>
<p style="top:641.6pt;left:224.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">RA (hor; 2&#xb0; to </span></p>
<p style="top:637.6pt;left:235.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">AC or trauma)</span></p>
<p style="top:580.1pt;left:224.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">17 (12M, </span></p>
<p style="top:576.2pt;left:235.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">18&#x2013;54 y)</span></p>
<p style="top:519.0pt;left:223.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Replicell</span><span style="font-family:Lato,serif;font-size:5.2pt">&#xae;</span><span style="font-family:Lato,serif;font-size:7.5pt"> or </span></p>
<p style="top:515.0pt;left:233.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Ixymyelocel-t</span><span style="font-family:Lato,serif;font-size:5.2pt">&#xae;</span><span style="font-family:Lato,serif;font-size:7.5pt"> Iliac </span></p>
<p style="top:515.0pt;left:245.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x201c;TRCs&#x201d;</span></p>
<p style="top:426.1pt;left:223.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">1.5&#x2013;4.4 &#xd7; 10</span><span style="font-family:Lato,serif;font-size:5.2pt">7</span><span style="font-family:Lato,serif;font-size:7.5pt"> cells/cc  </span></p>
<p style="top:422.1pt;left:235.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(2&#x2013;5 cc/pt)</span></p>
<p style="top:339.5pt;left:223.4pt;line-height:7.5pt"><span style="font-family:STIX,serif;font-size:7.5pt">&#x3b2;</span><span style="font-family:Lato,serif;font-size:7.5pt">- TCP (Cerasorb</span><span style="font-family:Lato,serif;font-size:5.2pt">&#xae;</span><span style="font-family:Lato,serif;font-size:7.5pt">)</span></p>
<p style="top:259.6pt;left:224.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Man AB</span></p>
<p style="top:187.6pt;left:224.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">4 m</span></p>
<p style="top:141.9pt;left:224.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Re- entry</span></p>
<p style="top:99.0pt;left:224.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">NS </span></p>
<p style="top:99.0pt;left:235.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Comp</span></p>
<p style="top:722.7pt;left:259.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Khalifa and Gomaa </span></p>
<p style="top:718.7pt;left:270.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(2017) (CT)</span></p>
<p style="top:641.6pt;left:259.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">AC</span></p>
<p style="top:580.1pt;left:259.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">16 (7&#x2013;12 y)</span></p>
<p style="top:519.0pt;left:259.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Iliac BMSCs (DMEM + 20% </span></p>
<p style="top:515.0pt;left:270.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">AS, pass. 3)</span></p>
<p style="top:426.1pt;left:258.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">5 &#xd7; 10</span><span style="font-family:Lato,serif;font-size:5.2pt">5</span><span style="font-family:Lato,serif;font-size:7.5pt"> cells/scaffold</span></p>
<p style="top:339.5pt;left:258.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">HA- Si (Nanobone</span><span style="font-family:Lato,serif;font-size:5.2pt">&#xae;</span><span style="font-family:Lato,serif;font-size:7.5pt">)</span></p>
<p style="top:259.6pt;left:259.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Man AB</span></p>
<p style="top:187.6pt;left:259.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">3, 6 m</span></p>
<p style="top:141.9pt;left:259.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">CT</span></p>
<p style="top:99.0pt;left:259.6pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">S</span></i></p>
<p style="top:722.7pt;left:284.2pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">ASCs (n = 5)</span></b></p>
<p style="top:722.7pt;left:298.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Alekseeva, Kulakov </span></p>
<p style="top:718.7pt;left:308.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">et al. (2012) (CT)</span></p>
<p style="top:641.6pt;left:298.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">SA (&lt;5 mm) </span></p>
<p style="top:637.6pt;left:308.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2014;uni/bilat</span></p>
<p style="top:580.1pt;left:298.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">25 (29&#x2013;60 y)</span></p>
<p style="top:519.0pt;left:298.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Abdominal ASCs </span></p>
<p style="top:515.0pt;left:308.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(DMEM/F12 + 10% AS, </span></p>
<p style="top:515.0pt;left:319.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">osteo+ 7d)</span></p>
<p style="top:426.1pt;left:297.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">5&#x2013;7 &#xd7; 10</span><span style="font-family:Lato,serif;font-size:5.2pt">6</span><span style="font-family:Lato,serif;font-size:7.5pt"> cells/cm</span><span style="font-family:Lato,serif;font-size:5.2pt">3</span><span style="font-family:Lato,serif;font-size:7.5pt"> </span></p>
<p style="top:422.1pt;left:308.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">scaffold</span></p>
<p style="top:339.5pt;left:298.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">HA- Col/GAG + PRP</span></p>
<p style="top:259.6pt;left:298.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">DBBM </span></p>
<p style="top:255.6pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(Bio- Oss</span><span style="font-family:Lato,serif;font-size:5.2pt">&#xae;</span><span style="font-family:Lato,serif;font-size:7.5pt">) + PRP</span></p>
<p style="top:187.6pt;left:298.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">4&#x2013;6 m</span></p>
<p style="top:141.9pt;left:298.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Histo </span></p>
<p style="top:141.9pt;left:308.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">CBCT</span></p>
<p style="top:99.0pt;left:298.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">T&gt;C</span></p>
<p style="top:722.7pt;left:333.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Khojasteh and </span></p>
<p style="top:718.7pt;left:343.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Sadeghi (2016) (CC)</span></p>
<p style="top:641.6pt;left:333.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">RA&#x2014;max/man </span></p>
<p style="top:637.6pt;left:343.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(hor)</span></p>
<p style="top:580.1pt;left:333.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">8 (5M, 25&#x2013;60 y)</span></p>
<p style="top:519.0pt;left:333.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Buccal fat pad ASCs </span></p>
<p style="top:515.0pt;left:343.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(DMEM + 10% AS, pass. </span></p>
<p style="top:515.0pt;left:354.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">3&#x2013;4)</span></p>
<p style="top:426.1pt;left:332.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">10</span><span style="font-family:Lato,serif;font-size:5.2pt">6</span><span style="font-family:Lato,serif;font-size:7.5pt"> cells/scaffold</span></p>
<p style="top:339.5pt;left:333.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Iliac AB + FDBA </span></p>
<p style="top:335.5pt;left:343.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">granules</span></p>
<p style="top:259.6pt;left:333.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Iliac AB + FDBA </span></p>
<p style="top:255.6pt;left:343.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">only</span></p>
<p style="top:187.6pt;left:333.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">5 m</span></p>
<p style="top:141.9pt;left:333.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Histo </span></p>
<p style="top:141.9pt;left:343.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">CBCT</span></p>
<p style="top:99.0pt;left:333.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">T&gt;C </span></p>
<p style="top:99.0pt;left:343.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">NS</span></p>
<p style="top:722.7pt;left:368.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Khojasteh et al. </span></p>
<p style="top:718.7pt;left:378.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(2017) (CT)</span></p>
<p style="top:641.6pt;left:368.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">AC&#x2014;uni</span></p>
<p style="top:580.2pt;left:368.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">10 (3F, </span></p>
<p style="top:576.2pt;left:378.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">8&#x2013;14 y + 4 </span></p>
<p style="top:576.2pt;left:389.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">adults)</span></p>
<p style="top:519.0pt;left:368.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Buccal fat pad ASCs </span></p>
<p style="top:515.0pt;left:378.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(DMEM + 10% AS, pass. </span></p>
<p style="top:515.0pt;left:389.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">3&#x2013;4)</span></p>
<p style="top:426.2pt;left:367.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">10</span><span style="font-family:Lato,serif;font-size:5.2pt">6</span><span style="font-family:Lato,serif;font-size:7.5pt"> cells/scaffold</span></p>
<p style="top:339.5pt;left:368.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Man AB + BBM </span></p>
<p style="top:335.5pt;left:377.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(Cerabone</span><span style="font-family:Lato,serif;font-size:5.2pt">&#xae;</span><span style="font-family:Lato,serif;font-size:7.5pt">) </span><i><span style="font-family:Lato,serif;font-size:7.5pt">or</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> Iliac </span></p>
<p style="top:335.5pt;left:389.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">AB + BBM,  + Col </span></p>
<p style="top:335.5pt;left:399.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">mem</span></p>
<p style="top:259.6pt;left:368.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Iliac AB + Col mem</span></p>
<p style="top:187.6pt;left:368.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">6 m</span></p>
<p style="top:141.9pt;left:368.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">CBCT </span></p>
<p style="top:141.9pt;left:378.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Histo (n=2)</span></p>
<p style="top:99.0pt;left:368.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">NS</span></p>
<p style="top:722.7pt;left:413.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Soliman, Ismail, </span></p>
<p style="top:718.7pt;left:424.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Shouman, </span></p>
<p style="top:718.7pt;left:434.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Bahaaeldin, and </span></p>
<p style="top:718.7pt;left:445.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">El- Hadidy (2018) (CC)</span></p>
<p style="top:641.6pt;left:413.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">AC&#x2014;uni/bi</span></p>
<p style="top:580.1pt;left:413.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">24 (15M, </span></p>
<p style="top:576.1pt;left:424.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">7&#x2013;27 y)</span></p>
<p style="top:519.0pt;left:413.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Abdominal ASCs </span></p>
<p style="top:515.0pt;left:424.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(DMEM + 10%&#x2013;13% FBS)</span></p>
<p style="top:426.1pt;left:412.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">3 &#xd7; 10</span><span style="font-family:Lato,serif;font-size:5.2pt">6</span><span style="font-family:Lato,serif;font-size:7.5pt"> cells/ml</span></p>
<p style="top:339.5pt;left:413.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Allograft </span><i><span style="font-family:Lato,serif;font-size:7.5pt">or</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> iliac AB</span></p>
<p style="top:259.6pt;left:413.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Iliac AB only</span></p>
<p style="top:187.6pt;left:413.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">6 m</span></p>
<p style="top:141.9pt;left:413.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Radio</span></p>
<p style="top:99.0pt;left:413.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">NS</span></p>
<p style="top:722.7pt;left:459.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Castillo- Cardiel et al. </span></p>
<p style="top:718.7pt;left:469.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(2017) (RCT)</span></p>
<p style="top:641.6pt;left:459.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Man condyle </span></p>
<p style="top:637.6pt;left:469.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">fractures</span></p>
<p style="top:580.1pt;left:459.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">20 (~29&#x2013;31 y)</span></p>
<p style="top:519.0pt;left:459.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Abdominal ASCs </span></p>
<p style="top:515.0pt;left:469.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(DMEM + 10% FBS, </span></p>
<p style="top:515.0pt;left:480.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">24 h)</span></p>
<p style="top:426.1pt;left:459.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">NR</span></p>
<p style="top:339.5pt;left:459.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Open reduction</span></p>
<p style="top:259.6pt;left:459.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Open reduction</span></p>
<p style="top:187.6pt;left:459.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">4, 12 w</span></p>
<p style="top:141.9pt;left:459.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">CT (BD)</span></p>
<p style="top:99.0pt;left:459.4pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">S</span></i></p>
<p style="top:725.7pt;left:496.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">CT: controlled trial; RCT: randomized CT; CC: case&#x2013;control; SA: sinus augmentation; RA: ridge augmentation/GBR; SP: socket preservation; AC: alveolar cleft; SD: segmental or continuity defects; CD: cranial defect; </span></p>
<p style="top:725.7pt;left:507.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">ORN: osteoradionecrosis; uni: unilateral; bi: bilateral; imp: simultaneous implant placement; man: mandible; max: maxilla; hor: horizontal; M: male; F: female; y: years; m: months; w: weeks; Histo: histomorphometry; </span></p>
<p style="top:725.7pt;left:517.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Histo (qual): qualitative histology; IHC: immunohistochemistry; Radio: radiographic; CT: computed tomography; </span><span style="font-family:STIX,serif;font-size:7.5pt">&#x3bc;</span><span style="font-family:Lato,serif;font-size:7.5pt">CT; micro- CT; V: volume; BV/TV: bone volume/total volume; BG: bone gain; T: test group; C: control </span></p>
<p style="top:725.7pt;left:528.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">group; Comp: complications; IS: implant survival; +: favourable bone regeneration outcomes; BMSC: bone marrow MSC; ASC: adipose tissue- derived MSC; TRCs: tissue repair cells; FBS: foetal bovine serum; HS: </span></p>
<p style="top:725.7pt;left:538.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">horse serum; AS: autologous serum; osteo+: osteogenic induction; pass.: passage; AB: autogenous bone; HA: hydroxyl- apatite; Si: silica; </span><span style="font-family:STIX,serif;font-size:7.5pt">&#x3b2;</span><span style="font-family:Lato,serif;font-size:7.5pt">- TCP: beta- tricalcium phosphate; BCP: biphasic calcium phosphate; BAG: bio-</span></p>
<p style="top:725.7pt;left:549.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">active glass; GAG: glycosaminoglycans; Col: collagen; DBBM: demineralized bovine bone mineral; ABB: anorganic bovine bone; Pep: PepGen; PRP: platelet- rich plasma; PRF: platelet- rich fibrin; </span><i><span style="font-family:Lato,serif;font-size:7.5pt">S</span></i><span style="font-family:Lato,serif;font-size:7.5pt">: statistically signifi-</span></p>
<p style="top:725.7pt;left:559.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">cant differences between T and C groups; NS: no statistically significant differences between T and C groups.</span></p>
<p style="top:11.6pt;left:578.8pt;line-height:5.1pt"><span style="font-family:Times New Roman,serif;font-size:5.1pt"> 1600051x, 2019, S21, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jcpe.13049 by Universit&#xe4;tsbibliothek Zuerich, Wiley Online Library on [27/12/2022]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</span></p>


<p style="top:23.8pt;left:46.5pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">170&#x2003; </span></b><b><span style="font-family:Lato,serif;font-size:9.1pt">|</span></b><b><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003; &#x2003;&#x2002;</span></b></p>
<img style="position:absolute;transform:matrix(.31940789,0,-0,.3187552,54.97612,3.7443963)" src="data:image/jpeg;base64,
/9j/7gAOQWRvYmUAZAAAAAAB/9sAxQAGBAQEBAQGBAQGCAYGBggKCAcHCAoMCgoK
CgoMDAwMDA4ODAwMDhAQFRMMExQUFBQZGhwcHBofHx8fHx8fHx8fAQcFBQYFBggG
BggJCAgICQwKCgoKDAwLDA0MCwwMDAwMDw4MDAwMDAwPDAwODg4ODhEQEBAQEBMT
ExMVFRUXFxcCBwUFBgUGCAYGCAkICAgJDAoKCgoMDAsMDQwLDAwMDAwPDgwMDAwM
DA8MDA4ODg4OERAQEBAQExMTExUVFRcXF//dAAQAFv/AABEIAFMBWQMAIgABEQEC
EQL/xAGiAAEAAQQDAAMAAAAAAAAAAAAACAQFBgcBAgMJCgsBAAICAgEFAAAAAAAA
AAAAAAAEAQUCAwYHCAkKCxAAAQEFAQQGBwp/AAAAAAAAAQIAAwQFEQYHEiExCBNB
UWFxFBUiNXORswkKFhcYMlKBocEZGiMkJSYnKCkqMzQ2Nzg5OkJDREVGR0hJSlNU
VVZXWFlaYmNkZWZnaGlqcnR1dnd4eXqCg4SFhoeIiYqSk5SVlpeYmZqio6Slpqeo
qaqxsrS1tre4ubrCw8TFxsfIycrR0tPU1dbX2Nna4eLj5OXm5+jp6vDx8vP09fb3
+Pn6EQAAAgIBBAheMwAAAAAAAAAAAQIRAwQSMUETITNRYXGR0QUGBwgJChQVFhcY
GRoiIyQlJicoKSoyNDU2Nzg5OkJDREVGR0hJSlJTVFVWV1hZWmJjZGVmZ2hpanJz
dHV2d3h5eoGCg4SFhoeIiYqSk5SVlpeYmZqhoqOkpaanqLGpqrKztLW2t7i5usHC
w8TFxsfIycrS09TV1tfY2drh4uPk5ebn6Onq8PHy8/T19vf4+fr/2gAMAwAAAREC
EQA/AI/MYxrUKA2QSaxsbOpU8mziIdO3bsvAULCr45WKnEKYWx9tmWD4wyK6uifP
A2bCgSaSjfjANZg1FWNcpBZ2ZWhfZTApAS7ALx8vAhFcVaVJJzAGy4XMIJIDp7NS
H5G7QhAFdAFd80IsSaZLInoA1+xr3aKyUzs4UvH96+hlm9S/dg0BzAoHCkt2RZV4
uy6rTakpvE14IXhrgeXm7r6mjiYbElmSnsiWcEAWJjGvz6ybxzZh3aYxSSlYScov
DUXy73d19TfGgkTSWp0SzALCxsudXOZhEwUHFwkU7WYsIWpKklIdJWi+JJqa0xUA
wt7qucJXMhLYeYiqYcP3i1O6ipWUXoCVYM/C2Twsj9ygDCmNmsvubPFuy+nEamEB
UQ7QACogEgE3ygBXHQVantBc+ipTCLmEBECMcOk3zxJTerSnNUKEggZrBsLIRLU9
AGJMatlEojp3GJgZei/WRVSjgShOapRzA2YouZQbp2lMdNQ7fKzEpSE1zhfKBLQi
xppktEnoAwFrtZyzkTaWJewsM+duVOkBZLwKIIJpQXoLXpNzWZGYmEXEoDguy8dx
SUFSVEEC8KaghWGuaGr7n8CZZaiay5Sw8MO7DsrAoFUWMNMNGyQYjbiJMlEZqAME
iHSod+9h1EEulqQSMRKSRvzebVEy15Rex3vn6m8XTt4+eJcuUla1kJQlIqVE4AAG
1m5AOrGzeX3Mn6nAfzmNTCVAOVoAUU6ClKITXSq3SZ3NIty4MTJ4pMaACcrUAlaq
bxIJSToYGzeFkUtthwDEYODiZhFOoKEQXj58q9QkZp+BmlsgndiVSGVKjoyPdKiA
UhMOgY6mhoVEE00A1xudyMGMROlxKEPHKnzkwihR5W9oVbuqMec3Nv5CNSIqfLj3
S1AukJhOSiU0Cabu3vE2RMamM0zJZuntwSnPqAGDtWSqUTGdROosucl6vAVHElAO
ao4gGpEIW8Wl27F8pZCUjPJNAG2hFPYa5/Zh26h0pXGPiBrWG/fEa2o9EpzBpNix
oEks0jUii5ALRD3LIku76MmDt2o8iu3ZUNmop841vm1zqdy50t/CqRGu0YSl2Cl5
TPvTj3otj8dM5jMn6omOiHj54rNKjQaAAoANANe7L21j5K/dw8a8XEQBNFIVrS3d
eRkE4cGdibIjYUjU2miT+sAs0olj2cTJzLHK0u1viQFLBoKAk1phzGuiLGxq7RLs
4Ih1lyHWWl7RV5S9CqUpXNa8wsZI5lbyXzCSlYy4vDEIUi8F+EK1oaebotzOZbFz
a6A/g4KLVBPTDpVlyb6tEoTUayUnCwTGiqvjb1PRuSUAYjOJY9k0yfSx8tLxbggK
UioBqkKwVw5rUbZM6snFzK08XI38ffPnCMsXErSpV/gRgoVV5Gz8xq2X3N37wPHs
2jEwjoLUh3gF+sJJAUb5QCQaVAwlsXiTSM21F6We6AMMa92bspF2lEQqFfu3Oo96
FZYFGt/WlL0HOa7zu5zEwEGuOlkTqYh2krW7Kb1d6MZTekhWk1DY+RTGdpizATFc
AHJRf3l/rd8FU3apOKjSTGkSZIpIma3S3OVAMcWm8WpBxpJGyNG4aulsnmE5jzAQ
CMseAm/UcCUgGhUo5gbL3dzKEdoSmPmodv1cipSkCuhfqBLYosaab2iT0AYExsit
FYmZyB2YsKTFQgOF6gEFFcRWnDQaIqGoZDZ2ZWhiFOYFISh3TLXy6hCK4gaYSTmA
MGgkSTao1vwBa2Nn6rmUCgB0ubXsQRgSUIAr1aV31Gt0Lc3mj2NiIOKiEOA5Slbt
6EFaHoUSMGFJBFMILSbCyE6cwQBbZBZSLtBCRUZDv3TpMKaKSsKJOslWCg0GsbbD
ubi9k04TnPCNk6U2uxiYTRIkEDJya1woByxjGwAP/9CPzGNXyES5U4hUTcVhFrvX
tSQBfAgEkUNAaNakSzIgoKBtmWE4wyK6uifPGt9qLnzwPHURZpyC7vb144v8Na4F
grOEGuHC11hoc2NsS/dzBaMvWl6b0GoLx6L1KBn0zW3sTGkxpmaRPREb26AKR1EL
svc6h4qX0TERKUKywitFvsat6SKBtdLWt48L14oqWTUrJJUTn1OFth2cXCWtsibN
vnodRMKkJTTCaINXa6ZozFNjT2wlqHcTqOIPLBWgeoWnKyM+pIIGmGxZEUkiQNEj
NFtJw/uwDJ7JRry0tl5hJ5kS+VDovELVhN6pJLupx1SU42pnFdyqeVx1V6EBq1Di
HsDZaITEvUvI+MvgAnkZZTegJrhKUg1Jbysi6cT+xMTIcsCXzsrTopvjfu1HQr5x
thEb0ic9PGZQxAGum2DHcascdWOtrFsdTYW1KonUbUMp1qmWlScrpvKta03qrZfa
iDdS6wBgHKw8TDBy6KxiKkvAF77VsGJBJEkzMjKVTJ7AOs/mMVLrBQS4RZdrfuYd
yVjGEqd1VTOJApVrVcrwzKYVzXDvz9qy13GAyvShdpFqO5Vryj9gO/P2yXLZAoAu
UAY3aaOiJjPIx9FKvil8t2gHElCFFKQBpBsyuYxT6Kl8fLohReOXSk3iVYQA9Cgp
OkaNgs317RvWS98/U2a3Kt2zPTc+xGwYTN5oNfXgHvZVCLP2PmE6cpCnyi+WK4qO
lF2gaVaktryKiYiNfriot4p8+eG+WtWEkls+sTHwkzgJhZSOVela3xdDEVO3hN8B
opOFsejrB2kg4hTlzDGKd11h66KaEZlQSCDptKZGkgg2kZkRKMif3YBfrmU4i3ry
Ikz9ZeOnbvLnN8alGtAKSNA31aNWWW4zuf6Z2oG9rEWYXZ8vH8xWgR0UiiXKVVvH
SSCdM1IrTA3jZbjO5/pnz8NmgSRExkk5bj5RgGvZlryi9jvfPy2TXMoFzEzx7EvB
VUK5vnegpZva7KrYxMteUX1kPfP1NerCztxJZ2DFEIcRSMpW8OJBqClR0Kih020s
ZkTIRm4WAUtq51FTqbv1PlkuHLxbtw6xJSlKiMWeaVJaosTOouVzuGhnazqPFvEu
nzrGDfGiVAZhBOMNdrVWDmRj3swkyBEuYlZeF0kgLQpRqaVIBTnEN62RsRHwsc7n
E7SIZ3CnLEOlEFRUMSlUJCUjG2RIMjyrUa1uQC4KgXMJdNcvHKQnUmFW+WBvMpUl
R3u9q2I24A3FceacjI2mlsil05czu6MiJhjVw6cvHLpW8koSaq0iSaNjtuOMqj+r
kbTS0spkaBmTh5D5QBbJWtDuaQa3holMQ6KtILDZxdWQvKpc8G7A8fJJzL4hJHnC
2vS2y5LNJbbaRGQzRWVxiEJGA60ooGsvUVxneQ34tDEpJFJjcGk4ygBrRjZNHXO7
Rwr0phnaIt3XWVu1hJpopUQRvrXqzlz8wT0TS0a3QQ41sOL4FIphq8VgFBjoN7bE
mFMzUoygTcAGOWGINqoCm8l7TU2XOeNovusP2Glre4nMBNreS5Ercu3cLDF4hC3a
AjLVFCr5WADBgwNcHPG0X3WH7DS21jIiIiI1qZCe8oAJVxsqa9Y+/OWw+2UwfzC0
MZl6iUQ7wuXSK4EpRgwDROEtmEp42VNesffnLYLaPjIJl1lPfPi2LLPCrjSAMtuW
Rz5T2Mli1FTlKUPUJJqEmt6oDOrUNU3OEJdRU8dp3ah+lI0gp6A1tuV69ozrHT5+
Gulzzi+n3WSPPnrZMT2TFBpcoA4svSR2OmE9dJCn7xT56KjmmooQDoVqW13ExD+M
friotanr14Spa1GpJLZ5YmYQcyl0dZOOXeKeqe5ViBUh4daCa41A4aNYI6wVpYSJ
U5cwxinddYeuim9I0QSCDn1bFMjSQQbSMyIlGp/dgHeR22ipVLXspi4cR0OsFKEv
FkFCVAhScSqjDvTZE5ijZm525i4AXkRFUIXjIW+UdaNc0JFA1JC2QlMgkr+Z2sCX
j48UnKHhFDTAgFJF8onHmANVWcXB2rsguzjxYdRMMmiRjIAVfO1gYyMN6WyQJMpV
SOVjQNtJ2QBrtalPFl48UVLJqVKNSSc0k4W2bc5ncTMZc/l8WovFQV7lbxWE5WsG
iSdAp2TYe+sLal0/LgQReYaB4hSSg6NSRQabZ/ZCROrOwj2CevUPI56EvogINb1J
qlA0sBw5rYsCCZJrMjInawCzXOddM62KdpqbXYxNsS5zrpnWxTtNTa7GJsWR82OC
PlgBjGNrAP/Rj8xjM0aYa1CgvEvtfaKWOEwsJGKypAolC0pWEjOF8CQNBqOZziZT
h8H8yiFP1JFEg0CUjQAoA01oS4jcmXCOHi7MQJUp0hSiQvGUgk7vbhdw247GILtN
nIIjNLlbxKhvaHoLInEZYzejJkUUFDjfHMk/kIQuH7+FfIiIZ4p09QaoWglKgdAh
r6m3tqgi81MB6KLp2VbO9bYt3m4fDXPUOrTWXL1cliHocvod6b9UI9VuyizhU7VS
grhBwVNW02kFSghAKlHEkCp2Qws4wNQTKgSbEkajymUOBGpJA0DbTcj2jo+NmUQq
Kj3y371WNSzXBnAYgNANzATGOlcSIuXvlOHqRS+Tmg4wQagjTbwWhbtV48SpCjmK
BSdkaN1JAFSaNks1rW9v4xGQPrd2pfui5VGXoUCCUO0JVQ6ITUb01uVO5quWiTri
FGDBrlJCaVvr7HS+xmuNqBJCiAk3xJoAMJq2/LlD7I8urEwbu6HqtE8S8f6kiKS+
y0Jy1WV316KbtpRsGdqEmJFuMk01mpSL2b31z0MkEW41LIoMaTip9No2BdS2KiVP
IZze5W6ISAm8FE4QAcAbpLJzM5M8W9lj8uFvEhKyAk1ANQNaBbvaAy4z6ZGUXmoB
jH+od5W8yjLFZXe1w0vaUq1Eh28e1LpClgY71JVTZBsyTM1JLMjVlSEA9evH71b5
6b5bxRWtWepRqS1ZLJ5NpNlmqyIU4y6mWUCTW9rTdwOeWoc0g4xgIzQxgjMjWRqM
QOyXrxL0PkqKXgVfBaTQhVa1BGItfndvLVOnYdiMCqCl8t2hStnetYUOnrxN87Qt
aRjUlJIG9gNv7Iy2BsZbORz2KtPKYeZPYaNdO3K3wUShCnV8Ui9UM1sGZqY5mM2Q
25RKW2wL0MkEDTSJEhpJFpZ67j1zNMY81KeIytTwhJ1ioN6AQQBUZjdYa0M5g45/
MYaKU7iYnis8CUkqw1xFJGybK7uUik9mrp02k0hhXcFAuEQxdQ7qt4krh3alUqSc
JJLYIhKnir12krVnJBJ2QbJjZTZEEUyM1JESRPb+XLEJE2mZPxqHLx4t68U9eGq1
qKlHPJNSW6tyoKQq8WClQ5FIIOyLdSoJwk002kQLvLbV2glTkQ0FGKDpO7Xawl4l
OlfA0GgG4mdqJ9OHWUR8WpbrGXaQEJOmEgV3trUkhdAjWiTQAYSTnYG7LQ8dEJeo
UgnEFApJ2dGlvSUpZqflgHtATCMlcSmMgHpcvkghKwASAoUOMEN1jI2KmESuMjXh
evnpBWsgAmgAGIAZjbLyOdmbPWut8/lVpIJ1MIVMtfPg4fVIDxLxyArAQa0Udm14
yTdjbKWMmkgcWYlriWoi4eJW+S5qMsUhbsJJqTiqW0G1SJM5NMpJZk3QDg4YZvGb
Y3uhpZuUqUhQWglKkmoUDQg54IbgYSEjCTiGaW7PHbx1TLUKRXFfJKa6VQG3DAXx
xbm1Lh2HaY0rCRQF4hCzsympaimdoZzOAETGKW9QMId4Eor1akAHe2qbEwcLMbZy
GXxzpL6GiplCOX7pW7Vu3j5CVJNKYCDRpD5IC5hYCytzeKm9nZHCwEaiKhXaX7oK
vglbyihhURhDamZrHjZEGFJuM2R6J7enKnt7GaLGaSJpE6EZIKNipfEojIN4XT52
SULABIqCDjBGItVi0M5TMjOBFK1MUi8L69TW9pSlL2mIZzW0kDHgbup29Qm/WhaU
7yUkgbMijbSSMnBmT2vKjAV7q0M5czF7NnUUpMW+TevH16mqhgwUvacijMaiiH76
KfvIqIVfvXqitajSpUo1JwYG82EgMGZm5MwCslk4mUmerfyx+XC1pvVKSEmoBrTW
gW9IC0E4la37yAiVOVRKr58QlJvlYTXCk55xNQrdvHdC8QpAOIqSRXSqG879G8hs
2kkjJSjN6cAHpfrC8sCiF1vgoYCDjqCGvrm3dqXLsOhGX4AoCt2hStmU1bHwtBwB
Q2bckgCpYJJJFwZlBAFXMptMZu+ERMn6n6wKJvsASM4AUAbxhomIg36ImEeKcvXZ
qlaDQgt4haSaAgnTbloWa1rewDIdx9aq8vNTB1dlTu+2d61BCWjnkFEP4qGjHiX0
VQv3hoorpWlb4HPa2saW9M3KRvUCYBXy+fTeVunzmXxKnKIg1epASb40pmg5hagY
xoMzN6W4ADGNywAf/9KPzBjGmGMzRphrUKD5EloW8kJduwVLXBFKQMZJdUADRLuS
XMbrMtugSSYmUzCVQ0NFoeRkTEAuneo44qoIKtavk1SBQ4S0uHD5EPK3UQ8reuoZ
K1UwmiXYJpsm1E9yWFzJCCp1DTZ6rMTqM7TXey/o1G0ibOiiyoMLG3km9G7U5DjI
SBmiaSSlOBml1+zEVbSw8RZWAKExEyiYR27eLOsuwl+h48eHNN6hCjQY2tAc3KMj
5ZpwqLDqFU9Ad5eXYex0c9QBfHAL446kCiU1zGxC5ldoiLqF1xMPEw4gJfCy2L1V
whVfrU+K3RW9eKFAV5WCABgArjrVth3R7W3NbLKgFXQ3Dl5qSHgg3j+BMWkXt6Xi
QrKnl6cINMFWg0GViNBpkySMjlc0EHJrLKrURcsC0UiNkJT8RmLfJ7SXJLvMripY
7dOZgXKb59CxLnKopwFYEvUHGMOJSDptqWwNzAWCyQjmy8zS7mMA+l8XFQTx+7Ss
PHCkkIv0qF7fpKSFU0xjbYsouy3B4OJVEyB27cxCU3qnkFJ3yXgSrMJdQ4IBpiby
hreWTtxdksmuzi3zx/By6bCJL+GfQygh4lyXYAfIQVCqVYm2oGzMTyoooMiLEkxp
PSboyRM1rUQhJtSbTM0TSIycO3sZvN5bc6slEItlOnEtlZhXZhnUW9Q6dJRlqgSE
0SNbVSmDDTe2tVzOAsvaKRxk6dwcFHuoyczR65ilOHbzLHSox6UKClIqRTE2tMmE
pWoFlndTel/GKIzKhDkA76WzrI08ailOx4v0IW2tJjNFo0WdvSNJNJUERNwluWym
golES+UNSXLrjkBb66Daacz13SRSibRLpMKiqExL7LlqDqqQKO0poVAUOEDFVt8T
e29yy5qYez8yjpfJiHaS6gnTvCh2cCSUOUKvQc9VKtbrh76FeWdnLtwUl45tJN0x
AGMLMSpQrppKaaDRVuzQc5gLp9okz+/y99GvHzpazgXDLNXBSc1IRegZ1KZjbyQN
rmoSY2RM0UWNF6RKAUS+vGBm8KBJIkRmkbkSotzcxsLdgs4JlLtRRFxDm/l06hAk
knkULKN3u64FJOEZlC2jrhVxNFqLSTSJtm4IgbOxJhH8EqoD+MSTVCjg4JpAqoZt
RmVbZ+RTgp1C3O4l9Mb5MFFR7x7LULqOCd6lLxaQeRVLBpnkEtsWyEdJoyLtImUl
BU4nT13GXlOLgOIe/Jpm5m9NqNnZWlJmYEEjSJE1Ek/Pb3BP0GMiQRZGxMyUZuSf
xRT63lzO5zlElnEfAyk5WMqgnbokpd4gcrcoVepzqgNcbJJsbGQ0RaOxYhFw84eB
6/iYMAIfPHYvL5QFAFjEcAOe0NLt0HNYG6paPVyFh5ERinzhawQFw6gMpKScaQmi
cGaKNuzIiQU2c2bnsbEJWmWxUW51DvgQlbx2hQfLTXGMKEkjNGg2TO0SLE0pMxMh
mkkSJm/Gt11+UAgymkyNjaSiWMbtpc3ibp2SNnElD0w8FDuYOJmD9O70OBDuU3qK
gi/UTQVxYTmNu59EXLrjkmcQ78wMhhHhKXQvKvXy0jWjrKVvXis9Rq1osY+ghdru
hwyqamKcSd4nPLlMOQqmhfKFd6bSmSwg5u6ugwcfGBRl7+XO3cCuhvApC15ciuK+
qQojOIaUSNqmRiadJI0UEWJE1E7lUjhXvdCDUxopJkSzNI+WN/xUsuX3abPPFuxB
ziEqp0mLcAJfw729xpVRLx2sVBoceaCG1Bcaucbgy7XPrIz1y6mDmHlK30I+fuUq
S+crfuMrehKgoBWNKqYiCGp8iFBTbVxP5mlDwSpUK6cKeYcqXEh5fJAzCpKSa5wO
i23lvHCrvjl2ggvUWSe5aBjAVHu7yuyLYptzTJMzTIpmkg2LJbo3o/UEkpkJFkMl
GsVdol3K7n0a5tbaF3L5VEvUahwz8uRfEAl4pLtDtBNcOtKArSgJo1fFy6w91Syw
K0Qs3lUehWUxCEglJBKb9CqBSFpI0CDgLaFyYC1Gf2aRU3og4ohOZUvXYJ3xs+yK
pJuWEE4BNIsDQwOzv7YpsBoNKg1RJpN5mpy4JZqU7dCSTWyJMaiUodrh02sjJq3L
3aUrtPIdTnUbECFvMsduopYCsuvdaqlaDSvnGvV2Ca2bfQSLCxjgPp9aWFiISSkw
2XBL1dEXxeXpLsAqBJzhXMbW1yzjp22WlMNruGzu2z6FcXeLnpiiE38JNXboqNOC
qndEjTOEBpZECJqSSlYzNjNlc002mkqCW6fhCKS2NT1PTblFqFyshc8ufXG7NmPj
NRUPYd0DMJ3GBIWtRx0Kq3iamiUJ0MZavlVr7lt1B3EyOXxcvnYCCX8G8da0XdaX
wQ9QkkdFJxYG1/ktIGcxNiZZFQIeKl8JHlcwCMSb5BS5WsDkUKJFcwkNo+4NCTiN
uryBUkvr6Hfl9FPE7tRChKg+vjiopJvRXGSGzY2mjoYEmqTZUm8lm5eiU6P1BCTI
2JkxkiSnoZvbm5I4ub3WbJzKSE6pJtOYXUd0olSoZ8h+7UtzU40UNUE4aVBxVO1M
lACbk0YEgqJjoMADCSS9wANcLtj+BRCWSh4gjUh9auVGFBx1Q9JeEaF6SDpt6Xd3
sO4sdBvosgOHc+lCnpViCBFuyonQo2KLMmyptKmm9mRmS39RiTQJEmQicGQs9x+4
nZywkhcT20sM4ip49dCJiH8UlKkQSSm+ytAWKJvRu9Zw1rho2Tyu6dcqtZMdwzLp
xL4+JfVdphVI1h9gNUoLxAQvBmJJq1Hd8gJ7M7lc7hrPBa3947ePnbrd7yGQtKn6
U0wnWQSRmgENC6z0JNplPZfA2eC1zJ7EuhBh0aLD0KBSoEYr0ipOZRs2Bp47kU2d
lZDJIjNSnBPS4SEcCE03hNFBFElKhRvDJF3FpXZqDFu7IQ4hYMvEOpjAOhwTdqeG
iHzsDdqSo3qk4qkEZrbJuPXFLP2Bkbid2icQ8VPXrvL4iJfgKdwaSL7K3d+KJvRu
5eMmuGjZfdFiYGCsLHPp8t3lCUwyX6lbsUov3IxHPVia3XcoObzG5VaKGkYUuIVD
pUpDsErW4Q8Qp8lIGEkoCsGaMDaiallZWJjYTSMiSTNE0n8pVVCLe8oMnjRRSSTI
lqJah5m6HcZt1EKsa8mktmi4w5QIR4g3j1RxJQtSEoKs69Nc5vW6JZ+Qyi51P4qW
yyCcv4KVv1w7wQ7q+Qt07JQalBNQQGg/LYaOmEwhYGUIW+jX75CIV25qXinpULwJ
phrXZNOu6Wl+i5VaJESb58mSxAenPWHJvjs2zalpiaRkYUUE0jJJJ7IzgSe3pTkY
sbIbIikZkRGRORbYWR2SupXMRFS+XQcNq+lig7eohnSFuX6kFJwpTUFDwHFnNHbI
62KM+unhM0coW4kDt8/i3L1IUlT0EuEIIUCN3KJw7xbY2RItfqTKZpYiJWovIFep
8IDhAcPSEvUjOouiqdFNtqyVhIKy1obUT2GvL+0Uc7iqJTQoSl0kKQdN4Xi8Gewm
ypNHHQwGZytPGV9ae6ASJMrYm/OfpBjTOSsmEjk8tlFkpTAw0NFRrwxsSty4du1Z
Q6qhCSpKQdaWSadEtG5s0uxWuFtbos4nDl4pcI7e6iQV9iDiH1gEDMClBSt7bC2s
WkYjYmBBE3Klmt/N73TgaGVJuTMycOCBjGNvGAMYxgAMYxgA/9OPzM0aYYxrUKCb
j27PcrVJVwwtNAF4YQuwm/VW+yu9pu3PaEYYxtDTNIg0rc2GZtylrU6XDjNkZTZF
LInoXKzloZrZSeQdopI+LmMgXgeOlZhGJSFDNSpJKVDOLSykt2K5BdSkCJbbFUFC
PllOpEsmt6EB6kA3zp4qiVCu7VAhWeA0O2Y2GoaRBqFGZmiki4SRcgY2U2NZOSN0
YmZEXSLh9yaURLuzb6X36zlmoEoKHr5+8pRN8pJIGmtVAMTaZud3V3c5u47j23Ma
6l8MuEiXLsvCcqh3ZTRy5SaVOM4c0knNbTIFMAY2DG0DGgimRmkkkmRkaRuVG/CU
mYzMlERET2ob6yTtubI2xhLOosvNYeZKhHsUX4cEm8C0ugkmoGO9LZfcFun3P7M3
NJbJ5/PYSBjXL6JU8h3qiFpC3y1JrRJxg1aKzGEmhY0mBFp25JtRNa3pbuAgQEzJ
EmaaiWZKG3bn92d3c7uhWhilpVH2enMwiHj9LihWOCyy6iHV9SusqoUmlRogNIU2
/uJ2zh3MVHzSRxoc0eO0zDKg8dHHu2IAUk54aDrKA42hniHsbMkSZGkgkRKWTtT1
CiUGdJElKIyfhL66JkjrF2YlLyDsbFOZxNVuy7hhDC+hYcgUC3ixRJAzEJrWlMAb
SFxW7E9ucWhjXs8D2Llc5UFzAoAU+Q/qSIhINL460QpOaMWENrBjZMbQsLGxpMSj
SJOejNyb9BKdCEmZNJIknCnAnLEW4uK2xg0P5nNZDMXLnW0JjlOb53m7sfgLSc8U
amg7u1yRMZESlxO4WGcQKHSXb6hRDvCq+qhzROtBASL4gUwilcLQjIBxhjaY9LEp
RppmTonp6GcdKTlRDcdr7rKbO3d463ljop3MoB6iGcvku1EOopwHDpL13UjAQpNQ
aYFBt7yy69cdt/KUOJlMJelD8AvZbNw7QpChmFL2qCRmFJLQlZSuNtjLEPYmVFAl
mikgiSJJE5UThYxRZ0kTNwZGa1CaloLt9yewkoLiURsJGrcC9hpZKQhQvswVdgOn
ac8k70W07ccuqQMTdbntubezCHlurKXrdoUsqDpBD1xlblGAmiUIwVziW0boMYY4
hzEggmitIzTJRpG5VAANnSMyN6UTghufJN2xsvbCdSGJsxMnEydQ0I/Q+W4JIQpT
xBSDUDGA2Z5HW6TYSylz0yq0c7hZfF6sIh7lD5RCrxYd3qsAOA0LRlY2STRIJMCL
TmaTaia1vS3cBAiCZTJM01Esxva55biyUqu/2ptRMZrDw8pjRG6jRiyQ7eZY9dKR
emlcISSG88kbdBkM9tFZec2Im7mMfSpL15l0OScpfB66W7JqBvGraNY0k0iBMqLK
szNFFtU9KUpQHlNtNF/Ne7WJh2CyRVg7WylENayJcSaZ3gdxUPF4IV8SKKU7WqqS
g7xVQjFhxtfVXQ7ilh4N89l8zksGh4C9W5lodKePTjGsQ4JUTmVaD7AAMTaUohTE
aRqSTRRM3tEnAyJqUiJ7IjN/G27XXZNzBupWdmz+svs9JplDLhnb6lUID52p7EPb
2oCiE4hWgFM9tj5IK6ZYC1VzaLk9n55CR8Y8ioVaXDlRKylDyqjhSMQaLrG2m0TG
3MSSK0XinkicOVvYxeVJSRG9tzkSjuO5Iyz72SQtm7fRWq+OgXSXLqYPAS4iHaAE
ov1AEoeAUBrgNK1zG2Ei21xORPXs+hprZ+FfxQq9iodTjLnufXKgXh39oNMoMba2
SIYxJpGkikkgSTkicDJFqEiJRkRqdjcl3u7dDXQw6sxZkPEySGe5a9iHgvFxb5FQ
ghJwpdpqSmuEnCQKBth3H8khZuNk0NILfRqJdM4N2HSI99gh4lCKJSVKFbx5Td19
QHGDmNFkKUlQWg0UkgpOcRhDTQuY3UbBXSJK5hIxMDCTgucqjpbEJdpKyE3q1u74
APHaseDCMRDYNYwMbC06KBMSSSKJnKxGoyN/cGtbsSxJpJpmbcRGbo3BipmVvbiF
kMvtQ4ipKY56hS76XpcPYyIJG7U5UL6qjgwkDPLXm6e+y25ZaR+pJd5ZJ4hRSrGm
+dE0Ojho1gldwi5DZmc7idzBISpwsP3LuJiSqFh1JN8FpQtVMFKi+JAbArv93Sz0
dZ+KsNY6KTMH0eA7j45yb5w7chVVukL5HWqgBIwAE4asmxsSLMysZMDyJKMjSSTd
ESoNwNqSRoopN6ifiIafuJTiZSa6jZ17LApS4qLRBvnSeSjh/rLwGuCgGtdmtLC7
ZbA2JuczWZw77Ko2JRqFAHkbL39U1TopTfL3pozXArT2FsXamJtNbSJU5XDwxdS5
KXD18Q8emjx5wTSoJokXorvItdckPdZkt0SIlEtstEPH8sgUPH75S3S3JVErN4BR
4EkhKBgPRRZxqWA2oaxjlQ2xEibklPRqe1LcQA1MaZIMST29m4IacGJjGNYDQDGM
YADGMYADGMYAP//Uj8xjGtQoDGMYADGMYADGMYADG5bhgAMYxgAMYxgAMYxgAMYx
gAMYxgAMYxgAMYxgAMYxgAMYxgAMYxgAMIGyYxgA7LePXib14ta05ylEjZEt1Yxg
AMYGMABjGMABjGMABjGMABjGMAH/2Q==">
<p style="top:23.8pt;left:493.4pt;line-height:7.0pt"><span style="font-family:Lato-Regular,serif;font-size:7.0pt">SHANBHAG </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">et</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt"> </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">Al</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt">.</span></p>
<p style="top:725.3pt;left:45.0pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">TA B LE&#xa0;4&#x2003;</span><span style="font-family:Lato,serif;font-size:8.0pt">Summary of controlled studies using &#x201c;committed&#x201d; culture- expanded cells</span></p>
<p style="top:723.1pt;left:82.2pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">Study (design)</span></b></p>
<p style="top:630.3pt;left:82.2pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">Site</span></b></p>
<p style="top:560.7pt;left:82.2pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">Patients (sex, age)</span></b></p>
<p style="top:495.3pt;left:64.3pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">Cell therapy group</span></b></p>
<p style="top:253.8pt;left:82.2pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">Control group</span></b></p>
<p style="top:193.7pt;left:82.2pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">Follow- up</span></b></p>
<p style="top:147.4pt;left:82.2pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">Method</span></b></p>
<p style="top:93.1pt;left:82.2pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">Outcome</span></b></p>
<p style="top:495.3pt;left:82.2pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">Cell source (culture)</span></b></p>
<p style="top:396.1pt;left:82.2pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">Cell number</span></b></p>
<p style="top:318.5pt;left:82.2pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">Scaffold</span></b></p>
<p style="top:723.1pt;left:97.2pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">POCs (n = 6)</span></b></p>
<p style="top:723.1pt;left:109.3pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt"> Springer et al. (2006) (CC)</span></p>
<p style="top:630.3pt;left:109.3pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">SA&#x2014;uni/bilat</span></p>
<p style="top:560.7pt;left:109.3pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">8 (4F, 43&#x2013;65 y)</span></p>
<p style="top:495.3pt;left:109.3pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Man POCs (aMEM + 20% AS, </span></p>
<p style="top:491.3pt;left:119.3pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">osteo+, 21d)</span></p>
<p style="top:396.2pt;left:108.2pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">6 &#xd7; 10</span><span style="font-family:Lato,serif;font-size:4.9pt">6</span><span style="font-family:Lato,serif;font-size:7.0pt"> cells/scaffold </span></p>
<p style="top:392.2pt;left:119.3pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">+ 1 w culture</span></p>
<p style="top:318.5pt;left:109.3pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Col fleece </span></p>
<p style="top:314.5pt;left:118.2pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">(Lyostypt</span><span style="font-family:Lato,serif;font-size:4.9pt">&#xae;</span><span style="font-family:Lato,serif;font-size:7.0pt">)</span></p>
<p style="top:253.8pt;left:109.3pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">DBBM </span></p>
<p style="top:249.8pt;left:118.2pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">(Bio- Oss</span><span style="font-family:Lato,serif;font-size:4.9pt">&#xae;</span><span style="font-family:Lato,serif;font-size:7.0pt">)</span></p>
<p style="top:193.7pt;left:109.3pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">6&#x2013;8 m</span></p>
<p style="top:147.4pt;left:109.3pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Histo (qual) </span></p>
<p style="top:147.4pt;left:119.3pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Radio</span></p>
<p style="top:93.1pt;left:109.3pt;line-height:7.0pt"><i><span style="font-family:Lato,serif;font-size:7.0pt">S</span></i></p>
<p style="top:723.1pt;left:131.3pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt"> Zizelmann et al. (2007) (CT)</span></p>
<p style="top:630.3pt;left:131.3pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">SA (&lt;5 mm) &#x2014;uni/</span></p>
<p style="top:626.3pt;left:141.3pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">bilat &#xb1; impl</span></p>
<p style="top:560.7pt;left:131.3pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">20</span></p>
<p style="top:495.3pt;left:131.3pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Man POCs (Bioseed- </span></p>
<p style="top:491.3pt;left:140.2pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Oralbone</span><span style="font-family:Lato,serif;font-size:4.9pt">&#xae;</span><span style="font-family:Lato,serif;font-size:7.0pt">, DMEM/F12 + </span></p>
<p style="top:491.3pt;left:151.3pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">10% AS, pass. 3&#x2013;4, osteo+, </span></p>
<p style="top:491.3pt;left:161.3pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">6w, +fibrinogen)</span></p>
<p style="top:396.1pt;left:130.2pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">1.5 &#xd7; 10</span><span style="font-family:Lato,serif;font-size:4.9pt">6</span><span style="font-family:Lato,serif;font-size:7.0pt"> cells/disc + </span></p>
<p style="top:392.2pt;left:141.3pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">6&#x2013;9 days culture</span></p>
<p style="top:318.5pt;left:130.2pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">PLGA (Ethisorb</span><span style="font-family:Lato,serif;font-size:4.9pt">&#xae;</span><span style="font-family:Lato,serif;font-size:7.0pt">) </span></p>
<p style="top:314.5pt;left:141.3pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">discs</span></p>
<p style="top:253.8pt;left:131.3pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Iliac AB</span></p>
<p style="top:193.7pt;left:131.3pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">3 m</span></p>
<p style="top:147.5pt;left:131.3pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">CT (V- loss%)</span></p>
<p style="top:93.1pt;left:131.3pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">T 90%, C 29%</span></p>
<p style="top:723.1pt;left:173.3pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt"> Voss et al. (2010) (CC)</span></p>
<p style="top:630.3pt;left:173.3pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">SA (class 4,5) &#x2014;uni/</span></p>
<p style="top:626.3pt;left:183.3pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">bilat &#xb1; impl</span></p>
<p style="top:560.7pt;left:173.3pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">35 (21F, 35&#x2013;69 y)</span><span style="font-family:Lato,serif;font-size:7.0pt"> </span></p>
<p style="top:556.7pt;left:183.3pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">(41C pts 38&#x2013;73 y)</span></p>
<p style="top:495.3pt;left:173.3pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Man POCs </span></p>
<p style="top:491.3pt;left:182.3pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">(Bioseed-Oralbone</span><span style="font-family:Lato,serif;font-size:4.9pt">&#xae;</span><span style="font-family:Lato,serif;font-size:7.0pt">)</span></p>
<p style="top:396.1pt;left:172.3pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">1.5 &#xd7; 10</span><span style="font-family:Lato,serif;font-size:4.9pt">6</span><span style="font-family:Lato,serif;font-size:7.0pt"> cells/disc + </span></p>
<p style="top:392.2pt;left:183.3pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">6&#x2013;9 days culture</span></p>
<p style="top:318.5pt;left:172.3pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">PLGA (Ethisorb</span><span style="font-family:Lato,serif;font-size:4.9pt">&#xae;</span><span style="font-family:Lato,serif;font-size:7.0pt">) </span></p>
<p style="top:314.5pt;left:183.3pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">discs</span></p>
<p style="top:253.8pt;left:173.3pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Iliac AB</span></p>
<p style="top:193.7pt;left:173.3pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">15 w</span></p>
<p style="top:147.5pt;left:173.3pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Histo (qual)</span></p>
<p style="top:93.1pt;left:173.3pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Comp </span></p>
<p style="top:93.1pt;left:183.3pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">T  &gt;  C</span></p>
<p style="top:723.1pt;left:195.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt"> Mangano et al. (2009) (CT)</span></p>
<p style="top:630.3pt;left:195.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">SA (2&#x2013;10 mm) </span></p>
<p style="top:626.3pt;left:205.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">&#x2014;bilat</span></p>
<p style="top:560.7pt;left:195.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">5 (3F, 45&#x2013;64 y)</span></p>
<p style="top:495.3pt;left:195.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Man POCs </span></p>
<p style="top:491.3pt;left:204.3pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">(Bioseed-Oralbone</span><span style="font-family:Lato,serif;font-size:4.9pt">&#xae;</span><span style="font-family:Lato,serif;font-size:7.0pt">)</span></p>
<p style="top:396.1pt;left:194.3pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">1.5 &#xd7; 10</span><span style="font-family:Lato,serif;font-size:4.9pt">6</span><span style="font-family:Lato,serif;font-size:7.0pt"> cells/disc + </span></p>
<p style="top:392.2pt;left:205.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">6&#x2013;9 days culture</span></p>
<p style="top:318.5pt;left:194.3pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">PLGA (Ethisorb</span><span style="font-family:Lato,serif;font-size:4.9pt">&#xae;</span><span style="font-family:Lato,serif;font-size:7.0pt">) </span></p>
<p style="top:314.5pt;left:205.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">discs</span></p>
<p style="top:253.8pt;left:195.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">CaP (Coral)</span></p>
<p style="top:193.7pt;left:195.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">6 m</span></p>
<p style="top:147.5pt;left:195.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Histo </span></p>
<p style="top:147.5pt;left:205.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">CT (BD)</span></p>
<p style="top:93.1pt;left:195.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">C  &gt;  T </span></p>
<p style="top:93.1pt;left:205.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">C  &gt;  T</span></p>
<p style="top:723.1pt;left:217.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt"> Nagata et al. (2012) (CC)</span></p>
<p style="top:630.3pt;left:217.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">SA (&lt;2 mm) &#x2014;uni/bi </span></p>
<p style="top:626.3pt;left:227.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">(n = 15) or RA (hor </span></p>
<p style="top:626.3pt;left:237.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">+ ver; n = 14)</span></p>
<p style="top:560.7pt;left:216.3pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">25</span><span style="font-family:Lato,serif;font-size:4.9pt">a</span><span style="font-family:Lato,serif;font-size:7.0pt"> (+15C pts) </span></p>
<p style="top:556.7pt;left:227.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">(13F, 18&#x2013;76 y)</span></p>
<p style="top:495.3pt;left:217.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Man POC sheet (M199 + </span></p>
<p style="top:491.3pt;left:227.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">10% FBS + AA, 6w)</span></p>
<p style="top:396.2pt;left:217.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">NR</span></p>
<p style="top:318.5pt;left:217.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Man AB + PRP</span></p>
<p style="top:253.8pt;left:217.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Man AB + PRP</span></p>
<p style="top:193.7pt;left:217.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">4 m </span></p>
<p style="top:189.7pt;left:227.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">3, 12 m</span></p>
<p style="top:147.5pt;left:217.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">IHC</span><span style="font-family:Lato,serif;font-size:7.0pt"> </span></p>
<p style="top:147.5pt;left:227.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">CT (V)</span></p>
<p style="top:93.1pt;left:217.4pt;line-height:7.0pt"><i><span style="font-family:Lato,serif;font-size:7.0pt">S</span></i></p>
<p style="top:93.1pt;left:227.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">NS</span></p>
<p style="top:723.1pt;left:249.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt"> Ogawa et al. (2016) (CC)</span></p>
<p style="top:630.3pt;left:249.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">SA (&lt;2 mm) &#x2014;uni/</span></p>
<p style="top:626.3pt;left:259.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">bilat</span></p>
<p style="top:560.7pt;left:248.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">23</span><span style="font-family:Lato,serif;font-size:4.9pt">a</span><span style="font-family:Lato,serif;font-size:7.0pt"> (+15C pts) </span></p>
<p style="top:556.7pt;left:259.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">(10M, 40&#x2013;70 y)</span></p>
<p style="top:495.3pt;left:249.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Man POC sheet</span></p>
<p style="top:396.2pt;left:249.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">NR</span></p>
<p style="top:318.5pt;left:249.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Man AB + PRP</span></p>
<p style="top:253.8pt;left:249.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Man AB + PRP</span></p>
<p style="top:193.7pt;left:249.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">4, 12 m</span></p>
<p style="top:147.5pt;left:249.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">CT (V%)</span></p>
<p style="top:93.1pt;left:249.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">NS</span></p>
<p style="top:723.1pt;left:271.5pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">OBs (n = 6)</span></b></p>
<p style="top:723.1pt;left:283.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt"> Pradel et al. (2006) (CC)</span></p>
<p style="top:630.3pt;left:283.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Man cysts</span></p>
<p style="top:560.7pt;left:283.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">8 (7M, 8&#x2013;16 y)</span></p>
<p style="top:495.3pt;left:283.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Max/man OBs (Exp, DMEM </span></p>
<p style="top:491.3pt;left:293.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">+ 10% AS, osteo+, pass. 2, </span></p>
<p style="top:491.3pt;left:303.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">8&#x2013;12w)</span></p>
<p style="top:396.2pt;left:282.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">5 &#xd7; 10</span><span style="font-family:Lato,serif;font-size:4.9pt">5</span><span style="font-family:Lato,serif;font-size:7.0pt"> cells/scaffold</span></p>
<p style="top:318.5pt;left:282.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">DBBM (Osteovit</span><span style="font-family:Lato,serif;font-size:4.9pt">&#xae;</span><span style="font-family:Lato,serif;font-size:7.0pt">)</span></p>
<p style="top:253.8pt;left:283.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Iliac AB</span></p>
<p style="top:193.7pt;left:283.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">3, 6, 12 m</span></p>
<p style="top:147.4pt;left:283.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Radio (BD)</span></p>
<p style="top:93.1pt;left:283.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">NS</span></p>
<p style="top:723.1pt;left:315.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt"> Pradel and Lauer (2012) </span></p>
<p style="top:719.1pt;left:325.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">(CC)</span></p>
<p style="top:630.3pt;left:315.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">AC&#x2014;uni/bi</span></p>
<p style="top:560.7pt;left:315.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">20 (15M, 16&#x2013;72 y)</span></p>
<p style="top:495.3pt;left:315.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Max/man OBs</span></p>
<p style="top:396.2pt;left:314.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">5 &#xd7; 10</span><span style="font-family:Lato,serif;font-size:4.9pt">5</span><span style="font-family:Lato,serif;font-size:7.0pt"> cells/scaffold</span></p>
<p style="top:318.5pt;left:314.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">DBBM (Osteovit</span><span style="font-family:Lato,serif;font-size:4.9pt">&#xae;</span><span style="font-family:Lato,serif;font-size:7.0pt">)</span></p>
<p style="top:253.8pt;left:315.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Iliac AB</span></p>
<p style="top:193.7pt;left:315.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">6 m</span></p>
<p style="top:147.4pt;left:315.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">CBCT (%fill)</span></p>
<p style="top:93.1pt;left:315.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">T 40.9%, C </span></p>
<p style="top:93.1pt;left:325.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">36.6%</span></p>
<p style="top:723.1pt;left:337.6pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt"> Pradel, Mai, Manolo </span></p>
<p style="top:719.1pt;left:347.6pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Hagedorn, Lauer, and </span></p>
<p style="top:719.1pt;left:357.6pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Allegrini (2008) (CC)</span></p>
<p style="top:630.3pt;left:337.6pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">SA (mod- sev) &#x2014;uni/</span></p>
<p style="top:626.3pt;left:347.6pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">bi</span></p>
<p style="top:560.6pt;left:337.6pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">6 (6F, 38&#x2013;52 y)</span></p>
<p style="top:495.3pt;left:337.6pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Max/man OBs</span></p>
<p style="top:396.2pt;left:336.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">5 &#xd7; 10</span><span style="font-family:Lato,serif;font-size:4.9pt">5</span><span style="font-family:Lato,serif;font-size:7.0pt"> cells/scaffold</span></p>
<p style="top:318.5pt;left:336.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">DBBM (Osteovit</span><span style="font-family:Lato,serif;font-size:4.9pt">&#xae;</span><span style="font-family:Lato,serif;font-size:7.0pt">)</span></p>
<p style="top:253.8pt;left:337.6pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">OBs + S-BBM </span></p>
<p style="top:249.8pt;left:346.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">(Tutobon</span><span style="font-family:Lato,serif;font-size:4.9pt">&#xae;</span><span style="font-family:Lato,serif;font-size:7.0pt">)</span></p>
<p style="top:193.7pt;left:337.6pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">5 m</span></p>
<p style="top:147.4pt;left:337.6pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Histo (qual)</span></p>
<p style="top:93.1pt;left:337.6pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">S- BBM&gt;BBM</span></p>
<p style="top:723.1pt;left:369.6pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt"> Gonshor et al. (2011) </span></p>
<p style="top:719.1pt;left:379.6pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">(RCT)</span></p>
<p style="top:630.3pt;left:369.6pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">SA (&lt;6 mm) &#x2014;uni/</span></p>
<p style="top:626.3pt;left:379.6pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">bilat</span></p>
<p style="top:560.7pt;left:369.6pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">18 (12F, 42&#x2013;79 y)</span></p>
<p style="top:495.3pt;left:368.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Cellular allograft (Osteocel</span><span style="font-family:Lato,serif;font-size:4.9pt">&#xae;</span><span style="font-family:Lato,serif;font-size:7.0pt">)</span></p>
<p style="top:396.2pt;left:368.5pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">&gt;5 &#xd7; 10</span><span style="font-family:Lato,serif;font-size:4.9pt">4</span><span style="font-family:Lato,serif;font-size:7.0pt"> cells/cm</span><span style="font-family:Lato,serif;font-size:4.9pt">3</span></p>
<p style="top:318.5pt;left:369.6pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Allograft</span></p>
<p style="top:253.8pt;left:369.6pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Allograft only</span></p>
<p style="top:193.7pt;left:369.6pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">3&#x2013;4 m</span></p>
<p style="top:147.5pt;left:369.6pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Histo</span></p>
<p style="top:93.1pt;left:369.6pt;line-height:7.0pt"><i><span style="font-family:Lato,serif;font-size:7.0pt">S</span></i></p>
<p style="top:723.1pt;left:391.6pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt"> Springer et al. (2006) (CC)</span></p>
<p style="top:630.3pt;left:391.6pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">SA&#x2014;uni/bilat</span></p>
<p style="top:560.7pt;left:391.6pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">5 (4F, 43&#x2013;65 y)</span></p>
<p style="top:495.3pt;left:391.6pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Max tuberosity OBs (Exp, </span></p>
<p style="top:491.3pt;left:401.6pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">DMEM + 20% AS)</span></p>
<p style="top:396.2pt;left:390.6pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">3.3 &#xd7; 10</span><span style="font-family:Lato,serif;font-size:4.9pt">6</span><span style="font-family:Lato,serif;font-size:7.0pt"> cells/cm</span><span style="font-family:Lato,serif;font-size:4.9pt">2</span><span style="font-family:Lato,serif;font-size:7.0pt"> </span></p>
<p style="top:392.1pt;left:401.6pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">scaffold (+40 days </span></p>
<p style="top:392.1pt;left:411.6pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">cult)</span></p>
<p style="top:318.5pt;left:390.6pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">DBBM (Bio- Oss</span><span style="font-family:Lato,serif;font-size:4.9pt">&#xae;</span><span style="font-family:Lato,serif;font-size:7.0pt">)</span></p>
<p style="top:253.8pt;left:391.6pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">DBBM only</span></p>
<p style="top:193.7pt;left:391.6pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">6&#x2013;8 m</span></p>
<p style="top:147.4pt;left:391.6pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Histo (qual) </span></p>
<p style="top:147.4pt;left:401.6pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Radio</span></p>
<p style="top:93.1pt;left:391.6pt;line-height:7.0pt"><i><span style="font-family:Lato,serif;font-size:7.0pt">S</span></i></p>
<p style="top:723.1pt;left:423.7pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt"> Hermund, Stavropoulos, </span></p>
<p style="top:719.1pt;left:433.7pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">(2012), </span><i><span style="font-family:Lato,serif;font-size:7.0pt">Hermund et al.,</span></i><span style="font-family:Lato,serif;font-size:7.0pt"> </span></p>
<p style="top:719.1pt;left:443.7pt;line-height:7.0pt"><i><span style="font-family:Lato,serif;font-size:7.0pt">(2013)</span></i><span style="font-family:Lato,serif;font-size:7.0pt"> (RCT)</span></p>
<p style="top:630.3pt;left:423.7pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">SA (&lt;3 mm)&#x2014;uni</span></p>
<p style="top:560.7pt;left:423.7pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">20 (11F, ~58&#x2013;60 y)</span></p>
<p style="top:495.3pt;left:423.7pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Max tuberosity OBs (Exp, </span></p>
<p style="top:491.3pt;left:433.7pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">DMEM/F12 + 20% FBS + </span></p>
<p style="top:491.3pt;left:443.7pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">AA, 10% AS 1w, 1 m)</span></p>
<p style="top:396.2pt;left:422.6pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">2 &#xd7; 10</span><span style="font-family:Lato,serif;font-size:4.9pt">6</span><span style="font-family:Lato,serif;font-size:7.0pt"> cells/ml</span></p>
<p style="top:318.5pt;left:422.6pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">DBBM (Bio- Oss</span><span style="font-family:Lato,serif;font-size:4.9pt">&#xae;</span><span style="font-family:Lato,serif;font-size:7.0pt">) </span></p>
<p style="top:314.5pt;left:433.7pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">+ Max AB (1:1)</span></p>
<p style="top:253.8pt;left:423.7pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">DBBM + Max AB </span></p>
<p style="top:249.8pt;left:433.7pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">(1:1)</span></p>
<p style="top:193.7pt;left:423.7pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">4 m</span></p>
<p style="top:147.5pt;left:423.7pt;line-height:7.0pt"><i><span style="font-family:Lato,serif;font-size:7.0pt">IS</span></i><span style="font-family:Lato,serif;font-size:7.0pt">Histo </span></p>
<p style="top:93.1pt;left:423.7pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">NS </span></p>
<p style="top:93.1pt;left:433.7pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">NS</span></p>
<p style="top:725.7pt;left:458.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">CT: controlled trial; RCT: randomized CT; CC: case&#x2013;control; SA: sinus augmentation; RA: ridge augmentation/GBR; SP: socket preservation; AC: alveolar cleft; SD: segmental or continuity defects; CD: </span></p>
<p style="top:725.7pt;left:469.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">cranial defect; ORN: osteoradionecrosis; uni: unilateral; bi: bilateral; imp: simultaneous implant placement; man: mandible; max: maxilla; hor: horizontal; ver: vertical; mod- sev: moderate- severe; M: male; F: </span></p>
<p style="top:725.7pt;left:479.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">female; y: years; m: months; w: weeks; Histo: histomorphometry; Histo (qual): qualitative histology; IHC: immunohistochemistry; Radio: radiographic; CT: computed tomography; V: volume; BD: bone den</span><span style="font-family:Lato,serif;font-size:7.5pt">-</span></p>
<p style="top:725.7pt;left:490.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">sity; T: test group; C: control group; Comp: complications; IS: implant survival; +: favourable bone regeneration outcomes; POCs: periosteal cells; OBs: osteoblasts; Exp: explant culture; FBS: foetal bovine </span></p>
<p style="top:725.7pt;left:500.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">serum; HS: horse serum; AS: autologous serum; osteo+: osteogenic induction; pass.: passage; AB: autogenous bone; HA: hydroxyl- apatite; Si: silica; </span><span style="font-family:STIX,serif;font-size:7.5pt">&#x3b2;</span><span style="font-family:Lato,serif;font-size:7.5pt">- TCP: beta- tricalcium phosphate; BCP: biphasic calcium </span></p>
<p style="top:725.7pt;left:511.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">phosphate; BAG: bioactive glass; GAG: glycosaminoglycans; Col: collagen; DBBM: demineralized bovine bone mineral; ABB: anorganic bovine bone; Pep: PepGen; PRP: platelet- rich plasma; PRF: platelet- </span></p>
<p style="top:725.7pt;left:521.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">rich fibrin; </span><i><span style="font-family:Lato,serif;font-size:7.5pt">S</span></i><span style="font-family:Lato,serif;font-size:7.5pt">: statistically significant differences between T and C groups; NS: no statistically significant differences between T and C groups; a: overlapping patient samples.</span></p>
<p style="top:11.6pt;left:578.8pt;line-height:5.1pt"><span style="font-family:Times New Roman,serif;font-size:5.1pt"> 1600051x, 2019, S21, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jcpe.13049 by Universit&#xe4;tsbibliothek Zuerich, Wiley Online Library on [27/12/2022]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</span></p>


<p style="top:23.8pt;left:511.9pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003;&#x2002; &#x2003;</span></b><b><span style="font-family:Lato,serif;font-size:9.1pt">|</span></b><b><span style="font-family:Lato,serif;font-size:7.0pt"> &#x2003;171</span></b></p>
<img style="position:absolute;transform:matrix(.31940789,0,-0,.3187552,395.0849,3.744316)" src="data:image/jpeg;base64,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">
<p style="top:23.9pt;left:44.8pt;line-height:7.0pt"><span style="font-family:Lato-Regular,serif;font-size:7.0pt">SHANBHAG </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">et</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt"> </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">Al</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt">.</span></p>
<p style="top:529.6pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">morbidity associated with BMA harvesting, lower donor site mor-</span></p>
<p style="top:542.6pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">bidity and donor site pain- intensity and - frequency were reported </span></p>
<p style="top:555.6pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">in patients treated with BMA/scaffolds vs. iliac AB grafting for AC </span></p>
<p style="top:568.6pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">repair (Gimbel et al., 2007). In one RCT of mandibular segmen</span><span style="font-family:Lato,serif;font-size:8.0pt">-</span></p>
<p style="top:581.6pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">tal defect- repair (Marx &amp; Harrell, 2014), significantly greater NBF </span></p>
<p style="top:594.6pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">was observed when using BMAC&#x2014;containing a higher fraction of </span></p>
<p style="top:607.6pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">CD34</span><sup><span style="font-family:Lato,serif;font-size:5.6pt">+</span></sup><span style="font-family:Lato,serif;font-size:8.0pt"> cells (1012 &#xb1; 752 cells/ml) compared to un- concentrated </span></p>
<p style="top:620.6pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">BMA (54 &#xb1; 38 cells/ml), although both groups had similar concentra</span><span style="font-family:Lato,serif;font-size:8.0pt">-</span></p>
<p style="top:633.6pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">tions of CD90</span><sup><span style="font-family:Lato,serif;font-size:5.6pt">+</span></sup><span style="font-family:Lato,serif;font-size:8.0pt">CD105</span><sup><span style="font-family:Lato,serif;font-size:5.6pt">+</span></sup><span style="font-family:Lato,serif;font-size:8.0pt"> MSCs (15 &#xd7; 10</span><sup><span style="font-family:Lato,serif;font-size:5.6pt">6</span></sup><span style="font-family:Lato,serif;font-size:8.0pt"> cells/ml) and were delivered </span></p>
<p style="top:646.6pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">in combination with rhBMP- 2- loaded COL and allograft scaffolds. </span></p>
<p style="top:659.6pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Interestingly, the NBF was higher when BMAC (67% &#xb1; 13%), but not </span></p>
<p style="top:672.6pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">BMA (36% &#xb1; 10%), was added to the constructs compared to only </span></p>
<p style="top:685.6pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">rhBMP- 2 (+PRP; 59% &#xb1; 12%) or AB (54% &#xb1; 10%), as reported by the </span></p>
<p style="top:698.6pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">group in a previous study (Marx, Armentano, Olavarria, &amp; Samaniego, </span></p>
<p style="top:711.6pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">2013). The authors highlighted an important complimentary role of </span></p>
<p style="top:724.6pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">CD34</span><sup><span style="font-family:Lato,serif;font-size:5.6pt">+</span></sup><span style="font-family:Lato,serif;font-size:8.0pt"> HSCs in MSC- mediated bone regeneration, and the benefits </span></p>
<p style="top:529.6pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">of implanting heterogeneous cell populations at regeneration sites </span></p>
<p style="top:542.6pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(Marx &amp; Harrell, 2014).</span></p>
<p style="top:555.6pt;left:318.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">One controlled trial (Prins et al., 2016) reported the application </span></p>
<p style="top:568.6pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">of autologous A- SVF for SA via enzymatic digestion of abdominal </span></p>
<p style="top:581.6pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">adipose tissues using a chair- side isolation system (Celution</span><sup><span style="font-family:Lato,serif;font-size:5.6pt">&#xae;</span></sup><span style="font-family:Lato,serif;font-size:8.0pt">, Cytori </span></p>
<p style="top:594.6pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Therapeutics, San Diego, CA, USA). Significantly greater NBF was </span></p>
<p style="top:607.6pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">observed in six patients treated with A- SVF- loaded vs. cell- free </span><span style="font-family:STIX,serif;font-size:8.0pt">&#x3b2;</span><span style="font-family:Lato,serif;font-size:8.0pt">- </span></p>
<p style="top:620.6pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">TCP or BCP scaffolds after 6 months&#x2014;most markedly in the &#x201c;cranial&#x201d; </span></p>
<p style="top:633.6pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">portion of the augmentation sites distant from the native residual </span></p>
<p style="top:646.6pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ridge (Prins et al., 2016). Interestingly, subsequent immunohisto</span><span style="font-family:Lato,serif;font-size:8.0pt">-</span></p>
<p style="top:659.6pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">chemical analyses of biopsy specimens also revealed a higher quan-</span></p>
<p style="top:672.6pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">tity and quality/maturity of blood vessels in the areas of active bone </span></p>
<p style="top:685.6pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">formation (Farre- Guasch et al., 2018). Similar results were observed </span></p>
<p style="top:698.6pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">in a phase I clinical study of orthopaedic fracture treatment with A- </span></p>
<p style="top:711.6pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">SVF (Saxer et al., 2016). Indeed, previous studies have demonstrated </span></p>
<p style="top:724.6pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">the angiogenic and vasculogenic potential of A- SVF, attributed to the </span></p>
<p style="top:49.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">TA B LE&#xa0;5&#x2003;</span><span style="font-family:Lato,serif;font-size:8.0pt">Comparison of cell therapy effect sizes in preclinical and clinical meta- analyses</span></p>
<p style="top:68.1pt;left:123.4pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Preclinical</span></b></p>
<p style="top:68.1pt;left:346.1pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Clinical</span></b></p>
<p style="top:86.4pt;left:123.4pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Category</span></b></p>
<p style="top:86.4pt;left:169.9pt;line-height:7.5pt"><b><i><span style="font-family:Lato,serif;font-size:7.5pt">n</span></i></b></p>
<p style="top:86.4pt;left:195.1pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">ES</span></b></p>
<p style="top:86.4pt;left:227.3pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">95% CI</span></b></p>
<p style="top:86.4pt;left:282.8pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">PI</span></b></p>
<p style="top:86.4pt;left:346.1pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Category</span></b></p>
<p style="top:86.4pt;left:394.9pt;line-height:7.5pt"><b><i><span style="font-family:Lato,serif;font-size:7.5pt">n</span></i></b></p>
<p style="top:86.4pt;left:416.3pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">ES</span></b></p>
<p style="top:86.4pt;left:448.3pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">95% CI</span></b></p>
<p style="top:86.4pt;left:497.5pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">PI</span></b></p>
<p style="top:102.6pt;left:49.8pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Sinus augmentation</span></b></p>
<p style="top:116.6pt;left:49.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt"> Dogs</span></p>
<p style="top:116.6pt;left:123.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">vs. </span></p>
<p style="top:127.1pt;left:127.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Scaffolds </span></p>
<p style="top:137.6pt;left:127.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(&lt;6 m)</span></p>
<p style="top:116.6pt;left:169.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">5</span></p>
<p style="top:116.6pt;left:195.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">10.21</span></p>
<p style="top:116.6pt;left:227.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">4.00, 16.42</span></p>
<p style="top:116.6pt;left:282.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2212;12.17, 32.59</span></p>
<p style="top:116.6pt;left:346.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">vs. </span></p>
<p style="top:127.1pt;left:350.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Scaffolds </span></p>
<p style="top:137.6pt;left:350.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(6 m)</span></p>
<p style="top:116.6pt;left:394.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">6</span></p>
<p style="top:116.6pt;left:416.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">4.12</span></p>
<p style="top:116.6pt;left:448.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">0.25, 7.98</span></p>
<p style="top:116.6pt;left:497.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2212;7.42, 15.65</span></p>
<p style="top:151.7pt;left:49.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt"> Sheep/goats</span></p>
<p style="top:151.7pt;left:123.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">vs. AB </span></p>
<p style="top:162.2pt;left:127.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(2&#x2013;4 m)</span></p>
<p style="top:151.7pt;left:169.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">3</span></p>
<p style="top:151.7pt;left:195.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">11.11</span></p>
<p style="top:151.7pt;left:227.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">5.33, 16.90</span></p>
<p style="top:151.7pt;left:282.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2212;13.37, 35.60</span></p>
<p style="top:151.7pt;left:346.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">vs. </span></p>
<p style="top:162.2pt;left:350.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Scaffolds</span><sup><span style="font-family:Lato,serif;font-size:5.2pt">b</span></sup><span style="font-family:Lato,serif;font-size:7.5pt"> </span></p>
<p style="top:172.7pt;left:350.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(4&#x2013;7 m)</span></p>
<p style="top:151.7pt;left:394.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">3</span></p>
<p style="top:151.7pt;left:416.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">4.76</span></p>
<p style="top:151.7pt;left:448.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">2.80, 6.71</span></p>
<p style="top:151.7pt;left:497.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">0.47, 9.04</span></p>
<p style="top:186.7pt;left:49.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt"> Pigs, sheep/goats</span></p>
<p style="top:186.7pt;left:123.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">vs. </span></p>
<p style="top:197.2pt;left:127.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Scaffolds </span></p>
<p style="top:207.7pt;left:127.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(2&#x2013;4 m)</span></p>
<p style="top:186.7pt;left:169.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">2, 5</span></p>
<p style="top:186.7pt;left:195.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">NS</span></p>
<p style="top:186.7pt;left:227.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2013;</span></p>
<p style="top:186.7pt;left:282.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2013;</span></p>
<p style="top:186.7pt;left:346.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">vs. </span></p>
<p style="top:197.2pt;left:350.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Scaffolds </span></p>
<p style="top:207.7pt;left:350.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(3&#x2013;4 m)</span></p>
<p style="top:186.7pt;left:394.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">12</span></p>
<p style="top:186.7pt;left:416.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">NS</span></p>
<p style="top:186.7pt;left:448.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2013;</span></p>
<p style="top:186.7pt;left:497.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2013;</span></p>
<p style="top:221.8pt;left:49.8pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Ridge augmentation (CSD</span></b><sup><b><span style="font-family:Lato,serif;font-size:5.2pt">a</span></b></sup><span style="font-family:Lato,serif;font-size:7.5pt">)</span></p>
<p style="top:235.8pt;left:49.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt"> Dogs</span></p>
<p style="top:235.8pt;left:123.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">vs. </span></p>
<p style="top:246.3pt;left:127.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Scaffolds </span></p>
<p style="top:256.8pt;left:127.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(1&#x2013;2 m)</span></p>
<p style="top:235.8pt;left:169.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">5</span></p>
<p style="top:235.8pt;left:195.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">12.14</span></p>
<p style="top:235.8pt;left:227.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">6.16, 18.11</span></p>
<p style="top:235.8pt;left:285.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2212;8.73, 33</span></p>
<p style="top:235.8pt;left:346.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">vs. </span></p>
<p style="top:246.3pt;left:350.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Scaffolds </span></p>
<p style="top:256.8pt;left:350.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(4&#x2013;6 m)</span></p>
<p style="top:235.8pt;left:394.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">4</span></p>
<p style="top:235.8pt;left:416.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">13.42</span></p>
<p style="top:235.8pt;left:448.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">7.75, 19.09</span></p>
<p style="top:235.8pt;left:497.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2212;2.09, 28.93</span></p>
<p style="top:270.8pt;left:49.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt"> Dogs</span></p>
<p style="top:270.8pt;left:123.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">vs. </span></p>
<p style="top:281.3pt;left:127.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Scaffolds </span></p>
<p style="top:291.8pt;left:127.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(2&#x2013;4 m)</span></p>
<p style="top:270.8pt;left:169.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">9</span></p>
<p style="top:270.8pt;left:195.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">20.11</span></p>
<p style="top:270.8pt;left:227.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">11.65, 28.56</span></p>
<p style="top:270.8pt;left:282.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2212;15.17, 55.39</span></p>
<p style="top:305.9pt;left:49.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt"> Dogs</span></p>
<p style="top:305.9pt;left:123.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">vs. </span></p>
<p style="top:316.4pt;left:127.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Scaffolds </span></p>
<p style="top:326.9pt;left:127.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(12 m)</span></p>
<p style="top:305.9pt;left:169.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">3</span></p>
<p style="top:305.9pt;left:195.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">48.73</span></p>
<p style="top:305.9pt;left:227.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">43.87, 53.60</span></p>
<p style="top:305.9pt;left:282.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">17.20, 80.26</span></p>
<p style="top:340.9pt;left:49.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt"> Pigs</span></p>
<p style="top:340.9pt;left:123.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">vs. </span></p>
<p style="top:351.4pt;left:127.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Scaffolds </span></p>
<p style="top:361.9pt;left:127.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(2&#x2013;3 m)</span></p>
<p style="top:340.9pt;left:169.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">4</span></p>
<p style="top:340.9pt;left:195.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">14.84</span></p>
<p style="top:340.9pt;left:227.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">9.66, 20.01</span></p>
<p style="top:340.9pt;left:285.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2212;2.50, 32.19</span></p>
<p style="top:376.0pt;left:49.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt"> Sheep</span></p>
<p style="top:376.0pt;left:123.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">vs. </span></p>
<p style="top:386.5pt;left:127.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Scaffolds </span></p>
<p style="top:397.0pt;left:127.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(3&#x2013;5 m)</span></p>
<p style="top:376.0pt;left:169.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">3</span></p>
<p style="top:376.0pt;left:195.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">25.78</span></p>
<p style="top:376.0pt;left:227.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">18.55, 33.01</span></p>
<p style="top:376.0pt;left:282.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2212;52.77, 104.32</span></p>
<p style="top:411.0pt;left:49.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt"> Dogs</span></p>
<p style="top:411.0pt;left:123.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">vs. AB </span></p>
<p style="top:421.5pt;left:127.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(12 m)</span></p>
<p style="top:411.0pt;left:169.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">3</span></p>
<p style="top:411.0pt;left:195.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">NS</span></p>
<p style="top:411.0pt;left:227.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2013;</span></p>
<p style="top:411.0pt;left:282.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2013;</span></p>
<p style="top:435.5pt;left:49.8pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Alveolar cleft repair</span></b></p>
<p style="top:449.6pt;left:49.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt"> Dogs</span></p>
<p style="top:449.6pt;left:123.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">vs. AB </span></p>
<p style="top:460.1pt;left:127.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(2&#x2013;5 m)</span></p>
<p style="top:449.6pt;left:169.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">3</span></p>
<p style="top:449.6pt;left:195.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">NS</span></p>
<p style="top:449.6pt;left:227.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2013;</span></p>
<p style="top:449.6pt;left:282.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2013;</span></p>
<p style="top:449.6pt;left:346.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">vs. AB </span></p>
<p style="top:460.1pt;left:350.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(6 m)</span></p>
<p style="top:449.6pt;left:394.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">3</span></p>
<p style="top:449.6pt;left:416.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">NS</span></p>
<p style="top:449.6pt;left:448.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2013;</span></p>
<p style="top:449.6pt;left:497.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2013;</span></p>
<p style="top:476.6pt;left:44.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Numbers indicate Effect Sizes (ES), 95% Confidence Intervals (CI) and estimated Prediction Intervals (PI); n: number of studies; NS: non- significant ef</span><span style="font-family:Lato,serif;font-size:7.5pt">-</span></p>
<p style="top:487.1pt;left:44.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">fects; AB: autogenous bone; m: months; CSD: critical size defects</span></p>
<p style="top:496.0pt;left:44.8pt;line-height:5.2pt"><span style="font-family:Lato,serif;font-size:5.2pt">a</span><span style="font-family:Lato,serif;font-size:7.5pt">In preclinical studies; all comparisons are based on histomorphometric outcomes, except </span><span style="font-family:Lato,serif;font-size:5.2pt">b</span><span style="font-family:Lato,serif;font-size:7.5pt">Based on micro- CT. </span></p>
<p style="top:11.6pt;left:578.8pt;line-height:5.1pt"><span style="font-family:Times New Roman,serif;font-size:5.1pt"> 1600051x, 2019, S21, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jcpe.13049 by Universit&#xe4;tsbibliothek Zuerich, Wiley Online Library on [27/12/2022]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</span></p>


<p style="top:23.8pt;left:46.5pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">172&#x2003; </span></b><b><span style="font-family:Lato,serif;font-size:9.1pt">|</span></b><b><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003; &#x2003;&#x2002;</span></b></p>
<img style="position:absolute;transform:matrix(.31940789,0,-0,.3187552,54.97612,3.7443963)" src="data:image/jpeg;base64,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">
<p style="top:23.8pt;left:493.4pt;line-height:7.0pt"><span style="font-family:Lato-Regular,serif;font-size:7.0pt">SHANBHAG </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">et</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt"> </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">Al</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt">.</span></p>
<p style="top:49.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">presence of ECs and perivascular cells (Jin, Chae, Son, &amp; Kim, 2017; </span></p>
<p style="top:62.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Zakhari, Zabonick, Gettler, &amp; Williams, 2018). However, whether </span></p>
<p style="top:75.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">the in vivo bone- forming potential of A- SVF may be enhanced by </span></p>
<p style="top:88.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">prior osteogenic stimulation, remains to be clinically determined </span></p>
<p style="top:101.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(Scherberich, Muller, Schafer, Banfi, &amp; Martin, 2010). Nevertheless, </span></p>
<p style="top:114.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">the expected surge in clinical use of A- SVF may be hampered by re-</span></p>
<p style="top:127.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">cent US and European guidelines, which seek to classify A- SVF as </span></p>
<p style="top:140.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">&#x201c;more- than- minimally manipulated&#x201d; cells (Raposio &amp; Ciliberti, 2017).</span></p>
<p style="top:153.0pt;left:59.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">One research group has reported the use of a proprietary chair- </span></p>
<p style="top:166.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">side mechanical tissue disaggregation system (Rigenera</span><sup><span style="font-family:Lato,serif;font-size:5.6pt">&#xae;</span></sup><span style="font-family:Lato,serif;font-size:8.0pt">, Human </span></p>
<p style="top:179.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Brain Wave srl, Turin, Italy) to isolate cell fractions termed &#x201c;autol</span><span style="font-family:Lato,serif;font-size:8.0pt">-</span></p>
<p style="top:192.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ogous micrografts&#x201d; from dental pulp (d&apos;Aquino et al., 2009; Monti </span></p>
<p style="top:205.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">et al. 2016) and periosteal tissues (D&apos;Aquino et al., 2016; Rodriguez </span></p>
<p style="top:218.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">et al., 2017). Significantly greater histological and/or radiographic </span></p>
<p style="top:231.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">bone regeneration was observed with dental pulp or periosteum </span></p>
<p style="top:244.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">micrograft- loaded versus cell- free scaffolds in SP and SA. The pro-</span></p>
<p style="top:257.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">tocol involves simultaneous mechanical disaggregation (using a </span></p>
<p style="top:270.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">micro- blade grid) of a small tissue sample and filtering of the solu-</span></p>
<p style="top:283.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">tion through a 50- </span><span style="font-family:STIX,serif;font-size:8.0pt">&#x3bc;</span><span style="font-family:Lato,serif;font-size:8.0pt">m strain, to yield a suspension of &#x201c;side popula-</span></p>
<p style="top:296.0pt;left:46.4pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">tion&#x201d; progenitor cells, which is then loaded onto a biomaterial prior </span></p>
<p style="top:309.0pt;left:46.4pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">to implantation. Characterization of this &#x201c;side population&#x201d; following </span></p>
<p style="top:322.0pt;left:46.4pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">in vitro culture revealed a heterogeneous population including MSC- </span></p>
<p style="top:335.0pt;left:46.4pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">like cells (CD73</span><sup><span style="font-family:Lato,serif;font-size:5.6pt">+</span></sup><span style="font-family:Lato,serif;font-size:8.0pt">CD90</span><sup><span style="font-family:Lato,serif;font-size:5.6pt">+</span></sup><span style="font-family:Lato,serif;font-size:8.0pt">CD105</span><sup><span style="font-family:Lato,serif;font-size:5.6pt">+</span></sup><span style="font-family:Lato,serif;font-size:8.0pt">CD45</span><sup><span style="font-family:Lato,serif;font-size:5.6pt">&#x2212;</span></sup><span style="font-family:Lato,serif;font-size:8.0pt">CD14</span><sup><span style="font-family:Lato,serif;font-size:5.6pt">&#x2212;</span></sup><span style="font-family:Lato,serif;font-size:8.0pt">) with multi- lineage dif-</span></p>
<p style="top:348.0pt;left:46.4pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ferentiation potential (Trovato et al., 2015).</span></p>
<p style="top:361.0pt;left:59.4pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Although the use of minimally manipulated whole tissue fractions </span></p>
<p style="top:374.0pt;left:46.4pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">is time-  and cost- effective, the yield of progenitor cells obtained is </span></p>
<p style="top:387.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">relatively low. MSCs represent &lt;1% of the MNC in BMA, and ap-</span></p>
<p style="top:400.0pt;left:46.4pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">proximately 1.4% in A- SVF, based on CFU potential (Prins et al., </span></p>
<p style="top:413.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">2016). This has encouraged ex vivo expansion strategies, which aim </span></p>
<p style="top:426.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">to exponentially increase the number of cells of a specific pheno-</span></p>
<p style="top:439.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">type, that is </span><i><span style="font-family:Lato,serif;font-size:8.0pt">committed</span></i><span style="font-family:Lato,serif;font-size:8.0pt"> or </span><i><span style="font-family:Lato,serif;font-size:8.0pt">uncommitted</span></i><span style="font-family:Lato,serif;font-size:8.0pt">, available for implantation, </span></p>
<p style="top:452.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">and thereby improve clinical outcomes.</span></p>
<p style="top:482.9pt;left:46.5pt;line-height:10.0pt"><b><span style="font-family:Lato,serif;font-size:10.0pt">4.2&#x2003;</span></b><span style="font-family:Lato,serif;font-size:10.0pt">|</span><b><span style="font-family:Lato,serif;font-size:10.0pt">&#x2003;Use of expanded uncommitted cells</span></b></p>
<p style="top:504.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Ten controlled (and 18 uncontrolled) studies reported the implan-</span></p>
<p style="top:517.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">tation of autologous MSCs from bone marrow or adipose tissues </span></p>
<p style="top:530.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(Table 3, Supporting Information Table S2). Culture- expanded </span></p>
<p style="top:543.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">BMSCs were used in SA (Hernandez Alfero et al., 2005; Kaigler et al., </span></p>
<p style="top:556.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">2013, 2015), RA (Bajestan et al., 2017) or AC repair (Khalifa &amp; Gomaa, </span></p>
<p style="top:569.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">2017). Of these, the former four studies reported the use of a com</span><span style="font-family:Lato,serif;font-size:8.0pt">-</span></p>
<p style="top:582.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">mercial automated bioreactor system (Replicell</span><sup><span style="font-family:Lato,serif;font-size:5.6pt">&#xae;</span></sup><span style="font-family:Lato,serif;font-size:8.0pt"> or Ixymyelocel- t</span><sup><span style="font-family:Lato,serif;font-size:5.6pt">&#xae;</span></sup><span style="font-family:Lato,serif;font-size:8.0pt">, </span></p>
<p style="top:595.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Aastrom Biosciences Inc., Ann Arbor, MI, USA) for isolation of a </span></p>
<p style="top:608.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">mixed population of CD90</span><sup><span style="font-family:Lato,serif;font-size:5.6pt">+</span></sup><span style="font-family:Lato,serif;font-size:8.0pt"> MSCs, HSCs, endothelial and inflam-</span></p>
<p style="top:621.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">matory cells, termed &#x201c;tissue repair cells&#x201d; (TRCs), from the MNC- </span></p>
<p style="top:634.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">fraction of bone marrow (Bartel et al., 2012). TRCs were obtained </span></p>
<p style="top:647.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">via a single- step process following a 12&#x2013;14 day- expansion period </span></p>
<p style="top:660.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">in a &#x201c;single- pass perfusion&#x201d; bioreactor, in which, unlike typical MSC </span></p>
<p style="top:673.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">cultures, the non- adherent (i.e., hematopoietic, endothelial and in-</span></p>
<p style="top:686.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">flammatory) cell fractions were retained and the adherent cells were </span></p>
<p style="top:699.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">not passaged. The authors hypothesize that these accessory cells </span></p>
<p style="top:712.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">may serve to enhance tissue regeneration by promoting vasculariza-</span></p>
<p style="top:725.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">tion and modulating the inflammatory response in the regenerating </span></p>
<p style="top:49.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">tissues (Dennis et al., 2007). However, no significant differences in </span></p>
<p style="top:62.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">NBF were observed when comparing TRC- scaffold constructs with </span></p>
<p style="top:75.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">scaffolds alone (Hernandez Alfero et al., 2005; Kaigler et al., 2013, </span></p>
<p style="top:88.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">2015) or AB (Bajestan et al., 2017).</span></p>
<p style="top:101.0pt;left:320.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">One strategy to enhance the regenerative efficacy of MSCs is via </span></p>
<p style="top:114.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">osteogenic induction and pre- differentiation (Oryan et al., 2017). In </span></p>
<p style="top:127.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">the present review, the evidence for osteogenic pre- differentiation </span></p>
<p style="top:140.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">of BMSCs prior to clinical application was conflicting. Among the UT, </span></p>
<p style="top:153.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">one group reported the application of osteogenically pre- induced </span></p>
<p style="top:166.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">MSCs seeded on HA scaffolds for RA/SA. The authors reported </span></p>
<p style="top:179.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">successful bone regeneration, suggestive of &#x201c;osteogenesis&#x201d; by the </span></p>
<p style="top:192.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">implanted cells, in only one of six patients (Meijer, de Bruijn, Koole, </span></p>
<p style="top:205.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">&amp; van Blitterswijk, 2008). Two other groups reported favourable </span></p>
<p style="top:218.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">bone regeneration in RA (Wojtowicz, Jodko, Perek, &amp; Popowski, </span></p>
<p style="top:231.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">2014; Wojtowicz et al., 2013), AC (Chai et al., 2006) and CD repair </span></p>
<p style="top:244.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(Chai, Zhang, Liu, Cui, &amp; Cao, 2003) when using osteogenically pre- </span></p>
<p style="top:257.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">differentiated cells. Conversely, another group has reported exten-</span></p>
<p style="top:270.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">sively on the application of autologous non- induced BMSCs mixed </span></p>
<p style="top:283.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">with PRP, termed &#x201c;injectable tissue engineered bone&#x201d; for successful </span></p>
<p style="top:296.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">SA and RA (Ueda, Yamada, Kagami, &amp; Hibi, 2008; Ueda, Yamada, </span></p>
<p style="top:309.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Ozawa, &amp; Okazaki, 2005; Yamada et al., 2008; Yamada, Nakamura, </span></p>
<p style="top:322.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Ito, et al., 2013; Yamada, Nakamura, Ueda, &amp; Ito, 2013). Other stud</span><span style="font-family:Lato,serif;font-size:8.0pt">-</span></p>
<p style="top:335.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ies also reported favourable outcomes when using non- induced </span></p>
<p style="top:348.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">BMSCs seeded on BCP scaffolds for SA (Shayesteh et al., 2008) and </span></p>
<p style="top:361.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">AC repair (Behnia, Khojasteh, Soleimani, Tehranchi, &amp; Atashi, 2012). </span></p>
<p style="top:374.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Moreover, one recent controlled study reported superior bone re-</span></p>
<p style="top:387.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">generation following AC repair with non- induced BMSC- loaded HA </span></p>
<p style="top:400.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">scaffolds, compared to the gold standard, that is AB grafts (Khalifa &amp; </span></p>
<p style="top:413.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Nowair, 2017). Nevertheless, since the current pre- clinical evidence </span></p>
<p style="top:426.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">from large- animal models is also conflicting (Adamzyk et al., 2016; </span></p>
<p style="top:439.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Corbella et al., 2017), no clear conclusions can be drawn regarding </span></p>
<p style="top:452.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">the benefits of osteogenic pre- differentiation of MSCs.</span></p>
<p style="top:465.0pt;left:320.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">A majority of the included studies (and all studies in the meta- </span></p>
<p style="top:478.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">analysis) of cell therapy for RA reported augmentation in the hor-</span></p>
<p style="top:491.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">izontal dimension, as a treatment for &#x201c;narrow ridges.&#x201d; It is well </span></p>
<p style="top:504.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">accepted that different types of ridge deficiencies, that is horizon-</span></p>
<p style="top:517.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">tal, vertical and segmental (in ascending order of complexity), have </span></p>
<p style="top:530.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">different regenerative potentials, and thus, may require different </span></p>
<p style="top:543.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">treatment strategies (Esposito et al., 2009). In context, a recent </span></p>
<p style="top:556.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">phase I feasibility study reported the use of autologous BMSCs to </span></p>
<p style="top:569.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">regenerate deficient ridges in the posterior mandible (Gjerde et al., </span></p>
<p style="top:582.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">2018). Regeneration in the atrophic posterior mandible is reported </span></p>
<p style="top:595.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">to be especially challenging due to difficulties in achieving optimal </span></p>
<p style="top:608.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">flap closure and graft stabilization, and the local microarchitecture </span></p>
<p style="top:621.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">of dense cortical bone with limited vascularity (Elnayef et al., 2017). </span></p>
<p style="top:634.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Nevertheless, successful regeneration in both horizontal and ver-</span></p>
<p style="top:647.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">tical dimensions was reported in 11 patients treated with BMSC- </span></p>
<p style="top:660.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">loaded BCP scaffolds contained by a titanium- reinforced membrane </span></p>
<p style="top:673.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(Gjerde et al., 2018). A similar strategy was successfully applied in </span></p>
<p style="top:686.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">the treatment of orthopaedic non- unions in a recent multicenter trial </span></p>
<p style="top:699.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(G&#xf3;mez- Barrena et al., 2018). Both studies included a highly stan</span><span style="font-family:Lato,serif;font-size:8.0pt">-</span></p>
<p style="top:712.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">dardized laboratory protocol for cell manufacturing and provide ex-</span></p>
<p style="top:725.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">amples of successful regeneration in challenging bone deficiencies.</span></p>
<p style="top:11.6pt;left:578.8pt;line-height:5.1pt"><span style="font-family:Times New Roman,serif;font-size:5.1pt"> 1600051x, 2019, S21, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jcpe.13049 by Universit&#xe4;tsbibliothek Zuerich, Wiley Online Library on [27/12/2022]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</span></p>


<p style="top:23.8pt;left:511.9pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003;&#x2002; &#x2003;</span></b><b><span style="font-family:Lato,serif;font-size:9.1pt">|</span></b><b><span style="font-family:Lato,serif;font-size:7.0pt"> &#x2003;173</span></b></p>
<img style="position:absolute;transform:matrix(.31940789,0,-0,.3187552,395.0849,3.744316)" src="data:image/jpeg;base64,
/9j/7gAOQWRvYmUAZAAAAAAB/9sAxQAGBAQEBAQGBAQGCAYGBggKCAcHCAoMCgoK
CgoMDAwMDA4ODAwMDhAQFRMMExQUFBQZGhwcHBofHx8fHx8fHx8fAQcFBQYFBggG
BggJCAgICQwKCgoKDAwLDA0MCwwMDAwMDw4MDAwMDAwPDAwODg4ODhEQEBAQEBMT
ExMVFRUXFxcCBwUFBgUGCAYGCAkICAgJDAoKCgoMDAsMDQwLDAwMDAwPDgwMDAwM
DA8MDA4ODg4OERAQEBAQExMTExUVFRcXF//dAAQAFv/AABEIAFMBWQMAIgABEQEC
EQL/xAGiAAEAAQQDAAMAAAAAAAAAAAAACAQFBgcBAgMJCgsBAAICAgEFAAAAAAAA
AAAAAAAEAQUCAwYHCAkKCxAAAQEFAQQGBwp/AAAAAAAAAQIAAwQFEQYHEiExCBNB
UWFxFBUiNXORswkKFhcYMlKBocEZGiMkJSYnKCkqMzQ2Nzg5OkJDREVGR0hJSlNU
VVZXWFlaYmNkZWZnaGlqcnR1dnd4eXqCg4SFhoeIiYqSk5SVlpeYmZqio6Slpqeo
qaqxsrS1tre4ubrCw8TFxsfIycrR0tPU1dbX2Nna4eLj5OXm5+jp6vDx8vP09fb3
+Pn6EQAAAgIBBAheMwAAAAAAAAAAAQIRAwQSMUETITNRYXGR0QUGBwgJChQVFhcY
GRoiIyQlJicoKSoyNDU2Nzg5OkJDREVGR0hJSlJTVFVWV1hZWmJjZGVmZ2hpanJz
dHV2d3h5eoGCg4SFhoeIiYqSk5SVlpeYmZqhoqOkpaanqLGpqrKztLW2t7i5usHC
w8TFxsfIycrS09TV1tfY2drh4uPk5ebn6Onq8PHy8/T19vf4+fr/2gAMAwAAAREC
EQA/AI/MYxrUKA2QSaxsbOpU8mziIdO3bsvAULCr45WKnEKYWx9tmWD4wyK6uifP
A2bCgSaSjfjANZg1FWNcpBZ2ZWhfZTApAS7ALx8vAhFcVaVJJzAGy4XMIJIDp7NS
H5G7QhAFdAFd80IsSaZLInoA1+xr3aKyUzs4UvH96+hlm9S/dg0BzAoHCkt2RZV4
uy6rTakpvE14IXhrgeXm7r6mjiYbElmSnsiWcEAWJjGvz6ybxzZh3aYxSSlYScov
DUXy73d19TfGgkTSWp0SzALCxsudXOZhEwUHFwkU7WYsIWpKklIdJWi+JJqa0xUA
wt7qucJXMhLYeYiqYcP3i1O6ipWUXoCVYM/C2Twsj9ygDCmNmsvubPFuy+nEamEB
UQ7QACogEgE3ygBXHQVantBc+ipTCLmEBECMcOk3zxJTerSnNUKEggZrBsLIRLU9
AGJMatlEojp3GJgZei/WRVSjgShOapRzA2YouZQbp2lMdNQ7fKzEpSE1zhfKBLQi
xppktEnoAwFrtZyzkTaWJewsM+duVOkBZLwKIIJpQXoLXpNzWZGYmEXEoDguy8dx
SUFSVEEC8KaghWGuaGr7n8CZZaiay5Sw8MO7DsrAoFUWMNMNGyQYjbiJMlEZqAME
iHSod+9h1EEulqQSMRKSRvzebVEy15Rex3vn6m8XTt4+eJcuUla1kJQlIqVE4AAG
1m5AOrGzeX3Mn6nAfzmNTCVAOVoAUU6ClKITXSq3SZ3NIty4MTJ4pMaACcrUAlaq
bxIJSToYGzeFkUtthwDEYODiZhFOoKEQXj58q9QkZp+BmlsgndiVSGVKjoyPdKiA
UhMOgY6mhoVEE00A1xudyMGMROlxKEPHKnzkwihR5W9oVbuqMec3Nv5CNSIqfLj3
S1AukJhOSiU0Cabu3vE2RMamM0zJZuntwSnPqAGDtWSqUTGdROosucl6vAVHElAO
ao4gGpEIW8Wl27F8pZCUjPJNAG2hFPYa5/Zh26h0pXGPiBrWG/fEa2o9EpzBpNix
oEks0jUii5ALRD3LIku76MmDt2o8iu3ZUNmop841vm1zqdy50t/CqRGu0YSl2Cl5
TPvTj3otj8dM5jMn6omOiHj54rNKjQaAAoANANe7L21j5K/dw8a8XEQBNFIVrS3d
eRkE4cGdibIjYUjU2miT+sAs0olj2cTJzLHK0u1viQFLBoKAk1phzGuiLGxq7RLs
4Ih1lyHWWl7RV5S9CqUpXNa8wsZI5lbyXzCSlYy4vDEIUi8F+EK1oaebotzOZbFz
a6A/g4KLVBPTDpVlyb6tEoTUayUnCwTGiqvjb1PRuSUAYjOJY9k0yfSx8tLxbggK
UioBqkKwVw5rUbZM6snFzK08XI38ffPnCMsXErSpV/gRgoVV5Gz8xq2X3N37wPHs
2jEwjoLUh3gF+sJJAUb5QCQaVAwlsXiTSM21F6We6AMMa92bspF2lEQqFfu3Oo96
FZYFGt/WlL0HOa7zu5zEwEGuOlkTqYh2krW7Kb1d6MZTekhWk1DY+RTGdpizATFc
AHJRf3l/rd8FU3apOKjSTGkSZIpIma3S3OVAMcWm8WpBxpJGyNG4aulsnmE5jzAQ
CMseAm/UcCUgGhUo5gbL3dzKEdoSmPmodv1cipSkCuhfqBLYosaab2iT0AYExsit
FYmZyB2YsKTFQgOF6gEFFcRWnDQaIqGoZDZ2ZWhiFOYFISh3TLXy6hCK4gaYSTmA
MGgkSTao1vwBa2Nn6rmUCgB0ubXsQRgSUIAr1aV31Gt0Lc3mj2NiIOKiEOA5Slbt
6EFaHoUSMGFJBFMILSbCyE6cwQBbZBZSLtBCRUZDv3TpMKaKSsKJOslWCg0GsbbD
ubi9k04TnPCNk6U2uxiYTRIkEDJya1woByxjGwAP/9CPzGNXyES5U4hUTcVhFrvX
tSQBfAgEkUNAaNakSzIgoKBtmWE4wyK6uifPGt9qLnzwPHURZpyC7vb144v8Na4F
grOEGuHC11hoc2NsS/dzBaMvWl6b0GoLx6L1KBn0zW3sTGkxpmaRPREb26AKR1EL
svc6h4qX0TERKUKywitFvsat6SKBtdLWt48L14oqWTUrJJUTn1OFth2cXCWtsibN
vnodRMKkJTTCaINXa6ZozFNjT2wlqHcTqOIPLBWgeoWnKyM+pIIGmGxZEUkiQNEj
NFtJw/uwDJ7JRry0tl5hJ5kS+VDovELVhN6pJLupx1SU42pnFdyqeVx1V6EBq1Di
HsDZaITEvUvI+MvgAnkZZTegJrhKUg1Jbysi6cT+xMTIcsCXzsrTopvjfu1HQr5x
thEb0ic9PGZQxAGum2DHcascdWOtrFsdTYW1KonUbUMp1qmWlScrpvKta03qrZfa
iDdS6wBgHKw8TDBy6KxiKkvAF77VsGJBJEkzMjKVTJ7AOs/mMVLrBQS4RZdrfuYd
yVjGEqd1VTOJApVrVcrwzKYVzXDvz9qy13GAyvShdpFqO5Vryj9gO/P2yXLZAoAu
UAY3aaOiJjPIx9FKvil8t2gHElCFFKQBpBsyuYxT6Kl8fLohReOXSk3iVYQA9Cgp
OkaNgs317RvWS98/U2a3Kt2zPTc+xGwYTN5oNfXgHvZVCLP2PmE6cpCnyi+WK4qO
lF2gaVaktryKiYiNfriot4p8+eG+WtWEkls+sTHwkzgJhZSOVela3xdDEVO3hN8B
opOFsejrB2kg4hTlzDGKd11h66KaEZlQSCDptKZGkgg2kZkRKMif3YBfrmU4i3ry
Ikz9ZeOnbvLnN8alGtAKSNA31aNWWW4zuf6Z2oG9rEWYXZ8vH8xWgR0UiiXKVVvH
SSCdM1IrTA3jZbjO5/pnz8NmgSRExkk5bj5RgGvZlryi9jvfPy2TXMoFzEzx7EvB
VUK5vnegpZva7KrYxMteUX1kPfP1NerCztxJZ2DFEIcRSMpW8OJBqClR0Kih020s
ZkTIRm4WAUtq51FTqbv1PlkuHLxbtw6xJSlKiMWeaVJaosTOouVzuGhnazqPFvEu
nzrGDfGiVAZhBOMNdrVWDmRj3swkyBEuYlZeF0kgLQpRqaVIBTnEN62RsRHwsc7n
E7SIZ3CnLEOlEFRUMSlUJCUjG2RIMjyrUa1uQC4KgXMJdNcvHKQnUmFW+WBvMpUl
R3u9q2I24A3FceacjI2mlsil05czu6MiJhjVw6cvHLpW8koSaq0iSaNjtuOMqj+r
kbTS0spkaBmTh5D5QBbJWtDuaQa3holMQ6KtILDZxdWQvKpc8G7A8fJJzL4hJHnC
2vS2y5LNJbbaRGQzRWVxiEJGA60ooGsvUVxneQ34tDEpJFJjcGk4ygBrRjZNHXO7
Rwr0phnaIt3XWVu1hJpopUQRvrXqzlz8wT0TS0a3QQ41sOL4FIphq8VgFBjoN7bE
mFMzUoygTcAGOWGINqoCm8l7TU2XOeNovusP2Glre4nMBNreS5Ercu3cLDF4hC3a
AjLVFCr5WADBgwNcHPG0X3WH7DS21jIiIiI1qZCe8oAJVxsqa9Y+/OWw+2UwfzC0
MZl6iUQ7wuXSK4EpRgwDROEtmEp42VNesffnLYLaPjIJl1lPfPi2LLPCrjSAMtuW
Rz5T2Mli1FTlKUPUJJqEmt6oDOrUNU3OEJdRU8dp3ah+lI0gp6A1tuV69ozrHT5+
Gulzzi+n3WSPPnrZMT2TFBpcoA4svSR2OmE9dJCn7xT56KjmmooQDoVqW13ExD+M
friotanr14Spa1GpJLZ5YmYQcyl0dZOOXeKeqe5ViBUh4daCa41A4aNYI6wVpYSJ
U5cwxinddYeuim9I0QSCDn1bFMjSQQbSMyIlGp/dgHeR22ipVLXspi4cR0OsFKEv
FkFCVAhScSqjDvTZE5ijZm525i4AXkRFUIXjIW+UdaNc0JFA1JC2QlMgkr+Z2sCX
j48UnKHhFDTAgFJF8onHmANVWcXB2rsguzjxYdRMMmiRjIAVfO1gYyMN6WyQJMpV
SOVjQNtJ2QBrtalPFl48UVLJqVKNSSc0k4W2bc5ncTMZc/l8WovFQV7lbxWE5WsG
iSdAp2TYe+sLal0/LgQReYaB4hSSg6NSRQabZ/ZCROrOwj2CevUPI56EvogINb1J
qlA0sBw5rYsCCZJrMjInawCzXOddM62KdpqbXYxNsS5zrpnWxTtNTa7GJsWR82OC
PlgBjGNrAP/Rj8xjM0aYa1CgvEvtfaKWOEwsJGKypAolC0pWEjOF8CQNBqOZziZT
h8H8yiFP1JFEg0CUjQAoA01oS4jcmXCOHi7MQJUp0hSiQvGUgk7vbhdw247GILtN
nIIjNLlbxKhvaHoLInEZYzejJkUUFDjfHMk/kIQuH7+FfIiIZ4p09QaoWglKgdAh
r6m3tqgi81MB6KLp2VbO9bYt3m4fDXPUOrTWXL1cliHocvod6b9UI9VuyizhU7VS
grhBwVNW02kFSghAKlHEkCp2Qws4wNQTKgSbEkajymUOBGpJA0DbTcj2jo+NmUQq
Kj3y371WNSzXBnAYgNANzATGOlcSIuXvlOHqRS+Tmg4wQagjTbwWhbtV48SpCjmK
BSdkaN1JAFSaNks1rW9v4xGQPrd2pfui5VGXoUCCUO0JVQ6ITUb01uVO5quWiTri
FGDBrlJCaVvr7HS+xmuNqBJCiAk3xJoAMJq2/LlD7I8urEwbu6HqtE8S8f6kiKS+
y0Jy1WV316KbtpRsGdqEmJFuMk01mpSL2b31z0MkEW41LIoMaTip9No2BdS2KiVP
IZze5W6ISAm8FE4QAcAbpLJzM5M8W9lj8uFvEhKyAk1ANQNaBbvaAy4z6ZGUXmoB
jH+od5W8yjLFZXe1w0vaUq1Eh28e1LpClgY71JVTZBsyTM1JLMjVlSEA9evH71b5
6b5bxRWtWepRqS1ZLJ5NpNlmqyIU4y6mWUCTW9rTdwOeWoc0g4xgIzQxgjMjWRqM
QOyXrxL0PkqKXgVfBaTQhVa1BGItfndvLVOnYdiMCqCl8t2hStnetYUOnrxN87Qt
aRjUlJIG9gNv7Iy2BsZbORz2KtPKYeZPYaNdO3K3wUShCnV8Ui9UM1sGZqY5mM2Q
25RKW2wL0MkEDTSJEhpJFpZ67j1zNMY81KeIytTwhJ1ioN6AQQBUZjdYa0M5g45/
MYaKU7iYnis8CUkqw1xFJGybK7uUik9mrp02k0hhXcFAuEQxdQ7qt4krh3alUqSc
JJLYIhKnir12krVnJBJ2QbJjZTZEEUyM1JESRPb+XLEJE2mZPxqHLx4t68U9eGq1
qKlHPJNSW6tyoKQq8WClQ5FIIOyLdSoJwk002kQLvLbV2glTkQ0FGKDpO7Xawl4l
OlfA0GgG4mdqJ9OHWUR8WpbrGXaQEJOmEgV3trUkhdAjWiTQAYSTnYG7LQ8dEJeo
UgnEFApJ2dGlvSUpZqflgHtATCMlcSmMgHpcvkghKwASAoUOMEN1jI2KmESuMjXh
evnpBWsgAmgAGIAZjbLyOdmbPWut8/lVpIJ1MIVMtfPg4fVIDxLxyArAQa0Udm14
yTdjbKWMmkgcWYlriWoi4eJW+S5qMsUhbsJJqTiqW0G1SJM5NMpJZk3QDg4YZvGb
Y3uhpZuUqUhQWglKkmoUDQg54IbgYSEjCTiGaW7PHbx1TLUKRXFfJKa6VQG3DAXx
xbm1Lh2HaY0rCRQF4hCzsympaimdoZzOAETGKW9QMId4Eor1akAHe2qbEwcLMbZy
GXxzpL6GiplCOX7pW7Vu3j5CVJNKYCDRpD5IC5hYCytzeKm9nZHCwEaiKhXaX7oK
vglbyihhURhDamZrHjZEGFJuM2R6J7enKnt7GaLGaSJpE6EZIKNipfEojIN4XT52
SULABIqCDjBGItVi0M5TMjOBFK1MUi8L69TW9pSlL2mIZzW0kDHgbup29Qm/WhaU
7yUkgbMijbSSMnBmT2vKjAV7q0M5czF7NnUUpMW+TevH16mqhgwUvacijMaiiH76
KfvIqIVfvXqitajSpUo1JwYG82EgMGZm5MwCslk4mUmerfyx+XC1pvVKSEmoBrTW
gW9IC0E4la37yAiVOVRKr58QlJvlYTXCk55xNQrdvHdC8QpAOIqSRXSqG879G8hs
2kkjJSjN6cAHpfrC8sCiF1vgoYCDjqCGvrm3dqXLsOhGX4AoCt2hStmU1bHwtBwB
Q2bckgCpYJJJFwZlBAFXMptMZu+ERMn6n6wKJvsASM4AUAbxhomIg36ImEeKcvXZ
qlaDQgt4haSaAgnTbloWa1rewDIdx9aq8vNTB1dlTu+2d61BCWjnkFEP4qGjHiX0
VQv3hoorpWlb4HPa2saW9M3KRvUCYBXy+fTeVunzmXxKnKIg1epASb40pmg5hagY
xoMzN6W4ADGNywAf/9KPzBjGmGMzRphrUKD5EloW8kJduwVLXBFKQMZJdUADRLuS
XMbrMtugSSYmUzCVQ0NFoeRkTEAuneo44qoIKtavk1SBQ4S0uHD5EPK3UQ8reuoZ
K1UwmiXYJpsm1E9yWFzJCCp1DTZ6rMTqM7TXey/o1G0ibOiiyoMLG3km9G7U5DjI
SBmiaSSlOBml1+zEVbSw8RZWAKExEyiYR27eLOsuwl+h48eHNN6hCjQY2tAc3KMj
5ZpwqLDqFU9Ad5eXYex0c9QBfHAL446kCiU1zGxC5ldoiLqF1xMPEw4gJfCy2L1V
whVfrU+K3RW9eKFAV5WCABgArjrVth3R7W3NbLKgFXQ3Dl5qSHgg3j+BMWkXt6Xi
QrKnl6cINMFWg0GViNBpkySMjlc0EHJrLKrURcsC0UiNkJT8RmLfJ7SXJLvMripY
7dOZgXKb59CxLnKopwFYEvUHGMOJSDptqWwNzAWCyQjmy8zS7mMA+l8XFQTx+7Ss
PHCkkIv0qF7fpKSFU0xjbYsouy3B4OJVEyB27cxCU3qnkFJ3yXgSrMJdQ4IBpiby
hreWTtxdksmuzi3zx/By6bCJL+GfQygh4lyXYAfIQVCqVYm2oGzMTyoooMiLEkxp
PSboyRM1rUQhJtSbTM0TSIycO3sZvN5bc6slEItlOnEtlZhXZhnUW9Q6dJRlqgSE
0SNbVSmDDTe2tVzOAsvaKRxk6dwcFHuoyczR65ilOHbzLHSox6UKClIqRTE2tMmE
pWoFlndTel/GKIzKhDkA76WzrI08ailOx4v0IW2tJjNFo0WdvSNJNJUERNwluWym
golES+UNSXLrjkBb66Daacz13SRSibRLpMKiqExL7LlqDqqQKO0poVAUOEDFVt8T
e29yy5qYez8yjpfJiHaS6gnTvCh2cCSUOUKvQc9VKtbrh76FeWdnLtwUl45tJN0x
AGMLMSpQrppKaaDRVuzQc5gLp9okz+/y99GvHzpazgXDLNXBSc1IRegZ1KZjbyQN
rmoSY2RM0UWNF6RKAUS+vGBm8KBJIkRmkbkSotzcxsLdgs4JlLtRRFxDm/l06hAk
knkULKN3u64FJOEZlC2jrhVxNFqLSTSJtm4IgbOxJhH8EqoD+MSTVCjg4JpAqoZt
RmVbZ+RTgp1C3O4l9Mb5MFFR7x7LULqOCd6lLxaQeRVLBpnkEtsWyEdJoyLtImUl
BU4nT13GXlOLgOIe/Jpm5m9NqNnZWlJmYEEjSJE1Ek/Pb3BP0GMiQRZGxMyUZuSf
xRT63lzO5zlElnEfAyk5WMqgnbokpd4gcrcoVepzqgNcbJJsbGQ0RaOxYhFw84eB
6/iYMAIfPHYvL5QFAFjEcAOe0NLt0HNYG6paPVyFh5ERinzhawQFw6gMpKScaQmi
cGaKNuzIiQU2c2bnsbEJWmWxUW51DvgQlbx2hQfLTXGMKEkjNGg2TO0SLE0pMxMh
mkkSJm/Gt11+UAgymkyNjaSiWMbtpc3ibp2SNnElD0w8FDuYOJmD9O70OBDuU3qK
gi/UTQVxYTmNu59EXLrjkmcQ78wMhhHhKXQvKvXy0jWjrKVvXis9Rq1osY+ghdru
hwyqamKcSd4nPLlMOQqmhfKFd6bSmSwg5u6ugwcfGBRl7+XO3cCuhvApC15ciuK+
qQojOIaUSNqmRiadJI0UEWJE1E7lUjhXvdCDUxopJkSzNI+WN/xUsuX3abPPFuxB
ziEqp0mLcAJfw729xpVRLx2sVBoceaCG1Bcaucbgy7XPrIz1y6mDmHlK30I+fuUq
S+crfuMrehKgoBWNKqYiCGp8iFBTbVxP5mlDwSpUK6cKeYcqXEh5fJAzCpKSa5wO
i23lvHCrvjl2ggvUWSe5aBjAVHu7yuyLYptzTJMzTIpmkg2LJbo3o/UEkpkJFkMl
GsVdol3K7n0a5tbaF3L5VEvUahwz8uRfEAl4pLtDtBNcOtKArSgJo1fFy6w91Syw
K0Qs3lUehWUxCEglJBKb9CqBSFpI0CDgLaFyYC1Gf2aRU3og4ohOZUvXYJ3xs+yK
pJuWEE4BNIsDQwOzv7YpsBoNKg1RJpN5mpy4JZqU7dCSTWyJMaiUodrh02sjJq3L
3aUrtPIdTnUbECFvMsduopYCsuvdaqlaDSvnGvV2Ca2bfQSLCxjgPp9aWFiISSkw
2XBL1dEXxeXpLsAqBJzhXMbW1yzjp22WlMNruGzu2z6FcXeLnpiiE38JNXboqNOC
qndEjTOEBpZECJqSSlYzNjNlc002mkqCW6fhCKS2NT1PTblFqFyshc8ufXG7NmPj
NRUPYd0DMJ3GBIWtRx0Kq3iamiUJ0MZavlVr7lt1B3EyOXxcvnYCCX8G8da0XdaX
wQ9QkkdFJxYG1/ktIGcxNiZZFQIeKl8JHlcwCMSb5BS5WsDkUKJFcwkNo+4NCTiN
uryBUkvr6Hfl9FPE7tRChKg+vjiopJvRXGSGzY2mjoYEmqTZUm8lm5eiU6P1BCTI
2JkxkiSnoZvbm5I4ub3WbJzKSE6pJtOYXUd0olSoZ8h+7UtzU40UNUE4aVBxVO1M
lACbk0YEgqJjoMADCSS9wANcLtj+BRCWSh4gjUh9auVGFBx1Q9JeEaF6SDpt6Xd3
sO4sdBvosgOHc+lCnpViCBFuyonQo2KLMmyptKmm9mRmS39RiTQJEmQicGQs9x+4
nZywkhcT20sM4ip49dCJiH8UlKkQSSm+ytAWKJvRu9Zw1rho2Tyu6dcqtZMdwzLp
xL4+JfVdphVI1h9gNUoLxAQvBmJJq1Hd8gJ7M7lc7hrPBa3947ePnbrd7yGQtKn6
U0wnWQSRmgENC6z0JNplPZfA2eC1zJ7EuhBh0aLD0KBSoEYr0ipOZRs2Bp47kU2d
lZDJIjNSnBPS4SEcCE03hNFBFElKhRvDJF3FpXZqDFu7IQ4hYMvEOpjAOhwTdqeG
iHzsDdqSo3qk4qkEZrbJuPXFLP2Bkbid2icQ8VPXrvL4iJfgKdwaSL7K3d+KJvRu
5eMmuGjZfdFiYGCsLHPp8t3lCUwyX6lbsUov3IxHPVia3XcoObzG5VaKGkYUuIVD
pUpDsErW4Q8Qp8lIGEkoCsGaMDaiallZWJjYTSMiSTNE0n8pVVCLe8oMnjRRSSTI
lqJah5m6HcZt1EKsa8mktmi4w5QIR4g3j1RxJQtSEoKs69Nc5vW6JZ+Qyi51P4qW
yyCcv4KVv1w7wQ7q+Qt07JQalBNQQGg/LYaOmEwhYGUIW+jX75CIV25qXinpULwJ
phrXZNOu6Wl+i5VaJESb58mSxAenPWHJvjs2zalpiaRkYUUE0jJJJ7IzgSe3pTkY
sbIbIikZkRGRORbYWR2SupXMRFS+XQcNq+lig7eohnSFuX6kFJwpTUFDwHFnNHbI
62KM+unhM0coW4kDt8/i3L1IUlT0EuEIIUCN3KJw7xbY2RItfqTKZpYiJWovIFep
8IDhAcPSEvUjOouiqdFNtqyVhIKy1obUT2GvL+0Uc7iqJTQoSl0kKQdN4Xi8Gewm
ypNHHQwGZytPGV9ae6ASJMrYm/OfpBjTOSsmEjk8tlFkpTAw0NFRrwxsSty4du1Z
Q6qhCSpKQdaWSadEtG5s0uxWuFtbos4nDl4pcI7e6iQV9iDiH1gEDMClBSt7bC2s
WkYjYmBBE3Klmt/N73TgaGVJuTMycOCBjGNvGAMYxgAMYxgA/9OPzM0aYYxrUKCb
j27PcrVJVwwtNAF4YQuwm/VW+yu9pu3PaEYYxtDTNIg0rc2GZtylrU6XDjNkZTZF
LInoXKzloZrZSeQdopI+LmMgXgeOlZhGJSFDNSpJKVDOLSykt2K5BdSkCJbbFUFC
PllOpEsmt6EB6kA3zp4qiVCu7VAhWeA0O2Y2GoaRBqFGZmiki4SRcgY2U2NZOSN0
YmZEXSLh9yaURLuzb6X36zlmoEoKHr5+8pRN8pJIGmtVAMTaZud3V3c5u47j23Ma
6l8MuEiXLsvCcqh3ZTRy5SaVOM4c0knNbTIFMAY2DG0DGgimRmkkkmRkaRuVG/CU
mYzMlERET2ob6yTtubI2xhLOosvNYeZKhHsUX4cEm8C0ugkmoGO9LZfcFun3P7M3
NJbJ5/PYSBjXL6JU8h3qiFpC3y1JrRJxg1aKzGEmhY0mBFp25JtRNa3pbuAgQEzJ
EmaaiWZKG3bn92d3c7uhWhilpVH2enMwiHj9LihWOCyy6iHV9SusqoUmlRogNIU2
/uJ2zh3MVHzSRxoc0eO0zDKg8dHHu2IAUk54aDrKA42hniHsbMkSZGkgkRKWTtT1
CiUGdJElKIyfhL66JkjrF2YlLyDsbFOZxNVuy7hhDC+hYcgUC3ixRJAzEJrWlMAb
SFxW7E9ucWhjXs8D2Llc5UFzAoAU+Q/qSIhINL460QpOaMWENrBjZMbQsLGxpMSj
SJOejNyb9BKdCEmZNJIknCnAnLEW4uK2xg0P5nNZDMXLnW0JjlOb53m7sfgLSc8U
amg7u1yRMZESlxO4WGcQKHSXb6hRDvCq+qhzROtBASL4gUwilcLQjIBxhjaY9LEp
RppmTonp6GcdKTlRDcdr7rKbO3d463ljop3MoB6iGcvku1EOopwHDpL13UjAQpNQ
aYFBt7yy69cdt/KUOJlMJelD8AvZbNw7QpChmFL2qCRmFJLQlZSuNtjLEPYmVFAl
mikgiSJJE5UThYxRZ0kTNwZGa1CaloLt9yewkoLiURsJGrcC9hpZKQhQvswVdgOn
ac8k70W07ccuqQMTdbntubezCHlurKXrdoUsqDpBD1xlblGAmiUIwVziW0boMYY4
hzEggmitIzTJRpG5VAANnSMyN6UTghufJN2xsvbCdSGJsxMnEydQ0I/Q+W4JIQpT
xBSDUDGA2Z5HW6TYSylz0yq0c7hZfF6sIh7lD5RCrxYd3qsAOA0LRlY2STRIJMCL
TmaTaia1vS3cBAiCZTJM01Esxva55biyUqu/2ptRMZrDw8pjRG6jRiyQ7eZY9dKR
emlcISSG88kbdBkM9tFZec2Im7mMfSpL15l0OScpfB66W7JqBvGraNY0k0iBMqLK
szNFFtU9KUpQHlNtNF/Ne7WJh2CyRVg7WylENayJcSaZ3gdxUPF4IV8SKKU7WqqS
g7xVQjFhxtfVXQ7ilh4N89l8zksGh4C9W5lodKePTjGsQ4JUTmVaD7AAMTaUohTE
aRqSTRRM3tEnAyJqUiJ7IjN/G27XXZNzBupWdmz+svs9JplDLhnb6lUID52p7EPb
2oCiE4hWgFM9tj5IK6ZYC1VzaLk9n55CR8Y8ioVaXDlRKylDyqjhSMQaLrG2m0TG
3MSSK0XinkicOVvYxeVJSRG9tzkSjuO5Iyz72SQtm7fRWq+OgXSXLqYPAS4iHaAE
ov1AEoeAUBrgNK1zG2Ei21xORPXs+hprZ+FfxQq9iodTjLnufXKgXh39oNMoMba2
SIYxJpGkikkgSTkicDJFqEiJRkRqdjcl3u7dDXQw6sxZkPEySGe5a9iHgvFxb5FQ
ghJwpdpqSmuEnCQKBth3H8khZuNk0NILfRqJdM4N2HSI99gh4lCKJSVKFbx5Td19
QHGDmNFkKUlQWg0UkgpOcRhDTQuY3UbBXSJK5hIxMDCTgucqjpbEJdpKyE3q1u74
APHaseDCMRDYNYwMbC06KBMSSSKJnKxGoyN/cGtbsSxJpJpmbcRGbo3BipmVvbiF
kMvtQ4ipKY56hS76XpcPYyIJG7U5UL6qjgwkDPLXm6e+y25ZaR+pJd5ZJ4hRSrGm
+dE0Ojho1gldwi5DZmc7idzBISpwsP3LuJiSqFh1JN8FpQtVMFKi+JAbArv93Sz0
dZ+KsNY6KTMH0eA7j45yb5w7chVVukL5HWqgBIwAE4asmxsSLMysZMDyJKMjSSTd
ESoNwNqSRoopN6ifiIafuJTiZSa6jZ17LApS4qLRBvnSeSjh/rLwGuCgGtdmtLC7
ZbA2JuczWZw77Ko2JRqFAHkbL39U1TopTfL3pozXArT2FsXamJtNbSJU5XDwxdS5
KXD18Q8emjx5wTSoJokXorvItdckPdZkt0SIlEtstEPH8sgUPH75S3S3JVErN4BR
4EkhKBgPRRZxqWA2oaxjlQ2xEibklPRqe1LcQA1MaZIMST29m4IacGJjGNYDQDGM
YADGMYADGMYAP//Uj8xjGtQoDGMYADGMYADGMYADG5bhgAMYxgAMYxgAMYxgAMYx
gAMYxgAMYxgAMYxgAMYxgAMYxgAMYxgAMIGyYxgA7LePXib14ta05ylEjZEt1Yxg
AMYGMABjGMABjGMABjGMABjGMAH/2Q==">
<p style="top:23.9pt;left:44.8pt;line-height:7.0pt"><span style="font-family:Lato-Regular,serif;font-size:7.0pt">SHANBHAG </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">et</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt"> </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">Al</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt">.</span></p>
<p style="top:49.0pt;left:57.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">In the case of mandibular defects (Gjerde et al., 2018), the au</span><span style="font-family:Lato,serif;font-size:8.0pt">-</span></p>
<p style="top:62.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">thors also reported an unexpected additional benefit on soft tissue </span></p>
<p style="top:75.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">healing, that is increased keratinized mucosa, at the augmented </span></p>
<p style="top:88.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">sites, attributed to the well- documented paracrine effects of MSCs </span></p>
<p style="top:101.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(Vizoso, Eiro, Cid, Schneider, &amp; Perez- Fernandez, 2017). Interestingly, </span></p>
<p style="top:114.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">this was the only study in which ex vivo MSC- expansion was per-</span></p>
<p style="top:127.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">formed using human platelet lysate (HPL)&#x2014;an emerging alternative </span></p>
<p style="top:140.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">to animal- and human- derived serum supplements for cell culture </span></p>
<p style="top:153.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(Shanbhag, Stavropoulos, Suliman, Hervig, &amp; Mustafa, 2017). A </span></p>
<p style="top:166.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">majority of the included studies reported the use of autologous or </span></p>
<p style="top:179.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">animal- derived serum [foetal bovine serum (FBS)] for cell expansion. </span></p>
<p style="top:192.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Several advantages of HPL over FBS and human serum have been </span></p>
<p style="top:205.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">documented, owing largely to the wide range of growth factors </span></p>
<p style="top:218.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">released by platelets, which can enhance the osteogenic potential </span></p>
<p style="top:231.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">and paracrine efficacy of MSCs (Shanbhag et al., 2017). Indeed, the </span></p>
<p style="top:244.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">authors of the present study acknowledged that expansion in HPL </span></p>
<p style="top:257.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">may have resulted in osteogenic &#x201c;pre- conditioning&#x201d; of the BMSCs, </span></p>
<p style="top:270.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">leading to bone formation, and the observed paracrine effects on </span></p>
<p style="top:283.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">soft tissues (Gjerde et al., 2018).</span></p>
<p style="top:296.0pt;left:57.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">In the context of MSCs paracrine effects, it is relevant to men</span><span style="font-family:Lato,serif;font-size:8.0pt">-</span></p>
<p style="top:309.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">tion the emerging &#x201c;cell- free&#x201d; strategies, which exploit the secretome </span></p>
<p style="top:322.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">or &#x201c;conditioned media&#x201d; from MSCs, that is the secreted bioactive </span></p>
<p style="top:335.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">molecules including extracellular vesicles, to promote regeneration </span></p>
<p style="top:348.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(Vizoso et al., 2017). This concept is based on observations that a </span></p>
<p style="top:361.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">very small fraction of implanted MSCs survives long enough in vivo to </span></p>
<p style="top:374.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">differentiate, suggesting that MSCs mainly exert their regenerative </span></p>
<p style="top:387.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">effects via paracrine mechanisms (Haumer et al., 2018). Following </span></p>
<p style="top:400.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">promising pre- clinical results, one group has recently reported the </span></p>
<p style="top:413.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">clinical application of allogeneic MSCs conditioned medium, in com-</span></p>
<p style="top:426.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">bination with </span><span style="font-family:STIX,serif;font-size:8.0pt">&#x3b2;</span><span style="font-family:Lato,serif;font-size:8.0pt">- TCP or COL sponge scaffolds, for bone regeneration </span></p>
<p style="top:439.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">in SA, RA and SP, in nine patients with favourable outcomes and no </span></p>
<p style="top:452.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">adverse events (Katagiri, Osugi, Kawai, &amp; Hibi, 2016; Katagiri et al., </span></p>
<p style="top:465.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">2017). The safety and efficacy of allogeneic MSCs secretome (lyoph-</span></p>
<p style="top:478.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ilised) as an &#x201c;off- the- shelf&#x201d; therapy for bone regeneration should be </span></p>
<p style="top:491.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">investigated in future clinical trials.</span></p>
<p style="top:504.0pt;left:57.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">As previously discussed, abdominal adipose tissue represents a </span></p>
<p style="top:517.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">promising alternative to iliac bone marrow, since; (a) it is relatively </span></p>
<p style="top:530.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">less invasive to harvest, and (b) the average yield of MSC- like cells </span></p>
<p style="top:543.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">are reportedly greater compared to bone marrow (Bajek et al., 2016; </span></p>
<p style="top:556.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Qadan et al., 2018). However, previous studies have suggested a </span></p>
<p style="top:569.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">lower intrinsic osteogenic potential of ASCs versus BMSCs in vitro </span></p>
<p style="top:582.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">and in vivo (Brennan et al., 2017; Liao &amp; Chen, 2014). Moreover, the </span></p>
<p style="top:595.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">in vivo bone- forming potential of ASCs has been demonstrated only </span></p>
<p style="top:608.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">when pre- cultured in the presence of additional osteogenic stim-</span></p>
<p style="top:621.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ulating factors (Scherberich et al., 2010). In this context, one re</span><span style="font-family:Lato,serif;font-size:8.0pt">-</span></p>
<p style="top:634.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">search group reported the use of osteogenically pre- induced ASCs </span></p>
<p style="top:647.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">together with HA- COL scaffolds and PRP for treatment of various </span></p>
<p style="top:660.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">alveolar defects (Alekseeva, Kulakov, Gol&apos;dshte&#x12d;n, &amp; Kulakov, 2012; </span></p>
<p style="top:673.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Alekseeva, Rachinskaia, Volkov, Kulakov, &amp; Gol&apos;dshte&#x12d;n, 2012; </span></p>
<p style="top:686.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Alekseeva, Volkov, Kulakov, &amp; Gol&apos;dshte&#x12d;n, 2012; Kulakov et al., </span></p>
<p style="top:699.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">2008) . In one controlled study of SA, the authors reported greater </span></p>
<p style="top:712.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">histological NBF with the ASC- constructs compared to DBBM </span></p>
<p style="top:725.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">alone (Alexeeva et al., 2012). Another research group reported </span></p>
<p style="top:49.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">the use of non- induced autologous ASCs and ceramic scaffolds, </span></p>
<p style="top:62.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">with or without additional recombinant human bone morphoge-</span></p>
<p style="top:75.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">netic protein- 2 (rhBMP- 2) to treat challenging segmental mandib-</span></p>
<p style="top:88.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ular (Sandor et al., 2014; Wolff et al., 2013) or CDs (Thesleff et al., </span></p>
<p style="top:101.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">2011, 2017), respectively. While uneventful healing and successful </span></p>
<p style="top:114.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">reconstruction (&#x201c;bridging&#x201d;) of segmental defects was reported in </span></p>
<p style="top:127.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">three patients treated with ASCs </span><i><span style="font-family:Lato,serif;font-size:8.0pt">with</span></i><span style="font-family:Lato,serif;font-size:8.0pt"> rhBMP- 2 (average follow- up </span></p>
<p style="top:140.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">of 35 months), late complications (6&#x2013;7 years post- operative) such </span></p>
<p style="top:153.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">as infection and partial or total graft resorption were observed in </span></p>
<p style="top:166.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">the cranial reconstructions of 4/5 patients receiving ASCs </span><i><span style="font-family:Lato,serif;font-size:8.0pt">without</span></i><span style="font-family:Lato,serif;font-size:8.0pt"> </span></p>
<p style="top:179.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">rhBMP- 2. The authors attributed the compromised results to large </span></p>
<p style="top:192.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">defect sizes, rapid resorption of the ceramic scaffolds, and possibly </span></p>
<p style="top:205.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">the lack of osteoinductive signals in the form of rhBMP- 2. In con</span><span style="font-family:Lato,serif;font-size:8.0pt">-</span></p>
<p style="top:218.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">text, a recent study demonstrated enhanced osteogenic differen-</span></p>
<p style="top:231.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">tiation of cells from &#x201c;whole adipose tissue&#x201d; stimulated by rhBMP- 2 </span></p>
<p style="top:244.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">compared to stimulation by osteogenic medium alone (Bondarava </span></p>
<p style="top:257.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">et al., 2017).</span></p>
<p style="top:270.0pt;left:318.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">An alternative source of ASCs identified in the present review </span></p>
<p style="top:283.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">was the intra- oral buccal fat pad (BFP). Similar to abdominal adi-</span></p>
<p style="top:296.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">pose tissue, BFP is reported to harbour a SVF with a sub- population </span></p>
<p style="top:309.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">of ASCs with osteogenic differentiation potential (Farre- Guasch </span></p>
<p style="top:322.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">et al., 2018), which can be enhanced by additional stimulation with </span></p>
<p style="top:335.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">rhBMP- 2 (Shiraishi, Sumita, Wakamastu, Nagai, &amp; Asahina, 2012). </span></p>
<p style="top:348.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Moreover, BFP shows limited donor- variation in size and is indepen-</span></p>
<p style="top:361.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">dent of body weight and fat distribution, thereby making it an attrac-</span></p>
<p style="top:374.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">tive source of ASCs for orofacial BTE (Salehi- Nik &amp; Rezai Rad, 2017). </span></p>
<p style="top:387.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">In the present review, one research group reported RA (Khojasteh </span></p>
<p style="top:400.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">&amp; Sadeghi, 2016) and AC repair (Khojasteh et al., 2017) using au-</span></p>
<p style="top:413.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">tologous BFP- ASCs compared to AB. Superior NBF was observed </span></p>
<p style="top:426.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">in both studies when AB scaffolds were supplemented with BFP- </span></p>
<p style="top:439.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ASCs compared the gold standard of AB grafts alone (Khojasteh &amp; </span></p>
<p style="top:452.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Sadeghi, 2016; Khojasteh et al., 2017).</span></p>
<p style="top:465.0pt;left:318.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">One completed single- arm trial has reported the use of autolo</span><span style="font-family:Lato,serif;font-size:8.0pt">-</span></p>
<p style="top:478.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">gous dental pulp stem cells (DPSCs) to treat unilateral AC defects </span></p>
<p style="top:491.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">in five 7&#x2013;12- year- old patients (Bueno, 2015). A sub- population of </span></p>
<p style="top:504.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">multipotent progenitor cells has been identified in the dental pulp </span></p>
<p style="top:517.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">of both permanent (DPSCs) and deciduous teeth [stem cells from </span></p>
<p style="top:530.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">human exfoliated deciduous teeth (SHED)] (Ducret et al., 2015). </span></p>
<p style="top:543.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">The proposed benefits of DPSCs and SHED include the ease of </span></p>
<p style="top:556.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">accessibility from unerupted third molars or exfoliated deciduous </span></p>
<p style="top:569.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">teeth, respectively, and their high proliferation and osteogenic dif-</span></p>
<p style="top:582.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ferentiation potential, both in vitro and in vivo (Leyendecker Junior, </span></p>
<p style="top:595.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Gomes Pinheiro, Lazzaretti Fernandes, &amp; Franco Bueno, 2018; </span></p>
<p style="top:608.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Nakajima et al., 2018). In particular, SHED might represent a prom</span><span style="font-family:Lato,serif;font-size:8.0pt">-</span></p>
<p style="top:621.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ising strategy for AC repair, since patients are usually treated with </span></p>
<p style="top:634.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">secondary bone grafts, most frequently iliac AB, between 6 and </span></p>
<p style="top:647.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">11 years of age (Kang, 2017; Pinheiro, de Pinho, Aranha, Fregnani, </span></p>
<p style="top:660.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">&amp; Bueno, 2018). In the included study, a substantial amount of re</span><span style="font-family:Lato,serif;font-size:8.0pt">-</span></p>
<p style="top:673.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">generation (89% BF) was observed in AC defects, 6 months after </span></p>
<p style="top:686.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">treatment with autologous SHED- loaded DBBM scaffolds (Bueno, </span></p>
<p style="top:699.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">2015). However, whether DPSCs and SHED represent a feasible </span></p>
<p style="top:712.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">alternative to the gold standard (AB grafts) in AC repair remains to </span></p>
<p style="top:725.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">be determined.</span></p>
<p style="top:11.6pt;left:578.8pt;line-height:5.1pt"><span style="font-family:Times New Roman,serif;font-size:5.1pt"> 1600051x, 2019, S21, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jcpe.13049 by Universit&#xe4;tsbibliothek Zuerich, Wiley Online Library on [27/12/2022]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</span></p>


<p style="top:23.8pt;left:46.5pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">174&#x2003; </span></b><b><span style="font-family:Lato,serif;font-size:9.1pt">|</span></b><b><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003; &#x2003;&#x2002;</span></b></p>
<img style="position:absolute;transform:matrix(.31940789,0,-0,.3187552,54.97612,3.7443963)" src="data:image/jpeg;base64,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">
<p style="top:23.8pt;left:493.4pt;line-height:7.0pt"><span style="font-family:Lato-Regular,serif;font-size:7.0pt">SHANBHAG </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">et</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt"> </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">Al</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt">.</span></p>
<p style="top:53.9pt;left:46.5pt;line-height:10.0pt"><b><span style="font-family:Lato,serif;font-size:10.0pt">4.3&#x2003;</span></b><span style="font-family:Lato,serif;font-size:10.0pt">|</span><b><span style="font-family:Lato,serif;font-size:10.0pt">&#x2003;Use of expanded committed cells</span></b></p>
<p style="top:75.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">The rationale for using committed cells is to circumvent the pos-</span></p>
<p style="top:88.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">sible limitation of differences in degrees of osteogenic potential </span></p>
<p style="top:101.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">found in heterogeneous cell populations, for example bone mar-</span></p>
<p style="top:114.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">row and adipose tissues. However, these cells may not possess </span></p>
<p style="top:127.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">self- renewal capacity and multipotency to the same extent as </span></p>
<p style="top:140.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">MSCs (Akintoye et al., 2006; Pettersson et al., 2017). Nine studies </span></p>
<p style="top:153.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(six controlled) reported the use of ex vivo expanded periosteal </span></p>
<p style="top:166.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">cells (POCs) for SA (Table 4, Supporitng Information Table S3). </span></p>
<p style="top:179.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Six studies reported the use of a commercial POC- seeded bone </span></p>
<p style="top:192.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">graft (BioSeed&#x2013;Oralbone</span><sup><span style="font-family:Lato,serif;font-size:5.6pt">&#xae;</span></sup><span style="font-family:Lato,serif;font-size:8.0pt">, Biotissue Technologies, Freiburg, </span></p>
<p style="top:205.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Germany) with conflicting results. The graft consists of autolo-</span></p>
<p style="top:218.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">gous ex vivo expanded POCs seeded on PLGA scaffolds and os</span><span style="font-family:Lato,serif;font-size:8.0pt">-</span></p>
<p style="top:231.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">teogenically induced for 1 week. While promising results were </span></p>
<p style="top:244.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">observed in preliminary reports (Beaumont, Schmidt, Tatakis, &amp; </span></p>
<p style="top:257.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Zafiropoulos, 2008; Trautvetter, Kaps, Schmelzeisen, Sauerbier, </span></p>
<p style="top:270.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">&amp; Sittinger, 2011), other studies frequently reported complica-</span></p>
<p style="top:283.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">tions and/or graft failure, especially when extensive sinus graft-</span></p>
<p style="top:296.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ing was performed, that is in patients with the most compromised </span></p>
<p style="top:309.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">residual ridges (Mangano et al., 2009; Schimming &amp; Schmelzeisen, </span></p>
<p style="top:322.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">2004; Voss et al., 2010; Zizelmann et al., 2007). In three controlled </span></p>
<p style="top:335.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">studies, inferior outcomes of the POC- autograft were observed </span></p>
<p style="top:348.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">in comparison to ceramic scaffolds (Mangano et al., 2009) or AB </span></p>
<p style="top:361.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(Voss et al., 2010; Zizelmann et al., 2007). The authors attributed </span></p>
<p style="top:374.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">the compromised outcomes to (a) poor vascularization of the con-</span></p>
<p style="top:387.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">structs upon implantation in vivo, and (b) the degradation profile </span></p>
<p style="top:400.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">of the PLGA scaffolds, which creates an acidic local microenviron-</span></p>
<p style="top:413.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ment unconducive to cell survival and function (Liu, Slamovich, &amp; </span></p>
<p style="top:426.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Webster, 2006). In contrast, when a similar strategy for ex vivo ex</span><span style="font-family:Lato,serif;font-size:8.0pt">-</span></p>
<p style="top:439.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">pansion and pre- differentiation of POCs was used in combination </span></p>
<p style="top:452.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">with collagen scaffolds, based on preliminary in vitro screening </span></p>
<p style="top:465.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(Petrovic, Schlegel, Schultze- Mosgau, &amp; Wiltfang, 2006), superior </span></p>
<p style="top:478.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">bone regeneration was observed after SA in comparison to cell- </span></p>
<p style="top:491.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">free NBBM scaffolds (Springer et al., 2006).</span></p>
<p style="top:504.0pt;left:59.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">One group reported the use periosteal &#x201c;cell- sheets&#x201d; formed by ex </span></p>
<p style="top:517.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">vivo expanded POCs, in combination with AB and PRP for SA and RA </span></p>
<p style="top:530.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(Nagata et al., 2012; Ogawa et al., 2016). The cell sheet technique </span></p>
<p style="top:543.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">is based on implantation of cells grown as single or multiple layers </span></p>
<p style="top:556.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">together with their secreted extracellular matrix (ECM), as opposed </span></p>
<p style="top:569.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">to conventional single- cell suspensions. Proposed advantages of this </span></p>
<p style="top:582.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">technique include preservation of the cell- to- cell connections and </span></p>
<p style="top:595.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ECM components along with a high cell- seeding efficacy (Yorukoglu, </span></p>
<p style="top:608.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Kiter, Akkaya, Satiroglu- Tufan, &amp; Tufan, 2017). Superior NBF after </span></p>
<p style="top:621.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">4 months and comparable volumetric stability of augmented sites </span></p>
<p style="top:634.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">after 6&#x2013;12 months were observed in the POC- seeded AB (+PRP) </span></p>
<p style="top:647.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">grafts compared to conventional AB (+PRP) grafts (Nagata et al., </span></p>
<p style="top:660.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">2012; Ogawa et al., 2016). The authors suggested that inclusion of </span></p>
<p style="top:673.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">POCs in tissue- engineered constructs could reduce the volume of </span></p>
<p style="top:686.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">AB needed by up to 40%, thereby reducing donor site morbidity </span></p>
<p style="top:699.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(Nagata et al., 2012). However, whether POC sheets used in com</span><span style="font-family:Lato,serif;font-size:8.0pt">-</span></p>
<p style="top:712.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">bination with a biomaterial could entirely eliminate the need for AB </span></p>
<p style="top:725.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">harvesting remains to be determined.</span></p>
<p style="top:49.0pt;left:320.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Six studies reported the use of autologous OBs for SA, RA or </span></p>
<p style="top:62.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">AC repair (Table 4). As previously stated, OBs are the fundamen</span><span style="font-family:Lato,serif;font-size:8.0pt">-</span></p>
<p style="top:75.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">tal cells involved in the function, repair, and maintenance of bone </span></p>
<p style="top:88.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(Jayakumar &amp; Di Silvio, 2010). In the present review, OBs were iso</span><span style="font-family:Lato,serif;font-size:8.0pt">-</span></p>
<p style="top:101.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">lated via enzymatic digestion or explant culture of intra- oral bone </span></p>
<p style="top:114.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">biopsies and usually cultured in osteogenic induction medium. The </span></p>
<p style="top:127.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">observed pre- clinical benefits of autologous OB- seeded DBBM </span></p>
<p style="top:140.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">scaffolds were favourably translated in an early patient case series </span></p>
<p style="top:153.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(Fuerst et al., 2009). In three controlled studies, comparable bone </span></p>
<p style="top:166.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">regeneration in SA and RA was observed with autologous ex vivo </span></p>
<p style="top:179.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">expanded OB- seeded DBBM scaffolds versus cell- free DBBM scaf</span><span style="font-family:Lato,serif;font-size:8.0pt">-</span></p>
<p style="top:192.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">folds (Springer et al., 2006), AB (Pradel, Eckelt, &amp; Lauer, 2006), or </span></p>
<p style="top:205.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">their 50&#x2013;50 combination (Hermund, Donatsky, Nielsen, Clausen, </span></p>
<p style="top:218.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">and Holmstrup, 2012). Interestingly, one study reported comparable </span></p>
<p style="top:231.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">bone regeneration in SA using POC- seeded collagen and OB- seeded </span></p>
<p style="top:244.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">DBBM scaffolds (both superior to cell- free scaffolds), suggesting a </span></p>
<p style="top:257.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">comparable degree of osteogenic commitment in the two cell types </span></p>
<p style="top:270.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(Springer et al., 2006). In one study, superior BF was observed when </span></p>
<p style="top:283.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">using autologous OB- seeded DBBM scaffolds versus the gold stan</span><span style="font-family:Lato,serif;font-size:8.0pt">-</span></p>
<p style="top:296.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">dard, iliac AB, for AC repair (Pradel &amp; Lauer, 2012). Since the OBs </span></p>
<p style="top:309.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">were isolated from a small (3&#x2013;4 mm) biopsy of maxillary bone, the </span></p>
<p style="top:322.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">authors proposed the cell- based strategy as a feasible alternative to </span></p>
<p style="top:335.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">more invasive AB grafting (Pradel &amp; Lauer, 2012).</span></p>
<p style="top:348.0pt;left:320.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">While all of the above studies reported the use of autologous </span></p>
<p style="top:361.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">cells, two SA studies (one controlled) reported the use of a commer-</span></p>
<p style="top:374.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">cial &#x201c;allogeneic cellular bone matrix&#x201d; (Osteocel</span><sup><span style="font-family:Lato,serif;font-size:5.6pt">&#xae;</span></sup><span style="font-family:Lato,serif;font-size:8.0pt">, NuVasive Biologics, </span></p>
<p style="top:387.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">CA, USA) containing viable osteoprogenitor cells (Gonshor, </span></p>
<p style="top:400.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">McAllister, Wallace, &amp; Prasad, 2011; McAllister, Haghighat, &amp; </span></p>
<p style="top:413.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Gonshor, 2009). Although, the clinical use of allografts has been lim-</span></p>
<p style="top:426.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ited by safety concerns with regards to disease transmission and lack </span></p>
<p style="top:439.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">of osteogenic properties comparable to autologous bone, recent ad-</span></p>
<p style="top:452.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">vances in donor screening and viral testing have greatly improved </span></p>
<p style="top:465.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">allograft safety. Moreover, novel tissue processing methods which </span></p>
<p style="top:478.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">selectively remove immune cells and preserve osteogenic cells, have </span></p>
<p style="top:491.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">been applied to allografts. Osteocel</span><sup><span style="font-family:Lato,serif;font-size:5.6pt">&#xae;</span></sup><span style="font-family:Lato,serif;font-size:8.0pt"> is obtained from cadaveric </span></p>
<p style="top:504.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">cancellous bone of screened donors following selective cell preser-</span></p>
<p style="top:517.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">vation. Previous studies have identified MSC- like cells in Osteocel</span><sup><span style="font-family:Lato,serif;font-size:5.6pt">&#xae;</span></sup><span style="font-family:Lato,serif;font-size:8.0pt"> </span></p>
<p style="top:530.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">at a higher frequency than those found in freshly isolated iliac bone </span></p>
<p style="top:543.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">or BMA (Baboolal et al., 2014; Skovrlj et al., 2014). In one RCT, sig</span><span style="font-family:Lato,serif;font-size:8.0pt">-</span></p>
<p style="top:556.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">nificantly greater NBF was observed following SA with Osteocel</span><sup><span style="font-family:Lato,serif;font-size:5.6pt">&#xae;</span></sup><span style="font-family:Lato,serif;font-size:8.0pt"> </span></p>
<p style="top:569.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">compared to cell- free allograft (Gonshor et al., 2011). Nevertheless, </span></p>
<p style="top:582.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">the need for further studies to investigate the mechanism of action </span></p>
<p style="top:595.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">of osteoprogenitors in cellular allografts, that is whether these cells </span></p>
<p style="top:608.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">participate directly in NBF via differentiation or whether they act </span></p>
<p style="top:621.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">as immunoregulators of host MSCs, has been highlighted (Baboolal </span></p>
<p style="top:634.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">et al., 2014).</span></p>
<p style="top:664.9pt;left:307.5pt;line-height:10.0pt"><b><span style="font-family:Lato,serif;font-size:10.0pt">4.4&#x2003;</span></b><span style="font-family:Lato,serif;font-size:10.0pt">|</span><b><span style="font-family:Lato,serif;font-size:10.0pt">&#x2003;Clinical relevance of findings</span></b></p>
<p style="top:686.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">While significant overall benefit of cell therapy (BTE) was observed in </span></p>
<p style="top:699.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">most pre- clinical in vivo studies and for most indications, in general, </span></p>
<p style="top:712.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">this benefit was not translated in the clinical studies included herein, </span></p>
<p style="top:725.0pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">that is the ES were much smaller in patients than large- animals and </span></p>
<p style="top:11.6pt;left:578.8pt;line-height:5.1pt"><span style="font-family:Times New Roman,serif;font-size:5.1pt"> 1600051x, 2019, S21, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jcpe.13049 by Universit&#xe4;tsbibliothek Zuerich, Wiley Online Library on [27/12/2022]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</span></p>


<p style="top:23.8pt;left:511.9pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003;&#x2002; &#x2003;</span></b><b><span style="font-family:Lato,serif;font-size:9.1pt">|</span></b><b><span style="font-family:Lato,serif;font-size:7.0pt"> &#x2003;175</span></b></p>
<img style="position:absolute;transform:matrix(.31940789,0,-0,.3187552,395.0849,3.744316)" src="data:image/jpeg;base64,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">
<p style="top:23.9pt;left:44.8pt;line-height:7.0pt"><span style="font-family:Lato-Regular,serif;font-size:7.0pt">SHANBHAG </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">et</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt"> </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">Al</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt">.</span></p>
<p style="top:49.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">did not extent to all indications, but only to SA and horizontal RA </span></p>
<p style="top:62.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(no studies of vertical RA were eligible for the meta- analysis). In this </span></p>
<p style="top:75.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">context, the model used is critical when interpreting the results re-</span></p>
<p style="top:88.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">garding the potential of a therapeutic intervention to enhance bone </span></p>
<p style="top:101.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">regeneration. In particular, the maxillary sinus represents a </span><i><span style="font-family:Lato,serif;font-size:8.0pt">sponta-</span></i></p>
<p style="top:114.0pt;left:44.8pt;line-height:8.0pt"><i><span style="font-family:Lato,serif;font-size:8.0pt">neously healing defect</span></i><span style="font-family:Lato,serif;font-size:8.0pt">, in the sense that space provided, that is the </span></p>
<p style="top:127.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Schneiderian membrane is elevated and kept at a distance to the sinus </span></p>
<p style="top:140.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">bone wall, and in the absence of infection, bone regeneration occurs </span></p>
<p style="top:153.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">in the sinus cavity in a predicable fashion&#x2014;even without the need </span></p>
<p style="top:166.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">for any grafting (Duan et al., 2017; Lundgren, Andersson, Gualini, &amp; </span></p>
<p style="top:179.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Sennerby, 2004; Riben &amp; Thor, 2016). The major bulk of bone re-</span></p>
<p style="top:192.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">generation in an augmented sinus forms within the first 4&#x2013;5 months </span></p>
<p style="top:205.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">post- operatively, and thereafter only relatively smaller increases </span></p>
<p style="top:218.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">in bone formation may be observed (Handschel et al., 2009; Klijn, </span></p>
<p style="top:231.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Meijer, Bronkhorst, &amp; Jansen, 2010). Thus, it appears that the regen-</span></p>
<p style="top:244.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">erative potential of the sinus is &#x201c;exhausted&#x201d; after a certain amount of </span></p>
<p style="top:257.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">bone formation is achieved and no intervention can produce larger </span></p>
<p style="top:270.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">amounts of bone regeneration within the sinus. This view appears </span></p>
<p style="top:283.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">supported by the circumstantial evidence indicating that even ap-</span></p>
<p style="top:296.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">plication of growth factors, including BMPs&#x2014;highly potent growth </span></p>
<p style="top:309.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">factors for bone regeneration, does not result in considerably differ-</span></p>
<p style="top:322.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ent bone densities compared with any other type of augmentation </span></p>
<p style="top:335.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">material (Schliephake, 2015). Even in the present analysis, the signifi-</span></p>
<p style="top:348.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">cant effect of BTE in SA (after 6 months) was largely due to a single </span></p>
<p style="top:361.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">study (Pasquali et al., 2015), showing a large positive effect over the </span></p>
<p style="top:374.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">control intervention. Thus, in retrospect, it may come as no surprise </span></p>
<p style="top:387.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">that BTE failed to show similarly remarkable potential in enhancing </span></p>
<p style="top:400.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">bone formation in human sinuses, comparing with animals. A similar </span></p>
<p style="top:413.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">concern regards the use of the extraction socket model, represent-</span></p>
<p style="top:426.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ing also a largely spontaneously healing defect; remarkable differ-</span></p>
<p style="top:439.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ences in terms of histological outcome of healing within the socket </span></p>
<p style="top:452.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">may not be expected among various types of treatments with similar </span></p>
<p style="top:465.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">mechanical stability and space provision capacities, in the absence of </span></p>
<p style="top:478.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">infection (MacBeth, Trullenque- Eriksson, Donos, &amp; Mardas, 2017).</span></p>
<p style="top:491.0pt;left:57.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">The lack of similarly remarkable effects of BTE in the clinic </span></p>
<p style="top:504.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">compared with those observed in pre- clinical in vivo models, may </span></p>
<p style="top:517.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">also be related to dimensional (size) differences in human and ani-</span></p>
<p style="top:530.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">mal defects. In particular, &#x201c;diffusion distances,&#x201d; important aspects </span></p>
<p style="top:543.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">for characterization of mass transport limitations (e.g., diffusion of </span></p>
<p style="top:556.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">oxygen and removal of metabolic waste) relevant to the survival </span></p>
<p style="top:569.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">of transplanted cells, are usually smaller in animals compared with </span></p>
<p style="top:582.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">humans (Muschler, Raut, Patterson, Wenke, &amp; Hollinger, 2010); this </span></p>
<p style="top:595.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">in turn may have allowed a better performance of the transplanted </span></p>
<p style="top:608.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">cells in animals compared with humans. In this context, it is also </span></p>
<p style="top:621.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">worth discussing the different outcome measures employed in the </span></p>
<p style="top:634.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">studies. Histomorphometry of biopsy specimens is considered the </span></p>
<p style="top:647.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">&#x201c;gold standard&#x201d; method for quantitative evaluation of bone struc-</span></p>
<p style="top:660.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ture (Vidal et al., 2012), and was therefore considered as the primary </span></p>
<p style="top:673.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">outcome measure in the meta- analyses. More recently, micro- CT </span></p>
<p style="top:686.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">has been proposed as a less- destructive and &#x2013;time/- labour intensive </span></p>
<p style="top:699.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">method for assessing 3- D bone microarchitecture (Hedberg et al., </span></p>
<p style="top:712.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">2005). In the present review, histological and radiographic data </span></p>
<p style="top:725.0pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">were analysed separately. However, it must be acknowledged that </span></p>
<p style="top:49.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">obtaining biopsy specimens of regenerated tissues is considerably </span></p>
<p style="top:62.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">easier in animals (usually following euthanasia) than in clinical situ-</span></p>
<p style="top:75.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ations. Loss or damage to clinical specimens during harvesting and/</span></p>
<p style="top:88.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">or processing cannot be excluded and may be a further contributing </span></p>
<p style="top:101.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">factor to the differences in outcomes. Moreover, variation between </span></p>
<p style="top:114.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">the studies regarding processing methods, difficulty in differenti-</span></p>
<p style="top:127.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ating between mineralized scaffolds and regenerated mineralized </span></p>
<p style="top:140.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">bone and investigator- related factors (inter- observer variation, lack </span></p>
<p style="top:153.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">of blinding, etc.), may have contributed to heterogeneity in the ob-</span></p>
<p style="top:166.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">served results (Shanbhag et al., 2017).</span></p>
<p style="top:179.0pt;left:318.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">It is relevant to discuss the results herein, in the context of fu</span><span style="font-family:Lato,serif;font-size:8.0pt">-</span></p>
<p style="top:192.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ture studies. Although statistically significant benefits of BTE were </span></p>
<p style="top:205.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">observed in certain indications, the prediction intervals in both the </span></p>
<p style="top:218.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">clinical and pre- clinical meta- analyses were generally quite large and </span></p>
<p style="top:231.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">often crossing the line of no effect, that is the &#x201c;zero line.&#x201d; Prediction </span></p>
<p style="top:244.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">intervals reflect the heterogeneity in the current studies and provide </span></p>
<p style="top:257.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">a range for the expected effect of the intervention in a future study </span></p>
<p style="top:270.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">under a different setting. Thus, although statistically significant </span></p>
<p style="top:283.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">effects of BTE were observed in certain indications in the current </span></p>
<p style="top:296.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">analysis, the wide prediction intervals suggest that future studies in </span></p>
<p style="top:309.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">different settings may show no, or even opposite, effects, that is in </span></p>
<p style="top:322.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">the favour of scaffolds alone (IntHout, Ioannidis, Rovers, &amp; Goeman, </span></p>
<p style="top:335.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">2016). Only in the case of clinical SA (vs. scaffolds, 4&#x2013;7 months) eval</span><span style="font-family:Lato,serif;font-size:8.0pt">-</span></p>
<p style="top:348.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">uated by </span><span style="font-family:STIX,serif;font-size:8.0pt">&#x3bc;</span><span style="font-family:Lato,serif;font-size:8.0pt">- CT, did BTE show a significant effect with a narrow pre-</span></p>
<p style="top:361.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">diction interval.</span></p>
<p style="top:374.0pt;left:318.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Finally, the cost of BTE, in comparison to current alternatives, is </span></p>
<p style="top:387.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">an important factor in clinical decision- making. One included study, </span></p>
<p style="top:400.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">reporting the use of autologous ASCs to treat extensive mandibular </span></p>
<p style="top:413.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">defects, estimated the cost of GMP- grade cell expansion alone to be </span></p>
<p style="top:426.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">12,000 USD (Wolff et al., 2013). In this context, the use of whole tis</span><span style="font-family:Lato,serif;font-size:8.0pt">-</span></p>
<p style="top:439.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">sue [BMA(C) or SVF] would considerably reduce costs in comparison </span></p>
<p style="top:452.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">to expanded cells. However, the per- patient costs associated with </span></p>
<p style="top:465.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">the &#x201c;gold standard&#x201d; treatment, that is iliac crest- derived AB grafting, </span></p>
<p style="top:478.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">are also reported to be considerably high, primarily due to the need </span></p>
<p style="top:491.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">for hospitalization and general anaesthesia (Dahlin &amp; Johansson, </span></p>
<p style="top:504.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">2011; Francis et al., 2013; Mehta et al., 2018). Indeed, one included </span></p>
<p style="top:517.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">study reported significantly greater costs (in addition to higher com-</span></p>
<p style="top:530.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">plications and morbidity) associated with AB grafting versus BTE </span></p>
<p style="top:543.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(BMA + scaffolds) for AC repair (Gimbel et al., 2007). Thus, in ad-</span></p>
<p style="top:556.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">dition to clinical efficacy, future controlled studies should evaluate </span></p>
<p style="top:569.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">the cost- effectiveness of cell therapy for bone regeneration to guide </span></p>
<p style="top:582.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">clinical decision- making.</span></p>
<p style="top:619.4pt;left:305.8pt;line-height:10.0pt"><b><span style="font-family:Lato,serif;font-size:10.0pt">5&#x2003;</span></b><span style="font-family:Lato,serif;font-size:10.0pt">|</span><b><span style="font-family:Lato,serif;font-size:10.0pt">&#x2003;CONCLUSIONS</span></b></p>
<p style="top:647.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Based on the reviewed evidence, the following conclusions may be </span></p>
<p style="top:660.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">drawn:</span></p>
<p style="top:686.0pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">1. Based on limited and heterogeneous evidence from clinical </span></p>
<p style="top:699.0pt;left:317.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">studies, transplantation of cells, most commonly whole BMA </span></p>
<p style="top:712.0pt;left:317.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">or BMAC, in combination with biomaterial scaffolds results in </span></p>
<p style="top:725.0pt;left:317.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">superior bone regeneration compared to implantation of </span></p>
<p style="top:11.6pt;left:578.8pt;line-height:5.1pt"><span style="font-family:Times New Roman,serif;font-size:5.1pt"> 1600051x, 2019, S21, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jcpe.13049 by Universit&#xe4;tsbibliothek Zuerich, Wiley Online Library on [27/12/2022]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</span></p>


<p style="top:23.8pt;left:46.5pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">176&#x2003; </span></b><b><span style="font-family:Lato,serif;font-size:9.1pt">|</span></b><b><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003; &#x2003;&#x2002;</span></b></p>
<img style="position:absolute;transform:matrix(.31940789,0,-0,.3187552,54.97612,3.7443963)" src="data:image/jpeg;base64,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">
<p style="top:23.8pt;left:493.4pt;line-height:7.0pt"><span style="font-family:Lato-Regular,serif;font-size:7.0pt">SHANBHAG </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">et</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt"> </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">Al</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt">.</span></p>
<p style="top:49.0pt;left:58.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">scaffolds alone in SA and horizontal RA, and comparable bone </span></p>
<p style="top:62.0pt;left:58.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">regeneration to the gold standard (AB grafts) in AC repair.</span></p>
<p style="top:75.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">2. It is unclear whether implantation of ex vivo expanded cells is </span></p>
<p style="top:88.0pt;left:58.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">superior to minimally manipulated whole tissue fractions </span></p>
<p style="top:101.0pt;left:58.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(BMA/C or A-SVF). In the case of ex vivo expanded cells, it is </span></p>
<p style="top:114.0pt;left:58.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">unclear whether implantation of committed cells (POCs or </span></p>
<p style="top:127.0pt;left:58.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">OBs) is superior to uncommitted cells (BMSCs or ASCs) in terms </span></p>
<p style="top:140.0pt;left:58.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">of bone regeneration.</span></p>
<p style="top:153.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">3. In the case of BMSCs, it is unclear whether osteogenic pre-</span></p>
<p style="top:166.0pt;left:58.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">differentiation is beneficial. In the case of ASCs, additional os</span><span style="font-family:Lato,serif;font-size:8.0pt">-</span></p>
<p style="top:179.0pt;left:58.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">teogenic stimulation, via osteogenic pre-differentiation or </span></p>
<p style="top:192.0pt;left:58.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">addition of osteoinductive factors, for example BMP-2, may be </span></p>
<p style="top:205.0pt;left:58.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">beneficial.</span></p>
<p style="top:218.0pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">4. The relatively larger ES in favour of cell therapy observed in pre-</span></p>
<p style="top:231.0pt;left:58.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">clinical studies are diminished in clinical trials, suggesting a gap in </span></p>
<p style="top:244.0pt;left:58.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">translation.</span></p>
<p style="top:288.0pt;left:46.5pt;line-height:8.0pt"><b><span style="font-family:Lato,serif;font-size:8.0pt">ACKNOWLEDGEMENT</span></b></p>
<p style="top:307.5pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">The authors acknowledge the support of the authors of the primary </span></p>
<p style="top:320.5pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">studies who provided additional information and data for the review.</span></p>
<p style="top:353.0pt;left:46.5pt;line-height:8.0pt"><b><span style="font-family:Lato,serif;font-size:8.0pt">CONFLICT OF INTEREST</span></b></p>
<p style="top:372.5pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">The authors have stated explicitly that there are no conflicts of inter-</span></p>
<p style="top:385.5pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">est in connection with this article.</span></p>
<p style="top:418.0pt;left:46.5pt;line-height:8.0pt"><b><span style="font-family:Lato,serif;font-size:8.0pt">ORCID</span></b></p>
<p style="top:437.5pt;left:46.5pt;line-height:8.0pt"><i><span style="font-family:Lato,serif;font-size:8.0pt">Andreas Stavropoulos</span></i><span style="font-family:Lato,serif;font-size:8.0pt"> </span></p>
<p style="top:437.5pt;left:134.2pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt"> </span><span style="font-family:Lato,serif;font-size:8.0pt;color:#0000ff">https://orcid.org/0000-0001-8161-3754</span><span style="font-family:Lato,serif;font-size:8.0pt"> </span></p>
<p style="top:453.5pt;left:46.5pt;line-height:8.0pt"><i><span style="font-family:Lato,serif;font-size:8.0pt">Mariano Sanz</span></i><span style="font-family:Lato,serif;font-size:8.0pt"> </span></p>
<p style="top:453.5pt;left:106.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt"> </span><span style="font-family:Lato,serif;font-size:8.0pt;color:#0000ff">https://orcid.org/0000-0002-6293-5755</span><span style="font-family:Lato,serif;font-size:8.0pt"> </span></p>
<p style="top:469.5pt;left:46.5pt;line-height:8.0pt"><i><span style="font-family:Lato,serif;font-size:8.0pt">Kamal Mustafa</span></i><span style="font-family:Lato,serif;font-size:8.0pt"> </span></p>
<p style="top:469.5pt;left:111.6pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt"> </span><span style="font-family:Lato,serif;font-size:8.0pt;color:#0000ff">https://orcid.org/0000-0002-2968-2856</span><span style="font-family:Lato,serif;font-size:8.0pt"> </span></p>
<p style="top:485.5pt;left:46.5pt;line-height:8.0pt"><i><span style="font-family:Lato,serif;font-size:8.0pt">Siddharth</span></i><span style="font-family:Lato,serif;font-size:8.0pt"> Shanbhag </span></p>
<p style="top:485.5pt;left:130.6pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt"> </span><span style="font-family:Lato,serif;font-size:8.0pt;color:#0000ff">http://orcid.org/0000-0003-0056-8379</span><span style="font-family:Lato,serif;font-size:8.0pt">  </span></p>
<p style="top:521.0pt;left:46.5pt;line-height:8.0pt"><b><span style="font-family:Lato,serif;font-size:8.0pt">REFERENCES</span></b></p>
<p style="top:538.4pt;left:46.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Adamzyk, C., Kachel, P., Hoss, M., Gremse, F., Modabber, A., Holzle, F., </span></p>
<p style="top:548.9pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2026; Lethaus, B. (2016). Bone tissue engineering using polyetherke-</span></p>
<p style="top:559.4pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">toneketone scaffolds combined with autologous mesenchymal stem </span></p>
<p style="top:569.9pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">cells in a sheep calvarial defect model. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Journal of Cranio- Maxillo- Facial </span></i></p>
<p style="top:580.4pt;left:59.4pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Surgery</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">44</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 985&#x2013;994. https://doi.org/10.1016/j.jcms.2016.04.012</span></p>
<p style="top:590.9pt;left:46.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Akintoye, S. O., Lam, T., Shi, S., Brahim, J., Collins, M. T., &amp; Robey, P. G. </span></p>
<p style="top:601.4pt;left:59.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(2006). Skeletal site- specific characterization of orofacial and iliac </span></p>
<p style="top:611.9pt;left:59.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">crest human bone marrow stromal cells in same individuals. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Bone</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">38</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span></p>
<p style="top:622.4pt;left:59.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">758&#x2013;768. https://doi.org/10.1016/j.bone.2005.10.027</span></p>
<p style="top:632.9pt;left:46.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Alekseeva, I. S., Kulakov, A. A., Gol&apos;dshte&#x12d;n, D. V., &amp; Kulakov, A. V. (2012). </span></p>
<p style="top:643.4pt;left:59.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Bone tissue restoration after tooth removal by means of tissue- </span></p>
<p style="top:653.9pt;left:59.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">engineering construction based on multipotent stromal adipose cells. </span></p>
<p style="top:664.4pt;left:59.4pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Stomatologiia (Mosk)</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">91</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 32&#x2013;35.</span></p>
<p style="top:674.9pt;left:46.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Alekseeva, I. S., Rachinskaia, O. A., Volkov, A. V., Kulakov, A. A., &amp; </span></p>
<p style="top:685.4pt;left:59.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Gol&apos;dshte&#x12d;n, D. V. (2012). A comparative evaluation of bone tissue </span></p>
<p style="top:695.9pt;left:59.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">formation by tissue scaffold and osteoplastic material &#xab;Bio- Oss&#xbb; </span></p>
<p style="top:706.4pt;left:59.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">transplantation in the maxillary sinus floor. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Stomatologiia (Mosk)</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">91</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span></p>
<p style="top:716.9pt;left:59.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">41&#x2013;44.</span></p>
<p style="top:49.0pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Alekseeva, I. S., Volkov, A. V., Kulakov, A. A., &amp; Gol&apos;dshte&#x12d;n, D. V. (2012). </span></p>
<p style="top:59.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Clinical and experimental study on the use of combined cell trans-</span></p>
<p style="top:70.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">plant on the basis of multipotent mesenchymal stromal cells of ad-</span></p>
<p style="top:80.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">ipose tissue in patients with severe deficiency of jaws bone tissue. </span></p>
<p style="top:91.0pt;left:320.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Cellular Transplantation and Tissue Engineering</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">7</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 97&#x2013;105.</span></p>
<p style="top:101.5pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Al-Ahmady, H. H., Abd Elazeem, A. F., Bellah Ahmed, N. E., Shawkat, </span></p>
<p style="top:112.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">W. M., Elmasry, M., Abdelrahman, M. A., &amp; Abderazik, M. A. (2018). </span></p>
<p style="top:122.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Combining autologous bone marrow mononuclear cells seeded on </span></p>
<p style="top:133.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">collagen sponge with Nano Hydroxyapatite, and platelet- rich fibrin: </span></p>
<p style="top:143.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Reporting a novel strategy for alveolar cleft bone regeneration. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">J </span></i></p>
<p style="top:154.0pt;left:320.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Craniomaxillofac Surg.</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">46</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 1593&#x2013;1600.</span></p>
<p style="top:164.5pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Al-Nawas, B., &amp; Schiegnitz, E. (2014). Augmentation procedures using </span></p>
<p style="top:175.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">bone substitute materials or autogenous bone -  a systematic review </span></p>
<p style="top:185.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">and meta- analysis. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">European Journal of Oral Implantology</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">7</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(Suppl 2), </span></p>
<p style="top:196.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">S219&#x2013;S234.</span></p>
<p style="top:206.5pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Al-Nbaheen, M., Vishnubalaji, R., Ali, D., Bouslimi, A., Al-Jassir, F., </span></p>
<p style="top:217.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Megges, M., &#x2026; Aldahmash, A. (2013). Human stromal (mesen</span><span style="font-family:Lato,serif;font-size:7.5pt">-</span></p>
<p style="top:227.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">chymal) stem cells from bone marrow, adipose tissue and skin </span></p>
<p style="top:238.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">exhibit differences in molecular phenotype and differentiation </span></p>
<p style="top:248.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">potential. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Stem Cell Reviews</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">9</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 32&#x2013;43. https://doi.org/10.1007/</span></p>
<p style="top:259.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">s12015-012-9365-8</span></p>
<p style="top:269.5pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">d&apos;Aquino, R., De Rosa, A., Lanza, V., Tirino, V., Laino, L., Graziano, A., </span></p>
<p style="top:280.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2026; Papaccio, G. (2009). Human mandible bone defect repair by the </span></p>
<p style="top:290.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">grafting of dental pulp stem/progenitor cells and collagen sponge </span></p>
<p style="top:301.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">biocomplexes. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">European Cells and Materials</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">18</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 75&#x2013;83. https://doi.</span></p>
<p style="top:311.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">org/10.22203/eCM</span></p>
<p style="top:322.0pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Avila-Ortiz, G., Bartold, P. M., Giannobile, W., Katagiri, W., Nares, S., </span></p>
<p style="top:332.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Rios, H., &#x2026; Wikesjo, U. M. (2016). Biologics and cell therapy tissue </span></p>
<p style="top:343.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">engineering approaches for the management of the edentulous max-</span></p>
<p style="top:353.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">illa: A systematic review. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">International Journal of Oral and Maxillofacial </span></i></p>
<p style="top:364.0pt;left:320.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Implants</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">31</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(Suppl), s121&#x2013;s164.</span></p>
<p style="top:374.5pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Baboolal, T. G., Boxall, S. A., El-Sherbiny, Y. M., Moseley, T. A., Cuthbert, </span></p>
<p style="top:385.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">R. J., Giannoudis, P. V., &#x2026; Jones, E. (2014). Multipotential stromal cell </span></p>
<p style="top:395.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">abundance in cellular bone allograft: Comparison with fresh age- </span></p>
<p style="top:406.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">matched iliac crest bone and bone marrow aspirate. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Regenerative </span></i></p>
<p style="top:416.5pt;left:320.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Medicine</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">9</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 593&#x2013;607. https://doi.org/10.2217/rme.14.17</span></p>
<p style="top:427.0pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Bajek, A., Gurtowska, N., Olkowska, J., Kazmierski, L., Maj, M., &amp; Drewa, </span></p>
<p style="top:437.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">T. (2016). Adipose- derived stem cells as a tool in cell- based thera-</span></p>
<p style="top:448.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">pies. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Archivum Immunolgiae et Therapiae Experimentalis</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">64</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 443&#x2013;454. </span></p>
<p style="top:458.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">https://doi.org/10.1007/s00005-016-0394-x</span></p>
<p style="top:469.0pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Bajestan, M. N., Rajan, A., Edwards, S. P., Aronovich, S., Cevidanes, L. </span></p>
<p style="top:479.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">H. S., Polymeri, A., &#x2026; Kaigler, D. (2017). Stem cell therapy for recon-</span></p>
<p style="top:490.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">struction of alveolar cleft and trauma defects in adults: A random-</span></p>
<p style="top:500.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">ized controlled, clinical trial. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Clinical Implant Dentistry and Related </span></i></p>
<p style="top:511.0pt;left:320.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Research</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">19</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 793&#x2013;801. https://doi.org/10.1111/cid.12506</span></p>
<p style="top:521.5pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Bartel, R. L., Cramer, C., Ledford, K., Longcore, A., Parrish, C., Stern, T., </span></p>
<p style="top:532.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2026; Zeigler, F. (2012). The Aastrom experience. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Stem Cell Research &amp; </span></i></p>
<p style="top:542.5pt;left:320.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Therapy</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">3</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 26. https://doi.org/10.1186/scrt117</span></p>
<p style="top:553.0pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Beaumont, C., Schmidt, R. J., Tatakis, D. N., &amp; Zafiropoulos, G. </span></p>
<p style="top:563.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">G. (2008). Use of engineered bone for sinus augmentation. </span></p>
<p style="top:574.0pt;left:320.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Journal of Periodontology</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">79</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 541&#x2013;548. https://doi.org/10.1902/</span></p>
<p style="top:584.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">jop.2008.070255</span></p>
<p style="top:595.0pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Behnia, H., Khojasteh, A., Soleimani, M., Tehranchi, A., &amp; Atashi, A. </span></p>
<p style="top:605.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(2012). Repair of alveolar cleft defect with mesenchymal stem cells </span></p>
<p style="top:616.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">and platelet derived growth factors: A preliminary report. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Journal </span></i></p>
<p style="top:626.5pt;left:320.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">of Cranio- Maxillo- Facial Surgery</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">40</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 2&#x2013;7. https://doi.org/10.1016/j.</span></p>
<p style="top:637.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">jcms.2011.02.003</span></p>
<p style="top:647.5pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Bertolai, R., Catelani, C., Aversa, A., Rossi, A., Giannini, D., &amp; Bani, D. </span></p>
<p style="top:658.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(2015). Bone graft and mesenchimal stem cells: Clinical observations </span></p>
<p style="top:668.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">and histological analysis. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Clinical cases in mineral and Bone Metabolism</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span></p>
<p style="top:679.0pt;left:320.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">12</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 183&#x2013;187. https://doi.org/10.11138/ccmbm/2015.12.2.183</span></p>
<p style="top:689.5pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Bondarava, M., Cattaneo, C., Ren, B., Thasler, W. E., Jansson, V., Muller, </span></p>
<p style="top:700.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">P. E., &amp; Betz, O. B. (2017). Osseous differentiation of human fat tis</span><span style="font-family:Lato,serif;font-size:7.5pt">-</span></p>
<p style="top:710.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">sue grafts: From tissue engineering to tissue differentiation. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Scientific </span></i></p>
<p style="top:721.0pt;left:320.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Reports</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">7</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 39712. https://doi.org/10.1038/srep39712</span></p>
<p style="top:11.6pt;left:578.8pt;line-height:5.1pt"><span style="font-family:Times New Roman,serif;font-size:5.1pt"> 1600051x, 2019, S21, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jcpe.13049 by Universit&#xe4;tsbibliothek Zuerich, Wiley Online Library on [27/12/2022]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</span></p>


<p style="top:23.8pt;left:511.9pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003;&#x2002; &#x2003;</span></b><b><span style="font-family:Lato,serif;font-size:9.1pt">|</span></b><b><span style="font-family:Lato,serif;font-size:7.0pt"> &#x2003;177</span></b></p>
<img style="position:absolute;transform:matrix(.31940789,0,-0,.3187552,395.0849,3.744316)" src="data:image/jpeg;base64,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">
<p style="top:23.9pt;left:44.8pt;line-height:7.0pt"><span style="font-family:Lato-Regular,serif;font-size:7.0pt">SHANBHAG </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">et</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt"> </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">Al</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt">.</span></p>
<p style="top:49.0pt;left:44.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Brennan, M. A., Renaud, A., Guilloton, F., Mebarki, M., Trichet, V., </span></p>
<p style="top:59.5pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Senseb&#xe9;, L., &#x2026; Layrolle, P. (2017). Inferior in vivo osteogenesis and </span></p>
<p style="top:70.0pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">superior angiogeneis of human adipose tissue: A comparison with </span></p>
<p style="top:80.5pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">bone marrow- derived stromal stem cells cultured in xeno- free con-</span></p>
<p style="top:91.0pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">ditions. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Stem Cells Translational Medicine</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">6</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 2160&#x2013;2172. https://doi.</span></p>
<p style="top:101.5pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">org/10.1002/sctm.17-0133</span></p>
<p style="top:112.0pt;left:44.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Bueno, D. F. (2015). Use of mesenchymal stem cells for alveolar bone </span></p>
<p style="top:122.5pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">tissue engineering for cleft lip and palate patients. Clinical-Trials.gov </span></p>
<p style="top:133.0pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Identifier: NCT01932164. Retreived from https://clinicaltrials.gov/</span></p>
<p style="top:143.5pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">ct2/show/NCT01932164</span></p>
<p style="top:154.0pt;left:44.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Caplan, A. I. (2017). Mesenchymal stem cells: Time to change the </span></p>
<p style="top:164.5pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">name!. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Stem Cells Translational Medicine</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">6</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 1445&#x2013;1451. https://doi.</span></p>
<p style="top:175.0pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">org/10.1002/sctm.17-0051</span></p>
<p style="top:185.5pt;left:44.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Castillo-Cardiel, G., Lopez-Echaury, A. C., Saucedo-Ortiz, J. A., Fuentes-</span></p>
<p style="top:196.0pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Orozco, C., Michel-Espinoza, L. R., Irusteta-Jimenez, L., &#x2026; Gonzalez-</span></p>
<p style="top:206.5pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Ojeda, A. (2017). Bone regeneration in mandibular fractures after the </span></p>
<p style="top:217.0pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">application of autologous mesenchymal stem cells, a randomized clin-</span></p>
<p style="top:227.5pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">ical trial. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Dental Traumatology</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">33</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 38&#x2013;44. https://doi.org/10.1111/</span></p>
<p style="top:238.0pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">edt.12303</span></p>
<p style="top:248.5pt;left:44.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Chahla, J., Dean, C. S., Moatshe, G., Pascual-Garrido, C., Serra Cruz, </span></p>
<p style="top:259.0pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">R., &amp; LaPrade, R. F. (2016). Concentrated bone marrow aspirate </span></p>
<p style="top:269.5pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">for the treatment of chondral injuries and osteoarthritis of the </span></p>
<p style="top:280.0pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">knee: A systematic review of outcomes. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Orthopaedic Journal of </span></i></p>
<p style="top:290.5pt;left:57.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Sports Medicine</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">4</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 2325967115625481. https://doi.org/10.1177/</span><span style="font-family:Lato,serif;font-size:7.5pt"> </span></p>
<p style="top:301.0pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">2325967115625481</span></p>
<p style="top:311.5pt;left:44.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Chahla, J., Mannava, S., Cinque, M. E., Geeslin, A. G., Codina, D., &amp; </span></p>
<p style="top:322.0pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">LaPrade, R. F. (2017). Bone marrow aspirate concentrate harvesting </span></p>
<p style="top:332.5pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">and processing technique. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Arthroscopy Techniques</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">6</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, e441&#x2013;e445. </span></p>
<p style="top:343.0pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">https://doi.org/10.1016/j.eats.2016.10.024</span></p>
<p style="top:353.5pt;left:44.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Chai, G., Zhang, Y., Hu, X. J., Wang, M., Liu, W., Cui, L., &amp; Cao, Y. L. (2006). </span></p>
<p style="top:364.0pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Repair alveolar cleft bone defects with bone marrow stromal cells. </span></p>
<p style="top:374.5pt;left:57.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Zhonghua Zheng Xing Wai Ke Za Zhi</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">22</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 409&#x2013;411.</span></p>
<p style="top:385.0pt;left:44.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Chai, G., Zhang, Y., Liu, W., Cui, L., &amp; Cao, Y. L. (2003). Clinical application </span></p>
<p style="top:395.5pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">of tissue engineered bone repair of human craniomaxillofacial bone </span></p>
<p style="top:406.0pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">defects. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Zhonghua Yi Xue Za Zhi</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">83</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 1676&#x2013;1681.</span></p>
<p style="top:416.5pt;left:44.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Chanchareonsook, N., Junker, R., Jongpaiboonkit, L., &amp; Jansen, J. A. </span></p>
<p style="top:427.0pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(2014). Tissue- engineered mandibular bone reconstruction for </span></p>
<p style="top:437.5pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">continuity defects: A systematic approach to the literature. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Tissue </span></i></p>
<p style="top:448.0pt;left:57.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Engineering Part B Reviews</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">20</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 147&#x2013;162. https://doi.org/10.1089/ten.</span></p>
<p style="top:458.5pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">teb.2013.0131</span></p>
<p style="top:469.0pt;left:44.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Chiapasco, M., &amp; Casentini, P. (2018). Horizontal bone- augmentation </span></p>
<p style="top:479.5pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">procedures in implant dentistry: Prosthetically guided regeneration. </span></p>
<p style="top:490.0pt;left:57.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Periodontology 2000</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">77</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 213&#x2013;240. https://doi.org/10.1111/prd.12219</span></p>
<p style="top:500.5pt;left:44.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Corbella, S., Weinstein, R., Francetti, L., Taschieri, S., &amp; Del Fabbro, M. </span></p>
<p style="top:511.0pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(2017). Periodontal regeneration in aggressive periodontitis pa-</span></p>
<p style="top:521.5pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">tients: A systematic review of the literature. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Journal of Investigative </span></i></p>
<p style="top:532.0pt;left:57.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">and Clinical Dentistry</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">8</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, e12245. https://doi.org/10.1111/jicd.12245</span></p>
<p style="top:542.5pt;left:44.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">da Costa, C. E., Pelegrine, A. A., Fagundes, D. J., Simoes Mde, J., &amp; Taha, </span></p>
<p style="top:553.0pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">M. O. (2011). Use of corticocancellous allogeneic bone blocks im</span><span style="font-family:Lato,serif;font-size:7.5pt">-</span></p>
<p style="top:563.5pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">pregnated with bone marrow aspirate: A clinical, tomographic, and </span></p>
<p style="top:574.0pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">histomorphometric study. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">General Dentistry</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">59</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, e200&#x2013;e205.</span></p>
<p style="top:584.5pt;left:44.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Dahlin, C., &amp; Johansson, A. (2011). Iliac crest autogenous bone graft versus </span></p>
<p style="top:595.0pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">alloplastic graft and guided bone regeneration in the reconstruction of </span></p>
<p style="top:605.5pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">atrophic maxillae: A 5- year retrospective study on cost- effectiveness </span></p>
<p style="top:616.0pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">and clinical outcome. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Clinical Implant Dentistry and Related Research</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span></p>
<p style="top:626.5pt;left:57.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">13</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 305&#x2013;310. https://doi.org/10.1111/j.1708-8208.2009.00221.x</span></p>
<p style="top:637.0pt;left:44.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Danesh-Sani, S. A., Engebretson, S. P., &amp; Janal, M. N. (2017). </span></p>
<p style="top:647.5pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Histomorphometric results of different grafting materials and effect </span></p>
<p style="top:658.0pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">of healing time on bone maturation after sinus floor augmentation: A </span></p>
<p style="top:668.5pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">systematic review and meta- analysis. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Journal of Periodontal Research</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span></p>
<p style="top:679.0pt;left:57.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">52</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 301&#x2013;312. https://doi.org/10.1111/jre.12402</span></p>
<p style="top:689.5pt;left:44.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">D&apos;Aquino, R., Trovato, L., Graziano, A., Ceccarelli, G., Cusella de Angelis, </span></p>
<p style="top:700.0pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">G., Marangini, A., &#x2026; Rodriguez y Baena, R. (2016). Periosteum- </span></p>
<p style="top:710.5pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">derived micro- grafts for tissue regeneration of human maxillary </span></p>
<p style="top:721.0pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">bone. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Journal of Translational Science</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">2</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 125&#x2013;129.</span></p>
<p style="top:49.0pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Daugela, P., Cicciu, M., &amp; Saulacic, N. (2016). Surgical regenerative treat-</span></p>
<p style="top:59.5pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">ments for peri- implantitis: Meta- analysis of recent findings in a sys-</span></p>
<p style="top:70.0pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">tematic literature review. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Journal of Oral and Maxillofacial Research</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">7</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span></p>
<p style="top:80.5pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">e15. https://doi.org/10.5037/jomr.2029.283X</span></p>
<p style="top:91.0pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">de Oliveira, T. A., Aloise, A. C., Orosz, J. E., de Mello, E. O. R., de Carvalho, </span></p>
<p style="top:101.5pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">P., &amp; Pelegrine, A. A. (2016). Double centrifugation versus single cen-</span></p>
<p style="top:112.0pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">trifugation of bone marrow aspirate concentrate in sinus floor ele-</span></p>
<p style="top:122.5pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">vation: A pilot study. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">International Journal of Oral and Maxillofacial </span></i></p>
<p style="top:133.0pt;left:318.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Implants</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">31</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 216&#x2013;222. https://doi.org/10.11607/jomi.4170</span></p>
<p style="top:143.5pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Dennis, J. E., Esterly, K., Awadallah, A., Parrish, C. R., Poynter, G. M., &amp; </span></p>
<p style="top:154.0pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Goltry, K. L. (2007). Clinical- scale expansion of a mixed population </span></p>
<p style="top:164.5pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">of bone- marrow- derived stem and progenitor cells for potential use </span></p>
<p style="top:175.0pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">in bone- tissue regeneration. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Stem Cells</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">25</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 2575&#x2013;2582. https://doi.</span></p>
<p style="top:185.5pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">org/10.1634/stemcells.2007-0204</span></p>
<p style="top:196.0pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, </span></p>
<p style="top:206.5pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">F., Krause, D., &#x2026; Horwitz, E. (2006). Minimal criteria for defining </span></p>
<p style="top:217.0pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">multipotent mesenchymal stromal cells. The International Society </span></p>
<p style="top:227.5pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">for Cellular Therapy position statement. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Cytotherapy</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">8</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 315&#x2013;317. </span></p>
<p style="top:238.0pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">https://doi.org/10.1080/14653240600855905</span></p>
<p style="top:248.5pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Du, F., Wu, H., Li, H., Cai, L., Wang, Q., Liu, X., &#x2026; Cao, Y. (2017). Bone </span></p>
<p style="top:259.0pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">marrow mononuclear cells combined with beta- tricalcium phosphate </span></p>
<p style="top:269.5pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">granules for alveolar cleft repair: A 12- month clinical study. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Scientific </span></i></p>
<p style="top:280.0pt;left:318.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Reports</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">7</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 13773. https://doi.org/10.1038/s41598-017-12602-1</span></p>
<p style="top:290.5pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Duan, D. H., Fu, J. H., Qi, W., Du, Y., Pan, J., &amp; Wang, H. L. (2017). </span></p>
<p style="top:301.0pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Graft- free maxillary sinus floor elevation: A systematic review and </span></p>
<p style="top:311.5pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">meta- analysis. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Journal of Periodontology</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">88</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 550&#x2013;564. https://doi.</span></p>
<p style="top:322.0pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">org/10.1902/jop.2017.160665</span></p>
<p style="top:332.5pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Ducret, M., Fabre, H., Degoul, O., Atzeni, G., McGuckin, C., Forraz, N., </span></p>
<p style="top:343.0pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2026; FARGES, J.-C. (2015). Manufacturing of dental pulp cell- based </span></p>
<p style="top:353.5pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">products from human third molars: Current strategies and future in-</span></p>
<p style="top:364.0pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">vestigations. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Frontiers in Physiology</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">6</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 213. https://doi.org/10.3389/</span></p>
<p style="top:374.5pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">fphys.2015.00213</span></p>
<p style="top:385.0pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Duttenhoefer, F., Hieber, S. F., Stricker, A., Schmelzeisen, R., Gutwald, </span></p>
<p style="top:395.5pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">R., &amp; Sauerbier, S. (2014). Follow- up of implant survival comparing </span></p>
<p style="top:406.0pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">ficoll and bone marrow aspirate concentrate methods for hard tissue </span></p>
<p style="top:416.5pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">regeneration with mesenchymal stem cells in humans. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">BioResearch </span></i></p>
<p style="top:427.0pt;left:318.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Open Access</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">3</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 75&#x2013;76. https://doi.org/10.1089/biores.2014.0003</span></p>
<p style="top:437.5pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Elgali, I., Omar, O., Dahlin, C., &amp; Thomsen, P. (2017). Guided bone re</span><span style="font-family:Lato,serif;font-size:7.5pt">-</span></p>
<p style="top:448.0pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">generation: Materials and biological mechanisms revisited. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">European </span></i></p>
<p style="top:458.5pt;left:318.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Journal of Oral Sciences</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">125</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 315&#x2013;337. https://doi.org/10.1111/</span></p>
<p style="top:469.0pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">eos.12364</span></p>
<p style="top:479.5pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">El-Jawhari, J. J., Sanjurjo-Rodriguez, C., Jones, E., &amp; Giannoudis, P. V. </span></p>
<p style="top:490.0pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(2016). Collagen- containing scaffolds enhance attachment and </span></p>
<p style="top:500.5pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">proliferation of non- cultured bone marrow multipotential stromal </span></p>
<p style="top:511.0pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">cells. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Journal of Orthopaedic Research</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">34</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 597&#x2013;606. https://doi.</span></p>
<p style="top:521.5pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">org/10.1002/jor.23070</span></p>
<p style="top:532.0pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Elnayef, B., Monje, A., Gargallo-Albiol, J., Galindo-Moreno, P., Wang, </span></p>
<p style="top:542.5pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">H. L., &amp; Hernandez-Alfaro, F. (2017). Vertical ridge augmentation </span></p>
<p style="top:553.0pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">in the atrophic mandible: A systematic review and meta- analysis. </span></p>
<p style="top:563.5pt;left:318.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">International Journal of Oral and Maxillofacial Implants</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">32</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 291&#x2013;312. </span></p>
<p style="top:574.0pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">https://doi.org/10.11607/jomi.4861</span></p>
<p style="top:584.5pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Elnayef, B., Porta, C., Suarez-Lopez Del Amo, F., Mordini, L., Gargallo-</span></p>
<p style="top:595.0pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Albiol, J., &amp; Hernandez-Alfaro, F. (2018). The fate of lateral ridge </span></p>
<p style="top:605.5pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">augmentation: A systematic review and meta- analysis. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">International </span></i></p>
<p style="top:616.0pt;left:318.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Journal of Oral and Maxillofacial Implants</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">33</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 622&#x2013;635. https://doi.</span></p>
<p style="top:626.5pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">org/10.11607/jomi.6290</span></p>
<p style="top:637.0pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Esposito, M., Grusovin, M. G., Felice, P., Karatzopoulos, G., Worthington, </span></p>
<p style="top:647.5pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">H. V., &amp; Coulthard, P. (2009). Interventions for replacing missing </span></p>
<p style="top:658.0pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">teeth: Horizontal and vertical bone augmentation techniques for </span></p>
<p style="top:668.5pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">dental implant treatment. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Cochrane Database Systematic Review</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">4</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span></p>
<p style="top:679.0pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">CD003607.</span></p>
<p style="top:689.5pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Evans, C. H., Palmer, G. D., Pascher, A., Porter, R., Kwong, F. N., Gouze, E., </span></p>
<p style="top:700.0pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2026; Ghivizzani, S. C. (2007). Facilitated endogenous repair: Making tis-</span></p>
<p style="top:710.5pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">sue engineering simple, practical, and economical. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Tissue Engineering</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span></p>
<p style="top:721.0pt;left:318.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">13</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 1987&#x2013;1993. https://doi.org/10.1089/ten.2006.0302</span></p>
<p style="top:11.6pt;left:578.8pt;line-height:5.1pt"><span style="font-family:Times New Roman,serif;font-size:5.1pt"> 1600051x, 2019, S21, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jcpe.13049 by Universit&#xe4;tsbibliothek Zuerich, Wiley Online Library on [27/12/2022]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</span></p>


<p style="top:23.8pt;left:46.5pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">178&#x2003; </span></b><b><span style="font-family:Lato,serif;font-size:9.1pt">|</span></b><b><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003; &#x2003;&#x2002;</span></b></p>
<img style="position:absolute;transform:matrix(.31940789,0,-0,.3187552,54.97612,3.7443963)" src="data:image/jpeg;base64,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">
<p style="top:23.8pt;left:493.4pt;line-height:7.0pt"><span style="font-family:Lato-Regular,serif;font-size:7.0pt">SHANBHAG </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">et</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt"> </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">Al</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt">.</span></p>
<p style="top:49.0pt;left:46.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Farre-Guasch, E., Bravenboer, N., Helder, M. N., Schulten, E., Ten </span></p>
<p style="top:59.5pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Bruggenkate, C. M., &amp; Klein-Nulend, J. (2018). Blood vessel forma-</span></p>
<p style="top:70.0pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">tion and bone regeneration potential of the stromal vascular frac-</span></p>
<p style="top:80.5pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">tion seeded on a calcium phosphate scaffold in the human maxillary </span></p>
<p style="top:91.0pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">sinus floor elevation model. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Materials (Basel)</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">11</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, pii:E161. https://doi.</span></p>
<p style="top:101.5pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">org/10.3390/ma11010161</span></p>
<p style="top:112.0pt;left:46.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Francis, C. S., Mobin, S. S., Lypka, M. A., Rommer, E., Yen, S., Urata, M. M., </span></p>
<p style="top:122.5pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&amp; Hammoudeh, J. A. (2013). rhBMP- 2 with a demineralized bone ma</span><span style="font-family:Lato,serif;font-size:7.5pt">-</span></p>
<p style="top:133.0pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">trix scaffold versus autologous iliac crest bone graft for alveolar cleft </span></p>
<p style="top:143.5pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">reconstruction. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Plastic and Reconstructive Surgery</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">131</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 1107&#x2013;1115. </span></p>
<p style="top:154.0pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">https://doi.org/10.1097/PRS.0b013e3182865dfb</span></p>
<p style="top:164.5pt;left:46.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Fraser, J. K., Hicok, K. C., Shanahan, R., Zhu, M., Miller, S., &amp; Arm, D. </span></p>
<p style="top:175.0pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">M. (2014). The Celution</span><sup><span style="font-family:Lato,serif;font-size:5.2pt">&#xae;</span></sup><span style="font-family:Lato,serif;font-size:7.5pt"> system: Automated processing of adipose- </span></p>
<p style="top:185.5pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">derived regenerative cells in a functionally closed system. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Advance </span></i></p>
<p style="top:196.0pt;left:59.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">in Wound Care (New Rochelle)</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">3</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 38&#x2013;45. https://doi.org/10.1089/</span></p>
<p style="top:206.5pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">wound.2012.0408</span></p>
<p style="top:217.0pt;left:46.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Friedenstein, A. J., Chailakhjan, K. R., &amp; Lalykina, K. S. (1970). The de-</span></p>
<p style="top:227.5pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">velopment of fibroblast colonies in monolayer cultures of guinea- pig </span></p>
<p style="top:238.0pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">bone marrow and spleen cells. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Cell and Tissue Kinetics</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">3</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 393&#x2013;403. </span></p>
<p style="top:248.5pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">https://doi.org/10.1111/j.1365-2184.1970.tb00347.x</span></p>
<p style="top:259.0pt;left:46.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Fuerst, G., Strbac, G. D., Vasak, C., Tangl, S., Leber, J., Gahleitner, </span></p>
<p style="top:269.5pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">A., &#x2026; Watzek, G. (2009). Are culture- expanded autoge-</span></p>
<p style="top:280.0pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">nous bone cells a clinically reliable option for sinus graft-</span></p>
<p style="top:290.5pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">ing? </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Clinical Oral Implants Research</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">20</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 135&#x2013;139. https://doi.</span></p>
<p style="top:301.0pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">org/10.1111/j.1600-0501.2008.01624.x</span></p>
<p style="top:311.5pt;left:46.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Giuliani, A., Manescu, A., Langer, M., Rustichelli, F., Desiderio, V., Paino, </span></p>
<p style="top:322.0pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">F., De Rosa, A., Laino, L., d&#x2018;Aquino, R., Tirino, V., &amp; Papaccio, G. </span></p>
<p style="top:332.5pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(2013). </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Stem Cells Transl Med.</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">2</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 316&#x2013;24.</span></p>
<p style="top:343.0pt;left:46.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Gimbel, M., Ashley, R. K., Sisodia, M., Gabbay, J. S., Wasson, K. L., Heller, </span></p>
<p style="top:353.5pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">J., &#x2026; Bradley, J. P. (2007). Repair of alveolar cleft defects: Reduced </span></p>
<p style="top:364.0pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">morbidity with bone marrow stem cells in a resorbable matrix. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">The </span></i></p>
<p style="top:374.5pt;left:59.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Journal of Craniofacial Surgery</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">18</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 895&#x2013;901. https://doi.org/10.1097/</span></p>
<p style="top:385.0pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">scs.0b013e3180a771af</span></p>
<p style="top:395.5pt;left:46.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Gjerde, C., Mustafa, K., Hellem, S., Rojewski, M., Gjengedal, H., </span></p>
<p style="top:406.0pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yassin, M. A., &#x2026;. Layrolle, P. (2018). Cell therapy induced regen-</span></p>
<p style="top:416.5pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">eration of severely atrophied mandibular bone in a clinical trial. </span></p>
<p style="top:427.0pt;left:59.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Stem Cell Research &amp; Therapy</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">9</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 213. https://doi.org/10.1186/</span></p>
<p style="top:437.5pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">s13287-018-0951-9</span></p>
<p style="top:448.0pt;left:46.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">G&#xf3;mez-Barrena, E., Rosset, P., Gebhard, F., Hernigou, P., Baldini, N., </span></p>
<p style="top:458.5pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Rouard, H., ... Layrolle, P. (2018). Feasibility and safety of treating </span></p>
<p style="top:469.0pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">non- unions in tibia, femur and humerus with autologous, expanded, </span></p>
<p style="top:479.5pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">bone marrow- derived mesenchymal stromal cells associated with </span></p>
<p style="top:490.0pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">biphasic calcium phosphate biomaterials in a multicentric, non- </span></p>
<p style="top:500.5pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">comparative trial. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Biomaterials</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">S0142&#x2013;9612</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(18), 30205&#x2013;30209.</span></p>
<p style="top:511.0pt;left:46.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Gonshor, A., McAllister, B. S., Wallace, S. S., &amp; Prasad, H. (2011). Histologic </span></p>
<p style="top:521.5pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">and histomorphometric evaluation of an allograft stem cell- based </span></p>
<p style="top:532.0pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">matrix sinus augmentation procedure. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">International Journal of Oral </span></i></p>
<p style="top:542.5pt;left:59.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">and Maxillofacial Implants</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">26</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 123&#x2013;131.</span></p>
<p style="top:553.0pt;left:46.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Handschel, J., Simonowska, M., Naujoks, C., Depprich, R. A., Ommerborn, </span></p>
<p style="top:563.5pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">M. A., Meyer, U., &amp; Kubler, N. R. (2009). A histomorphometric meta- </span></p>
<p style="top:574.0pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">analysis of sinus elevation with various grafting materials. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Head and </span></i></p>
<p style="top:584.5pt;left:59.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Face Medicine</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">5</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 12. https://doi.org/10.1186/1746-160X-5-12</span></p>
<p style="top:595.0pt;left:46.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Haumer, A., Bourgine, P. E., Occhetta, P., Born, G., Tasso, R., &amp; Martin, I. </span></p>
<p style="top:605.5pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(2018). Delivery of cellular factors to regulate bone healing. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Advanced </span></i></p>
<p style="top:616.0pt;left:59.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Drug Delivery Reviews</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">129</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 285&#x2013;294. https://doi.org/10.1016/j.</span></p>
<p style="top:626.5pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">addr.2018.01.010</span></p>
<p style="top:637.0pt;left:46.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Hayden, R. E., Mullin, D. P., &amp; Patel, A. K. (2012). Reconstruction of the </span></p>
<p style="top:647.5pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">segmental mandibular defect: Current state of the art. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Current opin-</span></i></p>
<p style="top:658.0pt;left:59.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">ion in otolaryngology and head and neck surgery</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">20</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 231&#x2013;236. https://</span></p>
<p style="top:668.5pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">doi.org/10.1097/MOO.0b013e328355d0f3</span></p>
<p style="top:679.0pt;left:46.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Hedberg, E. L., Kroese-Deutman, H. C., Shih, C. K., Lemoine, J. J., </span></p>
<p style="top:689.5pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Liebschner, M. A., Miller, M. J., &#x2026; Jansen, J. A. (2005). Methods: A </span></p>
<p style="top:700.0pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">comparative analysis of radiography, microcomputed tomography, </span></p>
<p style="top:710.5pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">and histology for bone tissue engineering. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Tissue Engineering</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">11</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span></p>
<p style="top:721.0pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">1356&#x2013;1367. https://doi.org/10.1089/ten.2005.11.1356</span></p>
<p style="top:49.0pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Hermund, N. U., Donatsky, O., Nielsen, H., Clausen, C., &amp; Holmstrup, </span></p>
<p style="top:59.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">P. (2013). Long- term changes in graft height after sinus floor aug</span><span style="font-family:Lato,serif;font-size:7.5pt">-</span></p>
<p style="top:70.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">mentation with mesenchymal stem cells in a randomised clinical </span></p>
<p style="top:80.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">trial: Radiographic evaluation with a minimum followup of 2.5 years. </span></p>
<p style="top:91.0pt;left:320.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Journal of Medical and Dental Sciences</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">2</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 5&#x2013;14.</span></p>
<p style="top:101.5pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Hermund, N. U., Stavropoulos, A., Donatsky, O., Nielsen, H., Clausen, </span></p>
<p style="top:112.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">C., Reibel, J., &#x2026; Holmstrup, P. (2012). Reimplantation of cultivated </span></p>
<p style="top:122.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">human bone cells from the posterior maxilla for sinus floor aug-</span></p>
<p style="top:133.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">mentation. Histological results from a randomized controlled clini-</span></p>
<p style="top:143.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">cal trial. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Clinical Oral Implants Research</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">23</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 1031&#x2013;1037. https://doi.</span></p>
<p style="top:154.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">org/10.1111/j.1600-0501.2011.02251.x</span></p>
<p style="top:164.5pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Hernandez Alfero, F., Marti, C., Orozco, L., Marinoso, M. L., Rodriguez, L., </span></p>
<p style="top:175.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Torrico, C., &#x2026; Hock, J. M. (2005). Aastrom Biosciences, Inc., Clinical </span></p>
<p style="top:185.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Feasibility Study: The Use of Autologous Bone Marrow-Derived </span></p>
<p style="top:196.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Tissue Repair Cells (TRC) for Maxillary Sinus Floor Augmentation in </span></p>
<p style="top:206.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Edentulous Humans [press release]. Retrieved from http://investors.</span></p>
<p style="top:217.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">vcel.com/static-files/f8394516-dfc8-45b8-bda6-ceca0c7eae71.</span></p>
<p style="top:227.5pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Higgins, J. P. T., &amp; Green, S. (eds). (2011). Cochrane handbook for system-</span></p>
<p style="top:238.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">atic reviews of interventions Version 5.1.0 [updated March 2011]. </span></p>
<p style="top:248.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">The Cochrane Collaboration, 2011. Retrieved from www.handbook.</span></p>
<p style="top:259.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">cochrane.org</span></p>
<p style="top:269.5pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Hutmacher, D. W., &amp; Sittinger, M. (2003). Periosteal cells in bone tissue </span></p>
<p style="top:280.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">engineering. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Tissue Engineering</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">9</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(Suppl 1), S45&#x2013;S64. https://doi.</span></p>
<p style="top:290.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">org/10.1089/10763270360696978</span></p>
<p style="top:301.0pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Ibanez, J. C., Agustina, J. M., Ibanez, M. C., &amp; Ibanez, M. I. (2012). Bio-Oss </span></p>
<p style="top:311.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">and stem cells from bone marrow obtained from the distal femur for </span></p>
<p style="top:322.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">sinus grafting. Abstract from the 20th Annual Scientific Meeting of </span></p>
<p style="top:332.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">the European Association of Osseointegration, 10-13 October 2012, </span></p>
<p style="top:343.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Copenhagen, Denmark (additional information obtained via personal </span></p>
<p style="top:353.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">communication). Retreived from https://www.researchgate.net/</span></p>
<p style="top:364.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">publication/285055976.</span></p>
<p style="top:374.5pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">IntHout, J., Ioannidis, J. P., Rovers, M. M., &amp; Goeman, J. J. (2016). Plea </span></p>
<p style="top:385.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">for routinely presenting prediction intervals in meta- analysis. </span></p>
<p style="top:395.5pt;left:320.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">British Medical Journal Open</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">6</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, e010247. https://doi.org/10.1136/</span></p>
<p style="top:406.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">bmjopen-2015-010247</span></p>
<p style="top:416.5pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Jager, M., Herten, M., Fochtmann, U., Fischer, J., Hernigou, P., Zilkens, </span></p>
<p style="top:427.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">C., &#x2026; Krauspe, R. (2011). Bridging the gap: Bone marrow aspira-</span></p>
<p style="top:437.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">tion concentrate reduces autologous bone grafting in osseous de-</span></p>
<p style="top:448.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">fects. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Journal of Orthopaedic Research</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">29</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 173&#x2013;180. https://doi.</span></p>
<p style="top:458.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">org/10.1002/jor.21230</span></p>
<p style="top:469.0pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Janssen, N. G., Weijs, W. L., Koole, R., Rosenberg, A. J., &amp; Meijer, G. J. </span></p>
<p style="top:479.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(2014). Tissue engineering strategies for alveolar cleft reconstruc-</span></p>
<p style="top:490.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">tion: A systematic review of the literature. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Clin Oral Investigations</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">18</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span></p>
<p style="top:500.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">219&#x2013;226. https://doi.org/10.1007/s00784-013-0947-x</span></p>
<p style="top:511.0pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Jayakumar, P., &amp; Di Silvio, L. (2010). Osteoblasts in bone tissue engineer</span><span style="font-family:Lato,serif;font-size:7.5pt">-</span></p>
<p style="top:521.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">ing. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Proceedings of the Institution of Mechanical Engineers. Part H</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">224</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span></p>
<p style="top:532.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">1415&#x2013;1440. https://doi.org/10.1243/09544119JEIM821</span></p>
<p style="top:542.5pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Jin, E., Chae, D. S., Son, M., &amp; Kim, S. W. (2017). Angiogenic char-</span></p>
<p style="top:553.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">acteristics of human stromal vascular fraction in ischemic hind-</span></p>
<p style="top:563.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">limb. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">International Journal of Cardiology</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">234</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 38&#x2013;47. https://doi.</span></p>
<p style="top:574.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">org/10.1016/j.ijcard.2017.02.080</span></p>
<p style="top:584.5pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Kaigler, D., Avila-Ortiz, G., Travan, S., Taut, A. D., Padial-Molina, M., </span></p>
<p style="top:595.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Rudek, I., &#x2026; Giannobile, W. V. (2015). Bone engineering of maxillary </span></p>
<p style="top:605.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">sinus bone deficiencies using enriched CD90 + stem cell therapy: A </span></p>
<p style="top:616.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">randomized clinical trial. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Journal of Bone and Mineral Research</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">30</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span></p>
<p style="top:626.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">1206&#x2013;1216. https://doi.org/10.1002/jbmr.2464</span></p>
<p style="top:637.0pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Kaigler, D., Pagni, G., Park, C. H., Braun, T. M., Holman, L. A., Yi, E., &#x2026; </span></p>
<p style="top:647.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Giannobile, W. V. (2013). Stem cell therapy for craniofacial bone regen</span><span style="font-family:Lato,serif;font-size:7.5pt">-</span></p>
<p style="top:658.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">eration: A randomized, controlled feasibility trial. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Cell Transplantation</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span></p>
<p style="top:668.5pt;left:320.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">22</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 767&#x2013;777. https://doi.org/10.3727/096368912X652968</span></p>
<p style="top:679.0pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Kang, N. H. (2017). Current methods for the treatment of alveolar cleft. </span></p>
<p style="top:689.5pt;left:320.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Archives of Plastic Surgery</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">44</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 188&#x2013;193. https://doi.org/10.5999/</span></p>
<p style="top:700.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">aps.2017.44.3.188</span></p>
<p style="top:710.5pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Katagiri, W., Osugi, M., Kawai, T., &amp; Hibi, H. (2016). First- in- human study </span></p>
<p style="top:721.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">and clinical case reports of the alveolar bone regeneration with the </span></p>
<p style="top:11.6pt;left:578.8pt;line-height:5.1pt"><span style="font-family:Times New Roman,serif;font-size:5.1pt"> 1600051x, 2019, S21, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jcpe.13049 by Universit&#xe4;tsbibliothek Zuerich, Wiley Online Library on [27/12/2022]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</span></p>


<p style="top:23.8pt;left:511.9pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003;&#x2002; &#x2003;</span></b><b><span style="font-family:Lato,serif;font-size:9.1pt">|</span></b><b><span style="font-family:Lato,serif;font-size:7.0pt"> &#x2003;179</span></b></p>
<img style="position:absolute;transform:matrix(.31940789,0,-0,.3187552,395.0849,3.744316)" src="data:image/jpeg;base64,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">
<p style="top:23.9pt;left:44.8pt;line-height:7.0pt"><span style="font-family:Lato-Regular,serif;font-size:7.0pt">SHANBHAG </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">et</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt"> </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">Al</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt">.</span></p>
<p style="top:49.0pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">secretome from human mesenchymal stem cells. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Head and Face </span></i></p>
<p style="top:59.5pt;left:57.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Medicine</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">12</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 5. https://doi.org/10.1186/s13005-016-0101-5</span></p>
<p style="top:70.0pt;left:44.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Katagiri, W., Watanabe, J., Toyama, N., Osugi, M., Sakaguchi, K., &amp; Hibi, </span></p>
<p style="top:80.5pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">H. (2017). Clinical study of bone regeneration by conditioned me-</span></p>
<p style="top:91.0pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">dium from mesenchymal stem cells after maxillary sinus floor ele-</span></p>
<p style="top:101.5pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">vation. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Implant Dentistry</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">26</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 607&#x2013;612. https://doi.org/10.1097/</span></p>
<p style="top:112.0pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">ID.0000000000000618</span></p>
<p style="top:122.5pt;left:44.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Khalifa, M. E., &amp; Gomaa, N. E. (2017). Dental Arch Expansion after </span></p>
<p style="top:133.0pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Alveolar Cleft Repair using Autogenous Bone Marrow Derived </span></p>
<p style="top:143.5pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Mesenchymal Stem Cells Versus Autogenous Chin Bone Graft. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">The </span></i></p>
<p style="top:154.0pt;left:57.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Journal of Dental Treatment Oral Care</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">2</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 103.</span></p>
<p style="top:164.5pt;left:44.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Khalifa, M. E., &amp; Nowair, I. M. (2017). Alveolar cleft repair using autoge</span><span style="font-family:Lato,serif;font-size:7.5pt">-</span></p>
<p style="top:175.0pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">nous bone marrow- derived mesenchymal stem cells. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Egyptian Journal </span></i></p>
<p style="top:185.5pt;left:57.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">of Oral &amp; Maxillofacial Surgery</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">8</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 46&#x2013;51. https://doi.org/10.1097/01.</span></p>
<p style="top:196.0pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">OMX.0000515464.02298.bb</span></p>
<p style="top:206.5pt;left:44.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Khojasteh, A., Kheiri, L., Behnia, H., Tehranchi, A., Nazeman, P., </span></p>
<p style="top:217.0pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Nadjmi, N., &amp; Soleimani, M. (2017). Lateral ramus cortical bone </span></p>
<p style="top:227.5pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">plate in alveolar cleft osteoplasty with concomitant use of buc-</span></p>
<p style="top:238.0pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">cal fat pad derived cells and autogenous bone: Phase I clinical </span></p>
<p style="top:248.5pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">trial. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">BioMed Research International</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">2017</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 6560234. https://doi.</span></p>
<p style="top:259.0pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">org/10.1155/2017/6560234</span></p>
<p style="top:269.5pt;left:44.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Khojasteh, A., &amp; Sadeghi, N. (2016). Application of buccal fat pad- derived </span></p>
<p style="top:280.0pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">stem cells in combination with autogenous iliac bone graft in the </span></p>
<p style="top:290.5pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">treatment of maxillomandibular atrophy: A preliminary human study. </span></p>
<p style="top:301.0pt;left:57.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">International Journal of Oral and Maxillofacial Surgery</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">45</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 864&#x2013;871. </span></p>
<p style="top:311.5pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">https://doi.org/10.1016/j.ijom.2016.01.003</span></p>
<p style="top:322.0pt;left:44.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Klijn, R. J., Meijer, G. J., Bronkhorst, E. M., &amp; Jansen, J. A. (2010). A meta- </span></p>
<p style="top:332.5pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">analysis of histomorphometric results and graft healing time of var-</span></p>
<p style="top:343.0pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">ious biomaterials compared to autologous bone used as sinus floor </span></p>
<p style="top:353.5pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">augmentation material in humans. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Tissue Engineering Part B Reviews</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span></p>
<p style="top:364.0pt;left:57.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">16</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 493&#x2013;507. https://doi.org/10.1089/ten.teb.2010.0035</span></p>
<p style="top:374.5pt;left:44.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Kuhl, S., Payer, M., Kirmeier, R., Wildburger, A., Wegscheider, W., &amp; Jakse, </span></p>
<p style="top:385.0pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">N. (2014). The influence of bone marrow aspirates and concentrates </span></p>
<p style="top:395.5pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">on the early volume stability of maxillary sinus grafts with deprotein-</span></p>
<p style="top:406.0pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">ized bovine bone mineral -  first results of a RCT. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Clinical Oral Implants </span></i></p>
<p style="top:416.5pt;left:57.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Research</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">25</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 221&#x2013;225. https://doi.org/10.1111/clr.12101</span></p>
<p style="top:427.0pt;left:44.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Kulakov, A. A., Goldshtein, D. V., Grigoryan, A. S., Rzhaninova, A. A., </span></p>
<p style="top:437.5pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Alekseeva, I. S., Arutyunyan, I. V., &amp; Volkov, A. V. (2008). Clinical </span></p>
<p style="top:448.0pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">study of the efficiency of combined cell transplant on the basis of </span></p>
<p style="top:458.5pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">multipotent mesenchymal stromal adipose tissue cells in patients </span></p>
<p style="top:469.0pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">with pronounced deficit of the maxillary and mandibulary bone </span></p>
<p style="top:479.5pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">tissue. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Bulletin of Experimental Biology and Medicine</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">146</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 522&#x2013;525. </span></p>
<p style="top:490.0pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">https://doi.org/10.1007/s10517-009-0322-8</span></p>
<p style="top:500.5pt;left:44.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Lavareda Correa, S. C., Elias de Sousa, J., Pasquali, P. J., Scavone de </span></p>
<p style="top:511.0pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Macedo, L. G., Aloise, A. C., Teixeira, M. L., &amp; Pelegrine, A. A. (2017). </span></p>
<p style="top:521.5pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Use of bone allograft with or without bone marrow aspirate con-</span></p>
<p style="top:532.0pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">centrate in appositional reconstructions: A tomographic and histo-</span></p>
<p style="top:542.5pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">morphometric study. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Implant Dentistry</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">26</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 915&#x2013;921. https://doi.</span></p>
<p style="top:553.0pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">org/10.1097/ID.0000000000000669</span></p>
<p style="top:563.5pt;left:44.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Lee, J., Cuddihy, M. J., &amp; Kotov, N. A. (2008). Three- dimensional cell cul-</span></p>
<p style="top:574.0pt;left:57.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">ture matrices: State of the art. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Tissue Engineering Part B Reviews</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">14</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span></p>
<p style="top:584.5pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">61&#x2013;86. https://doi.org/10.1089/teb.2007.0150</span></p>
<p style="top:595.0pt;left:44.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Leyendecker Junior, A., Gomes Pinheiro, C. C., Lazzaretti Fernandes, T., </span></p>
<p style="top:605.5pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&amp; Franco Bueno, D. (2018). The use of human dental pulp stem cells </span></p>
<p style="top:616.0pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">for in vivo bone tissue engineering: A systematic review. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Journal of </span></i></p>
<p style="top:626.5pt;left:57.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Tissue Engineering</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">9</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 2041731417752766.</span></p>
<p style="top:637.0pt;left:44.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Liao, H. T., &amp; Chen, C. T. (2014). Osteogenic potential: Comparison be</span><span style="font-family:Lato,serif;font-size:7.5pt">-</span></p>
<p style="top:647.5pt;left:57.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">tween bone marrow and adipose- derived mesenchymal stem cells. </span></p>
<p style="top:658.0pt;left:57.9pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">World Journal of Stem Cells</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">6</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 288&#x2013;295. https://doi.org/10.4252/</span></p>
<p style="top:668.5pt;left:57.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">wjsc.v6.i3.288</span></p>
<p style="top:679.0pt;left:44.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Liu, H., Slamovich, E. B., &amp; Webster, T. J. (2006). Less harmful acidic </span></p>
<p style="top:689.5pt;left:57.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">degradation of poly(lacticco- glycolic acid) bone tissue engineer-</span></p>
<p style="top:700.0pt;left:57.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">ing scaffolds through titania nanoparticle addition. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">International </span></i></p>
<p style="top:710.5pt;left:57.9pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Journal of Nanomedicine</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">1</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 541&#x2013;545. https://doi.org/10.2147/</span></p>
<p style="top:721.0pt;left:57.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">nano.2006.1.4.541</span></p>
<p style="top:49.0pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Lundgren, S., Andersson, S., Gualini, F., &amp; Sennerby, L. (2004). </span></p>
<p style="top:59.5pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Bone reformation with sinus membrane elevation: A new sur-</span></p>
<p style="top:70.0pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">gical technique for maxillary sinus floor augmentation. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Clinical </span></i></p>
<p style="top:80.5pt;left:318.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Implant Dentistry and Related Research</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">6</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 165&#x2013;173. https://doi.</span></p>
<p style="top:91.0pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">org/10.1111/j.1708-8208.2004.tb00224.x</span></p>
<p style="top:101.5pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">MacBeth, N., Trullenque-Eriksson, A., Donos, N., &amp; Mardas, N. (2017). </span></p>
<p style="top:112.0pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Hard and soft tissue changes following alveolar ridge preservation: </span></p>
<p style="top:122.5pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">A systematic review. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Clinical Oral Implants Research</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">28</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 982&#x2013;1004. </span></p>
<p style="top:133.0pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">https://doi.org/10.1111/clr.12911</span></p>
<p style="top:143.5pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Mangano, C., Piattelli, A., Mangano, A., Mangano, F., Mangano, A., </span></p>
<p style="top:154.0pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Iezzi, G., &#x2026; Shibli, J. A. (2009). Combining scaffolds and osteo</span><span style="font-family:Lato,serif;font-size:7.5pt">-</span></p>
<p style="top:164.5pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">genic cells in regenerative bone surgery: A preliminary histolog-</span></p>
<p style="top:175.0pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">ical report in human maxillary sinus augmentation. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Clinical Implant </span></i></p>
<p style="top:185.5pt;left:318.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Dentistry and Related Research</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">11</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(Suppl 1), e92&#x2013;e102. https://doi.</span></p>
<p style="top:196.0pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">org/10.1111/j.1708-8208.2009.00227.x</span></p>
<p style="top:206.5pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Marx, R. E., Armentano, L., Olavarria, A., &amp; Samaniego, J. (2013). rhB</span><span style="font-family:Lato,serif;font-size:7.5pt">-</span></p>
<p style="top:217.0pt;left:318.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">MP- 2/ACS grafts versus autogenous cancellous marrow grafts </span></p>
<p style="top:227.5pt;left:318.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">in large vertical defects of the maxilla: An unsponsored ran-</span></p>
<p style="top:238.0pt;left:318.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">domized open- label clinical trial. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">International Journal of Oral and </span></i></p>
<p style="top:248.5pt;left:318.9pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Maxillofacial Implants</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">28</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, e243&#x2013;e251. https://doi.org/10.11607/</span></p>
<p style="top:259.0pt;left:318.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">jomi.te04</span></p>
<p style="top:269.5pt;left:305.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Marx, R. E., &amp; Harrell, D. B. (2014). Translational research: The CD34 + </span></p>
<p style="top:280.0pt;left:318.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">cell is crucial for large- volume bone regeneration from the milieu of </span></p>
<p style="top:290.5pt;left:318.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">bone marrow progenitor cells in craniomandibular reconstruction. </span></p>
<p style="top:301.0pt;left:318.9pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">International Journal of Oral and Maxillofacial Implants</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">29</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, e201&#x2013;e209. </span></p>
<p style="top:311.5pt;left:318.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">https://doi.org/10.11607/jomi.te56</span></p>
<p style="top:322.0pt;left:305.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Mason, S., Tarle, S. A., Osibin, W., Kinfu, Y., &amp; Kaigler, D. (2014). </span></p>
<p style="top:332.5pt;left:318.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Standardization and safety of alveolar bone- derived stem cell </span></p>
<p style="top:343.0pt;left:318.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">isolation. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Journal of Dental Research</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">93</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 55&#x2013;61. https://doi.</span></p>
<p style="top:353.5pt;left:318.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">org/10.1177/0022034513510530</span></p>
<p style="top:364.0pt;left:305.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">McAllister, B. S., Haghighat, K., &amp; Gonshor, A. (2009). Histologic </span></p>
<p style="top:374.5pt;left:318.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">evaluation of a stem cell- based sinus- augmentation procedure. </span></p>
<p style="top:385.0pt;left:318.9pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Journal of Periodontology</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">80</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 679&#x2013;686. https://doi.org/10.1902/</span></p>
<p style="top:395.5pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">jop.2009.080345</span></p>
<p style="top:406.0pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Mehta, S., Blagg, R., Willcockson, J., Gociman, B., Yamashiro, D., &amp; </span></p>
<p style="top:416.5pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Siddiqi, F. (2018). Cost- effectiveness analysis of demineralized bone </span></p>
<p style="top:427.0pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">matrix and rhBMP- 2 versus autologous iliac crest bone grafting in al-</span></p>
<p style="top:437.5pt;left:318.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">veolar cleft patients. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Plastic and Reconstructive Surgery</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">142</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 737&#x2013;743. </span></p>
<p style="top:448.0pt;left:318.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">https://doi.org/10.1097/PRS.0000000000004646</span></p>
<p style="top:458.5pt;left:305.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Meijer, G. J., de Bruijn, J. D., Koole, R., &amp; van Blitterswijk, C. A. (2008). </span></p>
<p style="top:469.0pt;left:318.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Cell based bone tissue engineering in jaw defects. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Biomaterials</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">29</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span></p>
<p style="top:479.5pt;left:318.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">3053&#x2013;3061. https://doi.org/10.1016/j.biomaterials.2008.03.012</span></p>
<p style="top:490.0pt;left:305.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Miguita, L., Mantesso, A., Pannuti, C. M., &amp; Deboni, M. C. Z. (2017). Can </span></p>
<p style="top:500.5pt;left:318.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">stem cells enhance bone formation in the human edentulous alveolar </span></p>
<p style="top:511.0pt;left:318.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">ridge? A systematic review and meta- analysis. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Cell and Tissue Banking</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span></p>
<p style="top:521.5pt;left:318.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">18</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 217&#x2013;228. https://doi.org/10.1007/s10561-017-9612-y</span></p>
<p style="top:532.0pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Milinkovic, I., &amp; Cordaro, L. (2014). Are there specific indications for </span></p>
<p style="top:542.5pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">the different alveolar bone augmentation procedures for im-</span></p>
<p style="top:553.0pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">plant placement? A systematic review. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">International Journal of Oral </span></i></p>
<p style="top:563.5pt;left:318.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">and Maxillofacial Surgery</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">43</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 606&#x2013;625. https://doi.org/10.1016/j.</span></p>
<p style="top:574.0pt;left:318.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">ijom.2013.12.004</span></p>
<p style="top:584.5pt;left:305.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Moher, D., Liberati, A., Tetzlaff, J., &amp; Altman, D. G.; PRISMA Group. </span></p>
<p style="top:595.0pt;left:318.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(2009). Preferred reporting items for systematic reviews and meta- </span></p>
<p style="top:605.5pt;left:318.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">analyses: The PRISMA statement. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">BMJ</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> </span><i><span style="font-family:Lato,serif;font-size:7.5pt">339</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, b2535. https://doi.</span></p>
<p style="top:616.0pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">org/10.1136/bmj.b2535</span></p>
<p style="top:626.5pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Mohty, M., Richardson, P. G., McCarthy, P. L., &amp; Attal, M. (2015). </span></p>
<p style="top:637.0pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Consolidation and maintenance therapy for multiple myeloma </span></p>
<p style="top:647.5pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">after autologous transplantation: Where do we stand? </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Bone </span></i></p>
<p style="top:658.0pt;left:318.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Marrow Transplantation</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">50</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 1024&#x2013;1029. https://doi.org/10.1038/</span></p>
<p style="top:668.5pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">bmt.2015.83</span></p>
<p style="top:679.0pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Monti, M., Graziano, A., Rizzo, S., Perotti, C., Del Fante, C., d&#x2018;Aquino, R., &amp; </span></p>
<p style="top:689.5pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Redi, C. A. (2017). Rodriguez Y Baena R. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">J Cell Physiol.</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">232</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 548&#x2013;555.</span></p>
<p style="top:700.0pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Muschler, G. F., Raut, V. P., Patterson, T. E., Wenke, J. C., &amp; Hollinger, J. </span></p>
<p style="top:710.5pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">O. (2010). The design and use of animal models for translational re</span><span style="font-family:Lato,serif;font-size:7.5pt">-</span></p>
<p style="top:721.0pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">search in bone tissue engineering and regenerative medicine. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Tissue </span></i></p>
<p style="top:11.6pt;left:578.8pt;line-height:5.1pt"><span style="font-family:Times New Roman,serif;font-size:5.1pt"> 1600051x, 2019, S21, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jcpe.13049 by Universit&#xe4;tsbibliothek Zuerich, Wiley Online Library on [27/12/2022]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</span></p>


<p style="top:23.8pt;left:46.5pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">180&#x2003; </span></b><b><span style="font-family:Lato,serif;font-size:9.1pt">|</span></b><b><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003; &#x2003;&#x2002;</span></b></p>
<img style="position:absolute;transform:matrix(.31940789,0,-0,.3187552,54.97612,3.7443963)" src="data:image/jpeg;base64,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">
<p style="top:23.8pt;left:493.4pt;line-height:7.0pt"><span style="font-family:Lato-Regular,serif;font-size:7.0pt">SHANBHAG </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">et</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt"> </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">Al</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt">.</span></p>
<p style="top:49.0pt;left:59.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Engineering Part B Reviews</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">16</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 123&#x2013;145. https://doi.org/10.1089/ten.</span></p>
<p style="top:59.5pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">teb.2009.0658</span></p>
<p style="top:70.0pt;left:46.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Nagata, M., Hoshina, H., Li, M., Arasawa, M., Uematsu, K., Ogawa, S., &#x2026; </span></p>
<p style="top:80.5pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Takagi, R. (2012). A clinical study of alveolar bone tissue engineering </span></p>
<p style="top:91.0pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">with cultured autogenous periosteal cells: Coordinated activation of </span></p>
<p style="top:101.5pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">bone formation and resorption. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Bone</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">50</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 1123&#x2013;1129. https://doi.</span></p>
<p style="top:112.0pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">org/10.1016/j.bone.2012.02.631</span></p>
<p style="top:122.5pt;left:46.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Nakajima, K., Kunimatsu, R., Ando, K., Ando, T., Hayashi, Y., Kihara, T., </span></p>
<p style="top:133.0pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2026; Tanimoto, K. (2018). Comparison of the bone regeneration ability </span></p>
<p style="top:143.5pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">between stem cells from human exfoliated deciduous teeth, human </span></p>
<p style="top:154.0pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">dental pulp stem cells and human bone marrow mesenchymal stem </span></p>
<p style="top:164.5pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">cells. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Biochemical and Biophysical Research Communications</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">497</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 876&#x2013;</span></p>
<p style="top:175.0pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">882. https://doi.org/10.1016/j.bbrc.2018.02.156</span></p>
<p style="top:185.5pt;left:46.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Nancarrow-Lei, R., Mafi, P., Mafi, R., &amp; Khan, W. (2017). A systemic re-</span></p>
<p style="top:196.0pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">view of adult mesenchymal stem cell sources and their multilineage </span></p>
<p style="top:206.5pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">differentiation potential relevant to musculoskeletal tissue repair </span></p>
<p style="top:217.0pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">and regeneration. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Current Stem Cell Research &amp; Therapy</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">12</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 601&#x2013;610. </span></p>
<p style="top:227.5pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">https://doi.org/10.2174/1574888x12666170608124303</span></p>
<p style="top:238.0pt;left:46.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Nkenke, E., &amp; Neukam, F. W. (2014). Autogenous bone harvesting and </span></p>
<p style="top:248.5pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">grafting in advanced jaw resorption: Morbidity, resorption and im-</span></p>
<p style="top:259.0pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">plant survival. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">European Journal of Oral Implantology</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">7</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(Suppl 2), </span></p>
<p style="top:269.5pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">S203&#x2013;S217.</span></p>
<p style="top:280.0pt;left:46.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Ogawa, S., Hoshina, H., Nakata, K., Yamada, K., Uematsu, K., Kawase, </span></p>
<p style="top:290.5pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">T., &#x2026; Nagata, M. (2016). High- resolution three- dimensional com-</span></p>
<p style="top:301.0pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">puted tomography analysis of the clinical efficacy of cultured au-</span></p>
<p style="top:311.5pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">togenous periosteal cells in sinus lift bone grafting. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Clinical Implant </span></i></p>
<p style="top:322.0pt;left:59.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Dentistry and Related Research</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">18</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 707&#x2013;716. https://doi.org/10.1111/</span></p>
<p style="top:332.5pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">cid.12356</span></p>
<p style="top:343.0pt;left:46.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Olbrich, M., Rieger, M., Reinert, S., &amp; Alexander, D. (2012). Isolation of </span></p>
<p style="top:353.5pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">osteoprogenitors from human jaw periosteal cells: A comparison of </span></p>
<p style="top:364.0pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">two magnetic separation methods. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">PLoS ONE</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">7</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, e47176. https://doi.</span></p>
<p style="top:374.5pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">org/10.1371/journal.pone.0047176</span></p>
<p style="top:385.0pt;left:46.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Oppenheimer, A. J., Mesa, J., &amp; Buchman, S. R. (2012). Current and </span></p>
<p style="top:395.5pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">emerging basic science concepts in bone biology: Implications in </span></p>
<p style="top:406.0pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">craniofacial surgery. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">The Journal of Craniofacial Surgery</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">23</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 30&#x2013;36. </span></p>
<p style="top:416.5pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">https://doi.org/10.1097/SCS.0b013e318240c6d9</span></p>
<p style="top:427.0pt;left:46.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Oryan, A., Kamali, A., Moshiri, A., &amp; Baghaban Eslaminejad, M. (2017). </span></p>
<p style="top:437.5pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Role of mesenchymal stem cells in bone regenerative medicine: </span></p>
<p style="top:448.0pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">What is the evidence? </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Cells Tissues Organs</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">204</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 59&#x2013;83. https://doi.</span></p>
<p style="top:458.5pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">org/10.1159/000469704</span></p>
<p style="top:469.0pt;left:46.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Padial-Molina, M., O&apos;Valle, F., Lanis, A., Mesa, F., Dohan Ehrenfest, D. </span></p>
<p style="top:479.5pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">M., Wang, H. L., &amp; Galindo-Moreno, P. (2015). Clinical application of </span></p>
<p style="top:490.0pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">mesenchymal stem cells and novel supportive therapies for oral bone </span></p>
<p style="top:500.5pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">regeneration. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">BioMed Research International</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">2015</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 341327. https://</span></p>
<p style="top:511.0pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">doi.org/10.1155/2015/341327</span></p>
<p style="top:521.5pt;left:46.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Pasquali, P. J., Teixeira, M. L., de Oliveira, T. A., de Macedo, L. G., Aloise, </span></p>
<p style="top:532.0pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">A. C., &amp; Pelegrine, A. A. (2015). Maxillary sinus augmentation com-</span></p>
<p style="top:542.5pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">bining bio- oss with the bone marrow aspirate concentrate: A histo-</span></p>
<p style="top:553.0pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">morphometric study in humans. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">International Journal of Biomaterials</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span></p>
<p style="top:563.5pt;left:59.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">2015</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 121286. https://doi.org/10.1155/2015/121286</span></p>
<p style="top:574.0pt;left:46.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Patterson, T. E., Boehm, C., Nakamoto, C., Rozic, R., Walker, E., Piuzzi, </span></p>
<p style="top:584.5pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">N. S., &amp; Muschler, G. F. (2017). The efficiency of bone marrow as-</span></p>
<p style="top:595.0pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">piration for the harvest of connective tissue progenitors from the </span></p>
<p style="top:605.5pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">human iliac crest. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Journal of Bone and Joint Surgery. American Volume</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span></p>
<p style="top:616.0pt;left:59.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">99</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 1673&#x2013;1682. https://doi.org/10.2106/JBJS.17.00094</span></p>
<p style="top:626.5pt;left:46.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Payer, M., Lohberger, B., Strunk, D., Reich, K. M., Acham, S., &amp; Jakse, </span></p>
<p style="top:637.0pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">N. (2014). Effects of directly autotransplanted tibial bone marrow </span></p>
<p style="top:647.5pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">aspirates on bone regeneration and osseointegration of dental im-</span></p>
<p style="top:658.0pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">plants. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Clinical Oral Implants Research</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">25</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 468&#x2013;474. https://doi.</span></p>
<p style="top:668.5pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">org/10.1111/clr.12172</span></p>
<p style="top:679.0pt;left:46.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Pelegrine, A. A., da Costa, C. E., Correa, M. E., &amp; Marques, J. F. </span></p>
<p style="top:689.5pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Jr (2010). Clinical and histomorphometric evaluation of ex-</span></p>
<p style="top:700.0pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">traction sockets treated with an autologous bone marrow </span></p>
<p style="top:710.5pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">graft. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Clinical Oral Implants Research</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">21</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 535&#x2013;542. https://doi.</span></p>
<p style="top:721.0pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">org/10.1111/j.1600-0501.2009.01891.x</span></p>
<p style="top:49.0pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Pelegrine, A. A., Teixeira, M. L., Sperandio, M., Almada, T. S., Kahnberg, </span></p>
<p style="top:59.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">K. E., Pasquali, P. J., &amp; Aloise, A. C. (2016). Can bone marrow aspirate </span></p>
<p style="top:70.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">concentrate change the mineralization pattern of the anterior maxilla </span></p>
<p style="top:80.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">treated with xenografts? A preliminary study. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Contemporary Clinical </span></i></p>
<p style="top:91.0pt;left:320.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Dentistry</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">7</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 21&#x2013;26. https://doi.org/10.4103/0976-237X.177112</span></p>
<p style="top:101.5pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Petite, H., Viateau, V., Bensa&#xef;d, W., Meunier, A., de Pollak, C., Bourguignon, </span></p>
<p style="top:112.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">M., &#x2026; Guillemin, G. (2000). Tissue- engineered bone regeneration. </span></p>
<p style="top:122.5pt;left:320.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Nature Biotechnology</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">18</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 959&#x2013;963. https://doi.org/10.1038/79449</span></p>
<p style="top:133.0pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Petrovic, L., Schlegel, A. K., Schultze-Mosgau, S., &amp; Wiltfang, J. (2006). </span></p>
<p style="top:143.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Different substitute biomaterials as potential scaffolds in tissue en-</span></p>
<p style="top:154.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">gineering. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">International Journal of Oral and Maxillofacial Implants</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">21</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span></p>
<p style="top:164.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">225&#x2013;231.</span></p>
<p style="top:175.0pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Pettersson, L. F., Kingham, P. J., Wiberg, M., &amp; Kelk, P. (2017). In vitro os</span><span style="font-family:Lato,serif;font-size:7.5pt">-</span></p>
<p style="top:185.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">teogenic differentiation of human mesenchymal stem cells from jaw-</span></p>
<p style="top:196.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">bone compared with dental tissue. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Tissue Engineering and Regenerative </span></i></p>
<p style="top:206.5pt;left:320.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Medicine</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">14</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 763&#x2013;774. https://doi.org/10.1007/s13770-017-0071-0</span></p>
<p style="top:217.0pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Pinheiro, C. C. G., de Pinho, M. C., Aranha, A. C., Fregnani, E., &amp; Bueno, </span></p>
<p style="top:227.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">D. F. (2018). Low power laser therapy: A strategy to promote the </span></p>
<p style="top:238.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">osteogenic differentiation of deciduous dental pulp stem cells from </span></p>
<p style="top:248.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">cleft lip and palate patients. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Tissue Engineering Part A</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">24</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 569&#x2013;575. </span></p>
<p style="top:259.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">https://doi.org/10.1089/ten.tea.2017.0115</span></p>
<p style="top:269.5pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Pradel, W., Eckelt, U., &amp; Lauer, G. (2006). Bone regeneration after enucle-</span></p>
<p style="top:280.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">ation of mandibular cysts: Comparing autogenous grafts from tissue- </span></p>
<p style="top:290.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">engineered bone and iliac bone. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Oral Surgery, Oral Medicine, Oral </span></i></p>
<p style="top:301.0pt;left:320.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Pathology, Oral Radiology and Endodontics</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">101</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 285&#x2013;290. https://doi.</span></p>
<p style="top:311.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">org/10.1016/j.tripleo.2005.06.001</span></p>
<p style="top:322.0pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Pradel, W., &amp; Lauer, G. (2012). Tissue- engineered bone grafts for osteo-</span></p>
<p style="top:332.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">plasty in patients with cleft alveolus. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Annual of Anatomy</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">194</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 545&#x2013;</span></p>
<p style="top:343.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">548. https://doi.org/10.1016/j.aanat.2012.06.002</span></p>
<p style="top:353.5pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Pradel, W., Mai, R., Manolo Hagedorn, G., Lauer, G., &amp; Allegrini, S. Jr </span></p>
<p style="top:364.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(2008). The biomaterial influences the ossification after sinus floor </span></p>
<p style="top:374.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">elevation using tissue- engineered bone grafts. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Biomedizinische </span></i></p>
<p style="top:385.0pt;left:320.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Technik/Biomedical </span></i></p>
<p style="top:385.0pt;left:394.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Engineering</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span></p>
<p style="top:385.0pt;left:446.1pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">53</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span></p>
<p style="top:385.0pt;left:468.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">224&#x2013;228. </span></p>
<p style="top:385.0pt;left:512.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">https://doi.</span></p>
<p style="top:395.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">org/10.1515/BMT.2008.034</span></p>
<p style="top:406.0pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Prins, H. J., Schulten, E. A., Ten Bruggenkate, C. M., Klein-Nulend, J., &amp; </span></p>
<p style="top:416.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Helder, M. N. (2016). Bone regeneration using the freshly isolated au-</span></p>
<p style="top:427.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">tologous stromal vascular fraction of adipose tissue in combination </span></p>
<p style="top:437.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">with calcium phosphate ceramics. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Stem Cells Translational Medicine</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">5</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span></p>
<p style="top:448.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">1362&#x2013;1374. https://doi.org/10.5966/sctm.2015-0369</span></p>
<p style="top:458.5pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Qadan, M. A., Piuzzi, N. S., Boehm, C., Bova, W., Moos, M. Jr, Midura, R. J., </span></p>
<p style="top:469.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2026; Muschler, G. F. (2018). Variation in primary and culture- expanded </span></p>
<p style="top:479.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">cells derived from connective tissue progenitors in human bone mar-</span></p>
<p style="top:490.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">row space, bone trabecular surface and adipose tissue. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Cytotherapy</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span></p>
<p style="top:500.5pt;left:320.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">20</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 343&#x2013;360. https://doi.org/10.1016/j.jcyt.2017.11.013</span></p>
<p style="top:511.0pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Raposio, E., &amp; Ciliberti, R. (2017). Clinical use of adipose- derived stem </span></p>
<p style="top:521.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">cells: European legislative issues. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Annals of Medicine and Surgery </span></i></p>
<p style="top:532.0pt;left:320.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">(London)</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">24</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 61&#x2013;64. https://doi.org/10.1016/j.amsu.2017.11.002</span></p>
<p style="top:542.5pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Riben, C., &amp; Thor, A. (2016). Follow- up of the sinus membrane elevation </span></p>
<p style="top:553.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">technique for maxillary sinus implants without the use of graft ma-</span></p>
<p style="top:563.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">terial. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Clinical Implant Dentistry and Related Research</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">18</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 895&#x2013;905. </span></p>
<p style="top:574.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">https://doi.org/10.1111/cid.12360</span></p>
<p style="top:584.5pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Rickert, D., Sauerbier, S., Nagursky, H., Menne, D., Vissink, A., &amp; Raghoebar, </span></p>
<p style="top:595.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">G. M. (2011). Maxillary sinus floor elevation with bovine bone mineral </span></p>
<p style="top:605.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">combined with either autogenous bone or autogenous stem cells: A </span></p>
<p style="top:616.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">prospective randomized clinical trial. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Clinical Oral Implants Research</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span></p>
<p style="top:626.5pt;left:320.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">22</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 251&#x2013;258. https://doi.org/10.1111/j.1600-0501.2010.01981.x</span></p>
<p style="top:637.0pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Rickert, D., Vissink, A., Slot, W. J., Sauerbier, S., Meijer, H. J., &amp; Raghoebar, </span></p>
<p style="top:647.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">G. M. (2014). Maxillary sinus floor elevation surgery with BioOss(R) </span></p>
<p style="top:658.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">mixed with a bone marrow concentrate or autogenous bone: Test of </span></p>
<p style="top:668.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">principle on implant survival and clinical performance. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">International </span></i></p>
<p style="top:679.0pt;left:320.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Journal of Oral and Maxillofacial Surgery</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">43</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 243&#x2013;247. https://doi.</span></p>
<p style="top:689.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">org/10.1016/j.ijom.2013.09.006</span></p>
<p style="top:700.0pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Rocchietta, I., Ferrantino, L., &amp; Simion, M. (2018). Vertical ridge aug</span><span style="font-family:Lato,serif;font-size:7.5pt">-</span></p>
<p style="top:710.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">mentation in the esthetic zone. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Periodontology 2000</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">77</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 241&#x2013;255. </span></p>
<p style="top:721.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">https://doi.org/10.1111/prd.12218</span></p>
<p style="top:11.6pt;left:578.8pt;line-height:5.1pt"><span style="font-family:Times New Roman,serif;font-size:5.1pt"> 1600051x, 2019, S21, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jcpe.13049 by Universit&#xe4;tsbibliothek Zuerich, Wiley Online Library on [27/12/2022]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</span></p>


<p style="top:23.8pt;left:511.9pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003;&#x2002; &#x2003;</span></b><b><span style="font-family:Lato,serif;font-size:9.1pt">|</span></b><b><span style="font-family:Lato,serif;font-size:7.0pt"> &#x2003;181</span></b></p>
<img style="position:absolute;transform:matrix(.31940789,0,-0,.3187552,395.0849,3.744316)" src="data:image/jpeg;base64,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">
<p style="top:23.9pt;left:44.8pt;line-height:7.0pt"><span style="font-family:Lato-Regular,serif;font-size:7.0pt">SHANBHAG </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">et</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt"> </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">Al</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt">.</span></p>
<p style="top:49.0pt;left:44.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Rodriguez, Y. B. R., D&apos;Aquino, R., Graziano, A., Trovato, L., Aloise, A. C., </span></p>
<p style="top:59.5pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Ceccarelli, G., &#x2026; Lupi, S. M. (2017). Autologous periosteum- derived </span></p>
<p style="top:70.0pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">micrografts and PLGA/HA enhance the bone formation in sinus </span></p>
<p style="top:80.5pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">lift augmentation. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Frontiers in Cell and Developmental Biology</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">5</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 87. </span></p>
<p style="top:91.0pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">https://doi.org/10.3389/fcell.2017.00087</span></p>
<p style="top:101.5pt;left:44.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Salehi-Nik, N., &amp; Rezai Rad, M. (2017). Buccal fat pad as a poten-</span></p>
<p style="top:112.0pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">tial source of stem cells for bone regeneration: A literature </span></p>
<p style="top:122.5pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">review. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Stem Cell International</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">2017</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 8354640. https://doi.</span></p>
<p style="top:133.0pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">org/10.1155/2017/8354640</span></p>
<p style="top:143.5pt;left:44.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Sandor, G. K., Numminen, J., Wolff, J., Thesleff, T., Miettinen, A., </span></p>
<p style="top:154.0pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Tuovinen, V. J., &#x2026; Ohman, J. (2014). Adipose stem cells used to recon</span><span style="font-family:Lato,serif;font-size:7.5pt">-</span></p>
<p style="top:164.5pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">struct 13 cases with cranio- maxillofacial hard- tissue defects. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Stem </span></i></p>
<p style="top:175.0pt;left:57.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Cells Translational Medicine</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">3</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 530&#x2013;540. https://doi.org/10.5966/</span></p>
<p style="top:185.5pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">sctm.2013-0173</span></p>
<p style="top:196.0pt;left:44.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Sanz-S&#xe1;nchez, I., Ortiz-Vig&#xf3;n, A., Sanz-Mart&#xed;n, I., Figuero, E., &amp; Sanz, </span></p>
<p style="top:206.5pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">M. (2015). Effectiveness of lateral bone augmentation on the al-</span></p>
<p style="top:217.0pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">veolar crest dimension: A systematic review and meta- analysis. </span></p>
<p style="top:227.5pt;left:57.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Journal of Dental Research</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">94</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(9 Suppl), 128S&#x2013;142S. https://doi.</span></p>
<p style="top:238.0pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">org/10.1177/0022034515594780</span></p>
<p style="top:248.5pt;left:44.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Sauerbier, S., Rickert, D., Gutwald, R., Nagursky, H., Oshima, T., Xavier, S. P., </span></p>
<p style="top:259.0pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2026; Koch, F. P. (2011). Bone marrow concentrate and bovine bone mineral </span></p>
<p style="top:269.5pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">for sinus floor augmentation: A controlled, randomized, single- blinded </span></p>
<p style="top:280.0pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">clinical and histological trial&#x2013;per- protocol analysis. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Tissue Engineering </span></i></p>
<p style="top:290.5pt;left:57.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Part A</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">17</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 2187&#x2013;2197. https://doi.org/10.1089/ten.tea.2010.0516</span></p>
<p style="top:301.0pt;left:44.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Sauerbier, S., Stricker, A., Kuschnierz, J., Buhler, F., Oshima, T., Xavier, </span></p>
<p style="top:311.5pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">S. P., &#x2026; Gutwald, R. (2010). In vivo comparison of hard tissue regen</span><span style="font-family:Lato,serif;font-size:7.5pt">-</span></p>
<p style="top:322.0pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">eration with human mesenchymal stem cells processed with either </span></p>
<p style="top:332.5pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">the FICOLL method or the BMAC method. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Tissue Engineering Part C </span></i></p>
<p style="top:343.0pt;left:57.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Methods</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">16</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 215&#x2013;223. https://doi.org/10.1089/ten.tec.2009.0269</span></p>
<p style="top:353.5pt;left:44.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Saxer, F., Scherberich, A., Todorov, A., Studer, P., Miot, S., Schreiner, S., &#x2026; </span></p>
<p style="top:364.0pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Jakob, M. (2016). Implantation of stromal vascular fraction progeni</span><span style="font-family:Lato,serif;font-size:7.5pt">-</span></p>
<p style="top:374.5pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">tors at bone fracture sites: From a rat model to a first- in- man study. </span></p>
<p style="top:385.0pt;left:57.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Stem Cells</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">34</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 2956&#x2013;2966. https://doi.org/10.1002/stem.2478</span></p>
<p style="top:395.5pt;left:44.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Scherberich, A., Muller, A. M., Schafer, D. J., Banfi, A., &amp; Martin, I. (2010). </span></p>
<p style="top:406.0pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Adipose tissue- derived progenitors for engineering osteogenic and </span></p>
<p style="top:416.5pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">vasculogenic grafts. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Journal of Cellular Physiology</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">225</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 348&#x2013;353. </span></p>
<p style="top:427.0pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">https://doi.org/10.1002/jcp.22313</span></p>
<p style="top:437.5pt;left:44.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Schimming, R., &amp; Schmelzeisen, R. (2004). Tissue- engineered bone </span></p>
<p style="top:448.0pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">for maxillary sinus augmentation. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Journal of Oral and Maxillofacial </span></i></p>
<p style="top:458.5pt;left:57.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Surgery</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">62</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 724&#x2013;729. https://doi.org/10.1016/j.joms.2004.01.009</span></p>
<p style="top:469.0pt;left:44.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Schliephake, H. (2015). Clinical efficacy of growth factors to enhance </span></p>
<p style="top:479.5pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">tissue repair in oral and maxillofacial reconstruction: A systematic </span></p>
<p style="top:490.0pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">review. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Clinical Implant Dentistry and Related Research</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">17</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 247&#x2013;273. </span></p>
<p style="top:500.5pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">https://doi.org/10.1111/cid.12114</span></p>
<p style="top:511.0pt;left:44.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Shanbhag, S., Pandis, N., Mustafa, K., Nyengaard, J. R., &amp; Stavropoulos, </span></p>
<p style="top:521.5pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">A. (2016). Alveolar bone tissue engineering in critical- size defects of </span></p>
<p style="top:532.0pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">experimental animal models: A systematic review and meta- analysis. </span></p>
<p style="top:542.5pt;left:57.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Journal of Tissue Engineering and Regenerative Medicine</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">11</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 2935&#x2013;</span></p>
<p style="top:553.0pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">2949. https://doi.org/10.1002/term.2198</span></p>
<p style="top:563.5pt;left:44.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Shanbhag, S., Pandis, N., Mustafa, K., Nyengaard, J. R., &amp; Stavropoulos, </span></p>
<p style="top:574.0pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">A. (2018). Bone tissue engineering in oral peri- implant defects in </span></p>
<p style="top:584.5pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">preclinical in vivo research: A systematic review and meta- analysis. </span></p>
<p style="top:595.0pt;left:57.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">J Tissue Eng Regen Med</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">12</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, e336&#x2013;e349. https://doi.org/10.1002/</span></p>
<p style="top:605.5pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">term.2412</span></p>
<p style="top:616.0pt;left:44.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Shanbhag, S., Shanbhag, V., &amp; Stavropoulos, A. (2014). Volume changes </span></p>
<p style="top:626.5pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">of maxillary sinus augmentations over time: A systematic review. </span></p>
<p style="top:637.0pt;left:57.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">International Journal of Oral and Maxillofacial Implants</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">29</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 881&#x2013;892. </span></p>
<p style="top:647.5pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">https://doi.org/10.11607/jomi.3472</span></p>
<p style="top:658.0pt;left:44.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Shanbhag, S., Stavropoulos, A., Suliman, S., Hervig, T., &amp; Mustafa, K. </span></p>
<p style="top:668.5pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(2017). Efficacy of humanized mesenchymal stem cell cultures for </span></p>
<p style="top:679.0pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">bone tissue engineering: A systematic review with a focus on platelet </span></p>
<p style="top:689.5pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">derivatives. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Tissue Engineering Part B Reviews</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">23</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 552&#x2013;569. https://</span></p>
<p style="top:700.0pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">doi.org/10.1089/ten.teb.2017.0093</span></p>
<p style="top:710.5pt;left:44.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Shayesteh, Y. S., Khojasteh, A., Soleimani, M., Alikhasi, M., Khoshzaban, A., &amp; </span></p>
<p style="top:721.0pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Ahmadbeigi, N. (2008). Sinus augmentation using human mesenchymal </span></p>
<p style="top:49.0pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">stem cells loaded into a beta- tricalcium phosphate/hydroxyapatite </span></p>
<p style="top:59.5pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">scaffold. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and </span></i></p>
<p style="top:70.0pt;left:318.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Endodontics</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">106</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 203&#x2013;209. https://doi.org/10.1016/j.tripleo.2007.12.001</span></p>
<p style="top:80.5pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Shiraishi, T., Sumita, Y., Wakamastu, Y., Nagai, K., &amp; Asahina, I. (2012). </span></p>
<p style="top:91.0pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Formation of engineered bone with adipose stromal cells from </span></p>
<p style="top:101.5pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">buccal fat pad. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Journal of Dental Research</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">91</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 592&#x2013;597. https://doi.</span></p>
<p style="top:112.0pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">org/10.1177/0022034512445633</span></p>
<p style="top:122.5pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Skovrlj, B., Guzman, J. Z., Al Maaieh, M., Cho, S. K., Iatridis, J. C., &amp; Qureshi, </span></p>
<p style="top:133.0pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">S. A. (2014). Cellular bone matrices: Viable stem cell- containing </span></p>
<p style="top:143.5pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">bone graft substitutes. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Spine Journal</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">14</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 2763&#x2013;2772. https://doi.</span></p>
<p style="top:154.0pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">org/10.1016/j.spinee.2014.05.024</span></p>
<p style="top:164.5pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Soliman, H. A., Ismail, H. E. A., Shouman, O. O., Bahaaeldin, A. M., &amp; El-</span></p>
<p style="top:175.0pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Hadidy, M. R. (2018). Stem cells assisted cancellous bone graft versus </span></p>
<p style="top:185.5pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">stem cells with demineralized bone matrix for alveolar cleft recon-</span></p>
<p style="top:196.0pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">struction. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Egypt Journal of Plastic Reconstructive Surgery</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">42</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 93&#x2013;101.</span></p>
<p style="top:206.5pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Springer, I. N., Nocini, P. F., Schlegel, K. A., De Santis, D., Park, J., Warnke, </span></p>
<p style="top:217.0pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">P. H., &#x2026; Wiltfang, J. (2006). Two techniques for the preparation of </span></p>
<p style="top:227.5pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">cell- scaffold constructs suitable for sinus augmentation: Steps into </span></p>
<p style="top:238.0pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">clinical application. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Tissue Engineering</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">12</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 2649&#x2013;2656. https://doi.</span></p>
<p style="top:248.5pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">org/10.1089/ten.2006.12.2649</span></p>
<p style="top:259.0pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Sununliganon, L. (2013). Stem cell approach for maxillary sinus grafting in </span></p>
<p style="top:269.5pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">atrophic maxilla. (Thesis). University of Hong Kong, Pokfulam, Hong </span></p>
<p style="top:280.0pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Kong SAR. Retrieved from https://doi.org/10.5353/th_b5089951</span></p>
<p style="top:290.5pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Talaat, W. M., Ghoneim, M. M., Salah, O., &amp; Adly, O. A. (2018). Autologous </span></p>
<p style="top:301.0pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">bone marrow concentrates and concentrated growth factors accel-</span></p>
<p style="top:311.5pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">erate bone regeneration after enucleation of mandibular pathologic </span></p>
<p style="top:322.0pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">lesions. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">The Journal of Craniofacial Surgery</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">29</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 992&#x2013;997. https://doi.</span></p>
<p style="top:332.5pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">org/10.1097/SCS.0000000000004371</span></p>
<p style="top:343.0pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Thesleff, T., Lehtimaki, K., Niskakangas, T., Huovinen, S., Mannerstrom, </span></p>
<p style="top:353.5pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">B., Miettinen, S., &#x2026; Ohman, J. (2017). Cranioplasty with Adipose- </span></p>
<p style="top:364.0pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">derived stem cells, beta- tricalcium phosphate granules and support-</span></p>
<p style="top:374.5pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">ing mesh: Six- year clinical follow- up results. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Stem Cells Translational </span></i></p>
<p style="top:385.0pt;left:318.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Medicine</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">6</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 1576&#x2013;1582. https://doi.org/10.1002/sctm.16-0410</span></p>
<p style="top:395.5pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Thesleff, T., Lehtimaki, K., Niskakangas, T., Mannerstrom, B., Miettinen, </span></p>
<p style="top:406.0pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">S., Suuronen, R., &amp; Ohman, J. (2011). Cranioplasty with adipose- </span></p>
<p style="top:416.5pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">derived stem cells and biomaterial: A novel method for cranial recon-</span></p>
<p style="top:427.0pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">struction. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Neurosurgery</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">68</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 1535&#x2013;1540. https://doi.org/10.1227/</span></p>
<p style="top:437.5pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">NEU.0b013e31820ee24e</span></p>
<p style="top:448.0pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Trautvetter, W., Kaps, C., Schmelzeisen, R., Sauerbier, S., &amp; Sittinger, </span></p>
<p style="top:458.5pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">M. (2011). Tissue- engineered polymer- based periosteal bone </span></p>
<p style="top:469.0pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">grafts for maxillary sinus augmentation: Five- year clinical results. </span></p>
<p style="top:479.5pt;left:318.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Journal of Oral and Maxillofacial Surgery</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">69</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 2753&#x2013;2762. https://doi.</span></p>
<p style="top:490.0pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">org/10.1016/j.joms.2011.02.096</span></p>
<p style="top:500.5pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Trovato, L., Monti, M., Del Fante, C., Cervio, M., Lampinen, M., Ambrosio, </span></p>
<p style="top:511.0pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">L., &#x2026; Graziano, A. (2015). A new medical device rigeneracons al-</span></p>
<p style="top:521.5pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">lows to obtain viable micro- grafts from mechanical disaggregation </span></p>
<p style="top:532.0pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">of human tissues. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Journal of Cellular Physiology</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">230</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 2299&#x2013;2303. </span></p>
<p style="top:542.5pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">https://doi.org/10.1002/jcp.24973</span></p>
<p style="top:553.0pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Ueda, M., Yamada, Y., Kagami, H., &amp; Hibi, H. (2008). Injectable bone ap</span><span style="font-family:Lato,serif;font-size:7.5pt">-</span></p>
<p style="top:563.5pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">plied for ridge augmentation and dental implant placement: Human </span></p>
<p style="top:574.0pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">progress study. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Implant Dentistry</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">17</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 82&#x2013;90. https://doi.org/10.1097/</span></p>
<p style="top:584.5pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">ID.0b013e31815cd591</span></p>
<p style="top:595.0pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Ueda, M., Yamada, Y., Ozawa, R., &amp; Okazaki, Y. (2005). Clinical case re</span><span style="font-family:Lato,serif;font-size:7.5pt">-</span></p>
<p style="top:605.5pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">ports of injectable tissue- engineered bone for alveolar augmenta-</span></p>
<p style="top:616.0pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">tion with simultaneous implant placement. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">The International Journal </span></i></p>
<p style="top:626.5pt;left:318.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">of Periodontics and Restorative Dentistry</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">25</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 129&#x2013;137.</span></p>
<p style="top:637.0pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Vidal, B., Pinto, A., Galv&#xe3;o, M. J., Santos, A. R., Rodrigues, A., Casc&#xe3;o, R., </span></p>
<p style="top:647.5pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">et al. (2012). Bone histomorphometry revisited. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Acta Reumatol&#xf3;gica </span></i></p>
<p style="top:658.0pt;left:318.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Portuguesa</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">37</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 294&#x2013;300.</span></p>
<p style="top:668.5pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Vizoso, F. J., Eiro, N., Cid, S., Schneider, J., &amp; Perez-Fernandez, R. (2017). </span></p>
<p style="top:679.0pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Mesenchymal stem cell secretome: Toward cell- free therapeutic </span></p>
<p style="top:689.5pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">strategies in regenerative medicine. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">International Journal of Molecular </span></i></p>
<p style="top:700.0pt;left:318.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Sciences</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">18</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 1852. https://doi.org/10.3390/ijms18091852</span></p>
<p style="top:710.5pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Voss, P., Sauerbier, S., Wiedmann-Al-Ahmad, M., Zizelmann, C., Stricker, </span></p>
<p style="top:721.0pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">A., Schmelzeisen, R., &amp; Gutwald, R. (2010). Bone regeneration in </span></p>
<p style="top:11.6pt;left:578.8pt;line-height:5.1pt"><span style="font-family:Times New Roman,serif;font-size:5.1pt"> 1600051x, 2019, S21, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jcpe.13049 by Universit&#xe4;tsbibliothek Zuerich, Wiley Online Library on [27/12/2022]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</span></p>


<p style="top:23.8pt;left:46.5pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">182&#x2003; </span></b><b><span style="font-family:Lato,serif;font-size:9.1pt">|</span></b><b><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003; &#x2003;&#x2002;</span></b></p>
<img style="position:absolute;transform:matrix(.31940789,0,-0,.3187552,54.97612,3.7443963)" src="data:image/jpeg;base64,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">
<p style="top:23.8pt;left:493.4pt;line-height:7.0pt"><span style="font-family:Lato-Regular,serif;font-size:7.0pt">SHANBHAG </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">et</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt"> </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">Al</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt">.</span></p>
<p style="top:49.0pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">sinus lifts: Comparing tissue- engineered bone and iliac bone. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">British </span></i></p>
<p style="top:59.5pt;left:59.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Journal of Oral and Maxillofacial Surgery</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">48</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 121&#x2013;126. https://doi.</span></p>
<p style="top:70.0pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">org/10.1016/j.bjoms.2009.04.032</span></p>
<p style="top:80.5pt;left:46.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Wang, Y., Chen, X., Cao, W., &amp; Shi, Y. (2014). Plasticity of mesenchy-</span></p>
<p style="top:91.0pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">mal stem cells in immunomodulation: Pathological and therapeu-</span></p>
<p style="top:101.5pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">tic implications. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Nature Immunology</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">15</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 1009&#x2013;1016. https://doi.</span></p>
<p style="top:112.0pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">org/10.1038/ni.3002</span></p>
<p style="top:122.5pt;left:46.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Wildburger, A., Payer, M., Jakse, N., Strunk, D., Etchard-Liechtenstein, N., </span></p>
<p style="top:133.0pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&amp; Sauerbier, S. (2014). Impact of autogenous concentrated bone mar</span><span style="font-family:Lato,serif;font-size:7.5pt">-</span></p>
<p style="top:143.5pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">row aspirate on bone regeneration after sinus floor augmentation </span></p>
<p style="top:154.0pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">with a bovine bone substitute&#x2013;a split- mouth pilot study. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Clinical Oral </span></i></p>
<p style="top:164.5pt;left:59.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Implants Research</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">25</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 1175&#x2013;1181. https://doi.org/10.1111/clr.12228</span></p>
<p style="top:175.0pt;left:46.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Wojtowicz, A., Chaberek, S., Kis&#x142;owska-Syryczy&#x144;ska, M., Urbanowska, </span></p>
<p style="top:185.5pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">E., Wiktor-J&#x119;drzejczak, W., &amp; Ostrowski, K. (2003). Jaw bone aug</span><span style="font-family:Lato,serif;font-size:7.5pt">-</span></p>
<p style="top:196.0pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">mentation using autologous bone marrow hematopoietic stem cells </span></p>
<p style="top:206.5pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">and platelets: Fractal analysis of X- ray. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Post Biol Kom&#xf3;rki</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">30</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(Suppl. </span></p>
<p style="top:217.0pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">21), 115&#x2013;126.</span></p>
<p style="top:227.5pt;left:46.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Wojtowicz, A., Chaberek, S., Urbanowska, E., &amp; Ostrowski, K. (2007). </span></p>
<p style="top:238.0pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Comparison of efficiency of platelet rich plasma, hematopoieic stem </span></p>
<p style="top:248.5pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">cells and bone marrow in augmentation of mandibular bone defects. </span></p>
<p style="top:259.0pt;left:59.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">New York State Dental Journal</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">73</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 41&#x2013;45.</span></p>
<p style="top:269.5pt;left:46.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Wojtowicz, A., Jodko, M., Perek, J., &amp; Popowski, W. (2014). Interactive </span></p>
<p style="top:280.0pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">3D imaging technologies: Application in advanced methods of jaw </span></p>
<p style="top:290.5pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">bone reconstruction using stem cells/pre- osteoblasts in oral surgery. </span></p>
<p style="top:301.0pt;left:59.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Wideochirurgia i Inne Techniki Ma&#x142;oinwazyjne</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">9</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 441&#x2013;448. https://doi.</span></p>
<p style="top:311.5pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">org/10.5114/wiitm.2014.43126</span></p>
<p style="top:322.0pt;left:46.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Wojtowicz, A., Perek, J., Urbanowska, E., Kaminski, A., Olender, E., &amp; </span></p>
<p style="top:332.5pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Jodko, M. (2013). The treatment of maxillary bone defects used </span></p>
<p style="top:343.0pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">autologic pre- osteoblsts on allogenic bone scaffolds. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Dental and </span></i></p>
<p style="top:353.5pt;left:59.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Medical Problems</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">50</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 20&#x2013;29.</span></p>
<p style="top:364.0pt;left:46.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Wolff, J., Sandor, G. K., Miettinen, A., Tuovinen, V. J., Mannerstrom, </span></p>
<p style="top:374.5pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">B., Patrikoski, M., &amp; Miettinen, S. (2013). GMP- level adipose stem </span></p>
<p style="top:385.0pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">cells combined with computer- aided manufacturing to reconstruct </span></p>
<p style="top:395.5pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">mandibular ameloblastoma resection defects: Experience with </span></p>
<p style="top:406.0pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">three cases. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Annals of Maxillofacial Surgery</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">3</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 114&#x2013;125. https://doi.</span></p>
<p style="top:416.5pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">org/10.4103/2231-0746.119216</span></p>
<p style="top:427.0pt;left:46.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Wu, C., Pan, W., Feng, C., Su, Z., Duan, Z., Zheng, Q., &#x2026; Li, C. (2017). </span></p>
<p style="top:437.5pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Grafting materials for alveolar cleft reconstruction: A systematic re-</span></p>
<p style="top:448.0pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">view and best- evidence synthesis. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">International Journal of Oral and </span></i></p>
<p style="top:458.5pt;left:59.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Maxillofacial Surgery</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">47</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 345&#x2013;356.</span></p>
<p style="top:469.0pt;left:46.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yamada, Y., Nakamura, S., Ito, K., Kohgo, T., Hibi, H., Nagasaka, T., </span></p>
<p style="top:479.5pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&amp; Ueda, M. (2008). Injectable tissue- engineered bone using </span></p>
<p style="top:49.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">autogenous bone marrow- derived stromal cells for maxillary sinus </span></p>
<p style="top:59.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">augmentation: Clinical application report from a 2- 6- year follow- up. </span></p>
<p style="top:70.0pt;left:320.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Tissue Engineering Part A</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">14</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 1699&#x2013;1707. https://doi.org/10.1089/</span></p>
<p style="top:80.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">ten.tea.2007.0189</span></p>
<p style="top:91.0pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yamada, Y., Nakamura, S., Ito, K., Umemura, E., Hara, K., Nagasaka, T., </span></p>
<p style="top:101.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2026; Wakabayashi, T. (2013). Injectable bone tissue engineering using </span></p>
<p style="top:112.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">expanded mesenchymal stem cells. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Stem Cells</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">31</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 572&#x2013;580. https://</span></p>
<p style="top:122.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">doi.org/10.1002/stem.1300</span></p>
<p style="top:133.0pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yamada, Y., Nakamura, S., Ueda, M., &amp; Ito, K. (2013). Osteotome tech</span><span style="font-family:Lato,serif;font-size:7.5pt">-</span></p>
<p style="top:143.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">nique with injectable tissue- engineered bone and simultaneous im-</span></p>
<p style="top:154.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">plant placement by cell therapy. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Clinical Oral Implants Research</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">24</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span></p>
<p style="top:164.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">468&#x2013;474. https://doi.org/10.1111/j.1600-0501.2011.02353.x</span></p>
<p style="top:175.0pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yorukoglu, A. C., Kiter, A. E., Akkaya, S., Satiroglu-Tufan, N. L., &amp; Tufan, </span></p>
<p style="top:185.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">A. C. (2017). A concise review on the use of mesenchymal stem cells </span></p>
<p style="top:196.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">in cell sheet- based tissue engineering with special emphasis on bone </span></p>
<p style="top:206.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">tissue regeneration. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Stem Cells International</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">2017</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 2374161. https://</span></p>
<p style="top:217.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">doi.org/10.1155/2017/2374161</span></p>
<p style="top:227.5pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Zakhari, J. S., Zabonick, J., Gettler, B., &amp; Williams, S. K. (2018). Vasculogenic </span></p>
<p style="top:238.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">and angiogenic potential of adipose stromal vascular fraction cell </span></p>
<p style="top:248.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">populations in vitro. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">In Vitro Cellular &amp; Developmental Biology &#x2013; Animal</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span></p>
<p style="top:259.0pt;left:320.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">54</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 32&#x2013;40. https://doi.org/10.1007/s11626-017-0213-7</span></p>
<p style="top:269.5pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Zizelmann, C., Schoen, R., Metzger, M. C., Schmelzeisen, R., Schramm, </span></p>
<p style="top:280.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">A., Dott, B., &#x2026; Gellrich, N. C. (2007). Bone formation after sinus aug-</span></p>
<p style="top:290.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">mentation with engineered bone. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Clinical Oral Implants Research</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">18</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span></p>
<p style="top:301.0pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">69&#x2013;73. https://doi.org/10.1111/j.1600-0501.2006.01295.x</span></p>
<p style="top:333.1pt;left:307.5pt;line-height:8.0pt"><b><span style="font-family:Lato,serif;font-size:8.0pt">SUPPORTING INFORMATION</span></b></p>
<p style="top:352.1pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Additional supporting information may be found online in the </span></p>
<p style="top:365.1pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Supporting Information section at the end of the article.   </span></p>
<p style="top:408.1pt;left:319.5pt;line-height:8.0pt"><b><span style="font-family:Lato,serif;font-size:8.0pt">How to cite this article:</span></b><span style="font-family:Lato,serif;font-size:8.0pt"> Shanbhag S, Suliman S, Pandis N, et al. </span></p>
<p style="top:421.1pt;left:319.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Cell therapy for orofacial bone regeneration: A systematic </span></p>
<p style="top:434.1pt;left:319.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">review and meta- analysis. </span><i><span style="font-family:Lato,serif;font-size:8.0pt">J Clin Periodontol</span></i><span style="font-family:Lato,serif;font-size:8.0pt">. </span></p>
<p style="top:447.1pt;left:319.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">2019;46(Suppl. 21):162&#x2013;182. </span><span style="font-family:Lato,serif;font-size:8.0pt;color:#0000ff">https://doi.org/10.1111/</span></p>
<p style="top:460.1pt;left:319.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt;color:#0000ff">jcpe.13049</span></p>
<p style="top:11.6pt;left:578.8pt;line-height:5.1pt"><span style="font-family:Times New Roman,serif;font-size:5.1pt"> 1600051x, 2019, S21, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jcpe.13049 by Universit&#xe4;tsbibliothek Zuerich, Wiley Online Library on [27/12/2022]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</span></p>

</div>
